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Micron-scale neuroelectronic interfaces have been used as laboratory models in 
neuroscience, prosthetic devices, and components of computational systems. However, 
these devices interact with cells at the whole cell level, and cell signaling occurs through 
interactions with cell surface proteins that average 10 nm in size. To take advantage of 
these receptor-scale interactions additional systems are needed. We have designed and 
optimized one possible system, using semiconductor quantum dots. 
Quantum dots are crystalline particles, typically less than 10 nm in diameter, that 
display many unique optical and electronic properties because of quantum confinement 
of the exciton. As a result, they have been used in a number of optoelectronic and 
biological applications. Our research attempts to combine these functionalities to create 
an optically excited interface capable of electrically communicating with nerve cells. 
To achieve this goal, we manufactured CdS quantum dots using an aqueous 
synthesis. We characterized the effects of altered synthesis conditions on the size and 
quantum yield of the particles, indicators of their electrical properties. We then 
demonstrated three separate methods to produce quantum dot-neuron interfaces. The first 
 vii 
of these utilizes biorecognition molecules, including antibodies and peptides, to create 
controlled interfaces with cell membrane receptors. The second method uses non-specific 
interactions between the particle core and cell membrane surfaces to create diffuse 
binding, and the third technique provides interfacing through direct culture of cells on 
tethered films. Additionally, we present our initial attempts to incorporate these interfaces 
with existing micron-scale measurement technologies, which could be used to confirm 
quantum dot-neuron electrical connectivity. Our results, demonstrate one possible path to 
receptor-scale neuroelectronic interfacing. Ultimately, these devices could be 
incorporated into existing micron-scale systems to provide new classes of prosthetics and 
computational devices. 
 viii 
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Chapter 1: Introduction1 
Nerve cells, or neurons, form the basis of thought and control in the body. 
Additionally, neurons compose a plastic system, capable of processing large amounts of 
information and learning from those results. While signal transmission among these cells 
is generally well understood, their ability to regenerate and form new connections is not. 
These properties have motivated the study of neurons by two diverse communities: the 
medical community and the computational community. 
Neurons have provided fertile ground for study in the medical community 
because deficits in the nervous system are among the most challenging to treat. Damage 
to these cells can result from a variety of congenital conditions (e.g., retinosis 
pigmentosa, epilepsy), neurological diseases (e.g., stroke, Alzheimer’s, Parkinson’s) or 
mechanical injury (e.g., car accidents, gun shot wounds, etc.), leaving the patient with a 
potentially profound loss of function. While peripheral nerves, those located outside the 
brain and spinal cord, have the potential to regenerate, this process can take several 
months and the rate of recovery averages ~ 80%. [1] In the central nervous system (e.g., 
the brain), unaided regeneration does not occur. [2] Thus, there is a need for prosthetic 
devices that can repair or replace nerve function. 
Additionally, neuroscience continues to search for an understanding of the 
physiological mechanism for learning and thought. Neurons process information by 
integrating the response of multiple inputs that differ in location and strength. It is  
believed that learning is mediated by the alteration of these connections, which occurs in 
                                                 
1 Portions of this material have been previously published in the following reference: J.O. Winter and C.E. 
Schmidt. “Biomimetic Strategies and Applications in the Nervous System,” in Biomimetic Materials and 
Design, A.K. Dillow and A.M. Lowman, Eds., Marcel-Dekker, New York: 2002. 
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reaction to repeated electrical or chemical stimuli from neighboring neurons. [3] This 
ability of neurons to process massive amounts of information in parallel, while constantly 
adjusting the strength of their connections, has made the nervous system an attractive 
model for computational devices. [2] These concepts form the basis of neural network 
software programs, which emulate neurons. However, the ability to harness the 
computational power of groups of living neurons is in nascent stages. Systems that allow 




1.1 THE ELECTRICAL BASIS FOR NERVE SIGNAL PROPAGATION 
While neuron cell bodies and their extensions (neurites) are capable of interacting 
with standard electronic devices, neuronal signal propagation is actually ionic in nature. 
[4] Charge is carried by individual metal ions, and not migrating electrons. The nerve cell 
has an exterior membrane, composed of lipids, which serves as an insulator and separates 
these ions. The membrane is permeated with transmembrane proteins, known as ion 
channels, which allow ions to pass under certain conditions (Figure 1). Channels may be 
open constantly, passing ions based on their concentration gradient; or they may open in 
response to a stimulus, such as a voltage change or chemical binding event. 
Figure 1: Transmembrane Channel Proteins in Neurons. 
(A) Resting channel proteins are always open; these channels most commonly pass K+ 
ions. (B) Voltage-gated channels open in response to a membrane potential change. (C) 
Ligand-gated channels open following external neurotransmitter binding. (D) Signal-
gated channels open upon internal signal binding. [Adapted from Figure 21.2, H. Lodish, 
A. Berk, S.L. Zipursky, P. Matsudaira, D. Baltimore, and J.E. Darnell. Molecular Cell 
Biology, 4th ed., W. H. Freeman & Co, New York: 2000.] 
 
These ion channels render the membrane permeable to the sodium (Na+), 
potassium (K+), calcium (Ca2+) and chloride ions (Cl-) that form the basis of signal 
transmission. At rest, the interior of the cell contains an abundance of K+ ions, whereas 
the concentration of Na+ ions greater externally. [5] These concentration gradients 
A
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establish a voltage difference, known as a resting membrane potential, across the cell 
membrane (Figure 2).  
Figure 2: Origin of the Resting 
Membrane Potential.  
Ions are segregated as a result of the 
cell membrane and ion channels, 
which selectively transport certain 
molecules. This creates a voltage 
potential across the membrane. The 
total potential is a combination of the 
values for the three most common 
ions transported by cells: Na+, K+, and 
Cl-. Na+ and Cl- are more preva lent 
outside the cell, while K+ is more 
common inside the cell. The total 






In the standard model of neuronal signaling, propagation begins with the binding 
of a neurotransmitter to a ligand-gated channel (Figure 1c). These channels are primarily 
found on the extracellular surfaces of synaptic neuron extensions, known as dendrites, 
and also on the cell body. Binding produces a conformational change in the channel that 
allows ions to pass. These ions rush into the cell, altering the local membrane potential.  
These synaptic potentials can be either excitatory or inhibitory and decay in intensity 
with increasing distance from the synapse site. The signal is sensed at the cell body and 
its neurite extensions where it is integrated with other inputs. The decision to initiate an 
action potential is made in the axon hillock, which contains a high density of voltage-
 
Cell Interior Cell Exterior
[Na+] = 142 mM[Na+] = 12 mM
[K+] = 4 mM[K+] = 140 mM







sensitive channels that have a lower threshold than those in other parts of the neuron. If 
properly stimulated, these voltage-sensitive channels will open (Figures 1b, 3), causing 
the cell to fire a potential. The potential is carried away from the cell body by a nerve 







Figure 3: Voltage-Gated Ion Channel Structure and Signal Propagation. 
(A) Ion channel at rest. The cell exterior is positively charged, while the interior is 
negatively charged. The ion channel consists of four repeated units containing six 
transmembrane spanning segments. (B) Ion channel at rest, cut-away view. Positively-
charged alpha helices (pink) in the channel subunits are attracted to the negatively-
charged cell interior. The channel deactivating segment (black) is not bound. (C) Ion 
channel after depolarization, cut-away view. After depolarization, the membrane charges 
are inverted. The positively charged alpha helices move toward the exterior of the cell, 
producing a conformational change in the ion channel. This change opens the channel 
pore allowing ions, typically Na+, to pass. (D) Ion channel during the refractory period, 
cut-away view. To prevent continuous ion flow, the channel deactivating segment binds 
to the interior of the pore. [Adapted from Figure 21.13, H. Lodish, A. Berk, S.L. 
Zipursky, P. Matsudaira, D. Baltimore, and J.E. Darnell. Molecular Cell Biology, 4th ed., 
W. H. Freeman & Co, New York: 2000.] 
 
Voltage-sensitive channels produce an influx of Na+ ions, which alter the local 
membrane potential, opening yet more channels along the length of the axon. The signal 
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 6 
normally travels unidirectionally from the cell body to the axon terminal. This occurs 
because ion channels upstream from the signal are temporarily blocked by a globular 
protein shortly after the initial firing event (Figure 3d). At the axon terminal, voltage-
gated Ca2+ channels open in response to the membrane potential change. This influx of 
Ca2+ ions initiates the release of neurotransmitters contained in synaptic vesicles, 
allowing the signal to pass into the synaptic cleft and to a neighboring cell. Thus, nerve 
signals are propagated by a combination of chemical neurotransmitters and electrical 
signals carried by metal ions. [6] 
 
1.2 INTERFACING NEURONS AND ELECTRONICS 
Since the late 1700’s when Luigi Galvani discovered that electricity can cause 
nerves to fire, there has been a desire to manipulate nerves externally. [7] However, it 
was not until the next century that neurons were identified as the individual units of 
charge transmission, and the mechanism of signaling was explored until the 1950’s. [8] 
Stimulation and measurement from individual neurons has proved more difficult than that 
of nerve cables (as per Galvani) because of their small size (e.g., 10 microns in diameter 
versus 1-10 millimeters for a nerve cable). [7] 
The first significant manipulation of individual neurons  occurred with the use of 
microelectrodes, which measured intracellular potentials in the giant squid axon. [8, 9] 
This was followed by the development of the patch-clamp technique by Sakmann and 
Neher in 1976 (Figure 4). [10] This method uses micron-sized (or smaller) capillary 
pipettes filled with electrolytic solution. Pipettes are placed in direct contact with the 
membrane; and, using suction, the membrane is torn away from cell. The membrane 
section is then held at a constant voltage, and the current required for maintaining that 
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voltage is measured. This current corresponds to the  flux of ions that travel through the 
cell membrane in response to externa l stimuli. 
There are multiple variations of this technique (Figure 4), which have proven 
quite useful for discrete investigations. [11] For example, the whole-cell configuration 
(Figure 4B) allows recordings to be collected from intact cell bodies. However, there are 
several limitations to the application of patch-clamp techniques in either a computationa l 
or clinical setting. For example, patch-clamp techniques cannot be used to stimulate a 
particular class of ion channels unless a broad-spectrum pharmacological "cocktail" is 
applied to limit electrical signaling to the ion channel of interest. [12] This restriction 
requires exposure to a variety of neurotoxins, thus this approach is unlikely to be 
implemented for any commercial computational device. Furthermore, patch-clamp is by 
nature an invasive technique. The requirement of direct physical contact between the cell 
and the recording electrode excludes the use of this technique in long-term studies of cell-








Figure 4: The Patch-Clamp Technique.  
A micropipette (white) makes contact with ion channels (blue) in the cell membrane 
(purple). (A) Cell-attached configuration. The micropipette contacts ion channels in an 
intact membrane. (B) Whole-cell configuration. The membrane is broken inside the 
pipette allowing measurement of the entire cell through its intracellular fluid. (C) Inside-
out configuration. A portion of the membrane is torn from the cell surface, allowing 
measurement of a single ion channel from the external side. (D) Outside-out 
configuration. Initially the membrane is torn from the cell surface in the whole cell 
configuration (left). Then, the membrane ends anneal to produce a continuous unit 
(right). This allows measurement of ion channels from the intracellular side. [Adapted 
from Figure I.4.Box A, D. Purves, G.J. Augustine, D. Fitzpatrick, L.C. Katz, A.-S. 
LaMantia, J.O. McNamara, S.M. Williams. Neuroscience, 2nd Ed., Sinauer Associates, 
Sunderland, MA: 2001.] 
 
Thus, the development of neuron-based prosthetic and computational devices did 
not occur until micron-scale, non- invasive components could be manufactured by the 
microprocessor industry. The prototype prosthetic/computational device is based on a 
platform developed in 1979, known as the microelectrode array. [13] The device consists 
of gold conductors photolithographically patterned onto an insulating substrate connected 
to insulated wires that terminate at a bond pad. [13] Electrical signals are isolated by 





bond pad (Figure 5a). The electrode interacts with the cell through induction (Figure 5b) 








Figure 5: Microelectrode Arrays and Cells.  
A) Microelectrode Schematic. A microelectrode interacts with a cell at a de-insulated 
electrode site. The signal is then carried through an insulted wire to a de- insulated bond 
pad. A two-point probe monitors the voltage difference between the medium and the de-
insulated bond pad to determine the voltage change in the cell. A culture chamber isolates 
cell culture medium from the bond pads and external electrical components. B) Cell 
Interactions with the Electrode Surface. Upon firing, the cell experiences a voltage 
change that produces a charge at the membrane surface. The membrane acts as a 
capacitor, and can induce a charge in the electrode, which is then detected at the bond pad 
of the device. 
 
The microelectrode array platform has served as the basis for two clinical devices: 
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twenty years, [15] restores sound perception to profoundly deaf patients by interacting 
directly with existing neural circuitry in the cochlea. The retinal implant, while more 
recent (~ 10 years), restores vision to patients with damaged photoreceptors (i.e., those 
with macular degeneration or retinosis pigmentosa), interfacing instead with bipolar, 
horizontal, amacrine and ganglion cells in the retina. [15] Both devices operate by turning 
an external signal (e.g., sound waves or light) into an electrical signal [16] that is 
transmitted to the remaining functional neurons through the microelectrode array. Other 
types of microelectrode prosthetic devices are being developed to replace spinal cord and 
peripheral nerve function. [17] These devices include perforations that allow the 
electrode array to interface directly with damaged or regenerating fibers. 
Neuron-microelectrode arrays have also been of great interest to the electrical 
device community as a result of the unique way that signals are processed. Calculations 
in traditional digital computing occur in serial, one before the other, while nerves process 
signals in parallel, multiple calculations occurring simultaneously. [18] For example, in 
digital computing, calculation occurs by adding number A to number B to get number C, 
then adding number C to number D to get E and so on. Using this paradigm, internal 
circuit noise is eliminated at each calculation step by conversion of data into a single 
number (i.e. 1 or 0) which is passed to the next stage. However, the decision of a nerve to 
fire is not based on a sequential combination of two numbers, but comes from the 
simultaneous integration of multiple inputs that are either inhibitory or excitatory and 
which vary in magnitude. [18] There is no requirement for noise reduction between 
stages, because there are no stages. Instead, fidelity of the signal is ensured by providing 
a sufficient number of inputs to outnumber the sources of noise. [19]  The result is the 
ability to perform multiple calculations simultaneously with a high signal to noise ratio 
and a dramatically increased speed compared to traditional digital systems. 
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While the promise of neuron-based computational systems is evident, 
development has been slow. Microelectrode arrays can measure and stimulate individual 
neurons, and can even be multiplexed to interact with multiple neurons simultaneously.  
[2] However, systems that allow multiple neurons to interact with the device and each 
other have not proven easy to develop. One of the only examples of this kind of system, 
developed by Peter Fromherz et al. [20], uses a capacitor for stimulation and the gate of a 
field effect transistor for measurement. 
Fromherz employs neurons from the snail, Lymnaea stagnalis, which have the 
atypical ability to form synapses at their cell bodies instead of using axons and dendrites. 
This avoids the potential difficulties of guiding individual neurite extensions to form 
synapses. Additionally, synapsing cells may be hand picked from the culture dish and 
placed directly over the electrical components, eliminating cell adhesion and positioning 
concerns. While this system utilizes an ingenious juxtaposition of biology and 
microelectronic components, it represents a very unique application, one that is not likely 
to achieve commercial success and is not representative of the conditions found in 
mammalian cells. Additionally, it lacks the complexity that derives from large numbers 
of cells. Thus, the majority of computational systems are confined to the investigation of 
single neurons.  
 
1.3 LIMITATIONS OF M ICROELECTRODE ARRAY SYSTEMS  
The greatest challenge for both prosthetic and computational neuron-based 
devices has been the formation of an interface between the cell and electronic features. 
[7] To make contact with an array, cells must be carefully positioned on electrodes. 
Typically, this is accomplished by direct placement of hand-selected cells using 
micropositioners or random cell culture on device surfaces. If the cell migrates away 
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from the contact, the recording or stimulating interface is lost. One method to alleviate 
this difficulty is the incorporation of biorecognition molecules onto the array surface. 
[21] When peptides, such as the laminin fragment YIGSR, are added, cell adhesion is 
greatly enhanced. This technique has been used previously to modify implantable devices 
(i.e., neural probes, electrodes that are inserted directly into the cortex) [22]; however, 
this technology cannot be applied in every case. For example, in the retinal implant, the 
target cells (e.g., bipolar cells) are separated from the electrode surface by layers of 
additional cells and fibrous tissue [15]. Simply coating the electrode with peptides will 
not create interfaces with cells that may be up to 50 µm away. Additional steps must be 
taken to encourage cell growth to the device or bring electrode surfaces into greater 
proximity to the cell. Consequently, cell adhesion and migration remain significant issues 
in the development of neuroelectronic technologies. 
Further, microelectrode arrays present one critical limitation to forming fully 
functional interfaces with neurons. Most microelectrode arrays stimulate neurons at the 
cell body [7], not cell extensions; providing a single, time-dependant signal. However, 
true nerve signals are integrated from multiple dendritic inputs that can vary in strength 
and frequency. At a more detailed level, the propagation of each signal is managed 
through the opening and closing of ion channels embedded in the cell membrane surface. 
It is the manipulation of these channels that would provide a complete ability to interface 
with the cell. Ion channels average 10 nm in diameter [23], an impossible feature size for 
even the most advanced photolithography facility. [24] Although excitation could occur 
through larger interfaces, electrode separation must ideally be sufficient to excite 
individual channels. The spacing between ion channels is approximately 200 nm [25], a 
more manageable size.  However, it is unlikely that a patterned system would produce 
exact alignment between electrodes and ion channels using direct cell placement or 
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random cell culture. Therefore, microelectrode arrays currently can provide only a coarse 
approximation of true neural interfaces. 
To address these limitations, we have developed novel methods for interfacing 
neurons and optically-activated nano-scale electrical components (i.e., quantum dots or 
nanoparticles). The advantage of employing nano-scale components is two-fold. First, 
cell adhesion and migration concerns are eliminated. Particles may be bound to the cell 
itself using biorecognition molecules (e.g., antibodies or peptides) ensuring continuous 
contact. Additionally, cells can be cultured directly on tethered nanocomponents to create 
a useful interface. Optical excitation of the particles removes the need for connections to 
large external electrical components (i.e., bond pads). Thus, cells may be plated randomly 
on a thin layer of particles and a stable interface will still be achieved. The second 
advantage of a nano-scale system is that the electrical components have sizes comparable 
to the ion channels that propagate neuronal signals. Using biorecognition molecules, it 
may be possible to couple these components directly to ion channels, providing 
unprecedented fine control in a neuroelectronic system. We are utilizing 
nanocomponents, known as quantum dots, to create these novel interfaces with neurons.  
 
1.4 DISSERTATION OVERVIEW 
This dissertation is divided into seven chapters. In Chapter 2, the 
nanocomponents utilized in this work (i.e., semiconductor quantum dots) are described. 
Quantum dots are crystalline solids averaging 1-10 nm in diameter. [26] Because of their 
small size, they follow the laws of quantum mechanics (i.e., they exhibit quantum 
confinement) producing several unique optical and electrical properties. These properties 
have generated a great deal of interest in the optics community, and quantum dots have 
been employed in a variety of optoelectronic applications, most notably light emitting 
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diodes and solar cells. [27] Additionally, their unique features have been exploited in a 
limited number of biological applications. Resistance to photobleaching, high quantum 
yields, and narrow bandwidths have made quantum dots ideal fluorescent labels for 
histology and cell staining. [28] Because of their ability to convert optical inputs to heat 
or Raman signals, they have been used in several biosensors platforms [29] and 
therapeutic treatments [30]. This chapter reviews the properties of quantum dots, their use 
in electrical devices, and existing biological applications. Finally, we present our 
proposed interface, which combines electrical and biological functionalities. 
 Chapter 3 discusses two basic methods of nanoparticle synthesis: arrested 
precipitation in aqueous solution [31] and precursor decomposition in organic solution 
[32]. Additionally, our characterization of the aqueous method is given in detail. 
Synthesis conditions are critical to the development of a neuron-quantum dot interface 
because they determine nanoparticle size, which has been linked directly to the optical 
and electrical properties of the crystals. [26] For the aqueous synthesis, alteration of pH,  
ligand length, concentration or charge, and Cd:S ratio all produced changes in 
nanoparticle size, fluorescent emission wavelength, and quantum yield. Most notably, 
optimal quantum yields (~15%) were produced for intermediate particle sizes (~2 nm). 
We discuss possible causes of these variations and their dependences on particle growth 
patterns. From this work, we determined the optimum synthesis conditions and particle 
sizes for our system. 
 In Chapter 4, two methods of attaching nanoparticles to cell surface receptors 
using biorecognition molecules are described. The first method uses antibodies 
conjugated to the quantum dot surface to create interfaces with neurons. Conjugation was 
accomplished by condensing carboxyl groups on the nanoparticle surface with amines in 
the antibody, producing amide bonds. [33] Antibody binding to the particle surface was 
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confirmed through absorbance measurements. Additionally, binding was verified using 
fluorescence microscopy of neurons (i.e., SK-N-SH neuroblastoma cells) labeled with a 
two antibody technique. A primary antibody that recognizes and binds to extracellular 
matrix receptors (i.e., vitronectin receptors) on the cell membrane surface was applied. 
Secondary antibodies that recognize and bind to this primary antibody were linked to 
nanoparticles, as described previously, and the quantum dot–antibody conjugates were 
incubated with the cells. Binding was evidenced only in the presence of both antibodies. 
This system demonstrates the ability to link quantum dots directly to a desired receptor. 
Further, because the secondary antibody attached to the nanoparticle will bind a wide 
class of primary antibodies, the system is easily adapted by simply changing the primary 
antibody to one that targets a different receptor. 
In the second system, peptide molecules were used to mediate attachment of 
nanoparticles to cells. Peptides were incorporated directly onto the quantum dot surface 
using thiol chemistry, and this binding was confirmed through absorbance measurements, 
FTIR spectroscopy, and fluorescence anisotropy. Two  peptides were investigated, 
CGGGRGDS and CDPGYIGSR, both of which adhere to extracellular matrix receptors 
(i.e., fibronectin [34] and laminin [35] receptors, respectively). Interfaces were created by 
exposing neurons to peptide-nanocrystal conjugates and confirmed using fluorescence 
microscopy. Interfaces were only formed in the presence of peptides known to adhere to 
the cell surface. This work demonstrated the ability to attach quantum dots to specific 
receptors on the cell surface. Additionally, since peptides are significantly smaller than 
proteins (e.g., antibodies) [36], the separation distance between the electrical components 
and the receptor targets was greatly reduced.  
Chapter 5 explores the relationships between nanoparticle synthesis conditions 
and material properties, non-specific binding of the cell surface, and cell viability and 
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behavior. We altered the methods developed in Chapter 4 for use with a primary cell line 
(i.e., rat neonatal cortical cells, RNCs). We explored the effect of washing conditions, 
solvent, and quantum dot material on cell viability. We established that primary cells are 
extremely sensitive to environmental conditions, and found that some materials (e.g. 
CdTe) that are compatible with other cell types produce toxicity in these cells. We also 
investigated the effect of different cell compatible buffer systems on the solubility, non-
specific binding, and cytocompatibility of quantum dots. Increasing the number of 
additives (e.g., salt ions or dextrose) in a buffer system reduced particle solubility and 
decreased non-specific binding. This reduction in solubility most likely occurs because 
increased additives can limit the effectiveness of solvating molecules. Also, we examined 
the ability of neurons to take up, or endocytose, nanoparticles. This factor contributes to 
the long-term stability of quantum dot–neuron interfaces. It was determined that particles 
are endocytosed within 30 minutes unless the cells are metabolically suppressed (i.e., by 
exposing them to cold temperatures, ~4 ºC). 
This factor is extremely liming in the development of stable quantum dot-neuron 
interfaces; therefore, we developed two additional binding methods using non-specific 
interactions. First, we utilized non-specific binding to create delocalized labeling of the 
cell surface. We characterized quantum dot affinity for the cell surface as a function of 
synthesis conditions. Quantum dots of increasing size exhibited an increase in binding, 
whereas nanoparticles with the highest quantum yield (~2 nm, as determined in our 
synthesis experiments, Chapter 3) produced the least non-specific binding. As an 
alternative material, we also examined CdTe nanoparticles created using an organic 
synthesis. CdTe produced diffuse non-specific binding on cell surfaces. Increased binding 
appears to result from reduced ligand passivation on the nanocrystal surface. We discuss 
the likely relationship between particle surface coverage, cell viability, and non-specific 
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binding. Next, we investigated endocytosis of non-specifically bound particles. Although 
endocytosis occurred at a lower rate than for recognition molecule binding, particles were 
internalized. Thus, this method is not suitable for long-term neuroelectronic interfacing. 
Finally, we developed an additional interfacing technique using tethered 
nanoparticle films. Although this technique does not produce specific binding to 
receptors, it is likely that uniform films would create some interfaces with ion channels of 
cells cultured on their surfaces. Quantum dots were attached to glass surfaces with 
siloxanes [37] and poly-D-lysine [38] chemistries. Films were analyzed for stability in 
cell culture medium and with cells. Although films displayed excellent compatibility in 
medium, films demonstrated diminished and red-shifted fluorescence in the presence of 
cells. This most likely resulted from Ostwald ripening of the particles, which may have 
been accelerated by oxidizing agents released from the cells. On the other hand, these 
interfaces did not produce endocytosis and represent a viable method for interfacing 
nanoparticles with cell surfaces. From all of these results, we were able to optimize the 
nanoparticle size, buffer system, and binding conditions to produce nanoparticle-cell 
interfaces with good cell viability and a minimum of non-specific binding and 
endocytosis. 
 In Chapter 6, we discuss two measurement systems that could be used to explore 
the influence of excited nanoparticles on the cell membrane potential. We explored 
whole-cell clamping as a system for measuring the neuronal membrane potential. We 
discuss modification of our interface to this measurement technique, and our initial 
results. Creation of an interface with sufficient stability for measurement was extremely 
difficult, and we offer some suggestions for improvement. However, whole-cell clamping 
is an invasive technology that cannot be used to create a long-term device. Therefore, we 
also investigated microelectrode arrays. We demonstrated the ability to create arrays 
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using electron beam lithography, which can produce feature sizes compatible with ion 
channels. [24] Additionally, we demonstrated that the resist layer (i.e., poly (methyl 
methacrylate)) can be used as an insulating layer, eliminating a manufacturing step, and 
that this resist layer supports cell adhesion and growth. From this work, we identified two 
possible measurement systems for exploring the neuron-quantum dot interface and 
discuss implementation of each system. 
 In Chapter 7 our results are summarized, conclusions presented, and 
recommendations for future work are made.  
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Chapter 2: Quantum Dots and Their Applications 
Quantum dots, also known as semiconductor nanoparticles, have generated a great 
deal of interest as a result of their small sizes (i.e., ~1-10 nm [1]) and unique optical and 
electrical properties. These properties, resulting from quantum confinement, include 
electron transfer, strong dipole moments, and size-tunable absorbance and fluorescent 
emission. [1] Although still in nascent stages, the applications of these materials have 
been widespread. Quantum dots have been integrated into a number of electrical devices, 
including LEDs, solar cells, and lasers, [2] and also show great potential in the biological 
sciences. [3] They exhibit size scales comparable to or smaller than the fundamental 
components of living systems. For example, the diameter of DNA is ~2 nm, a cell surface 
receptor is ~10 nm, and a virus is ~50 nm. [4] The ability to manufacture electronic 
materials with these biologically compatible feature sizes allows for the development of 
new sensing technologies, treatments, and therapeutics. Already, quantum dots have been 
utilized as fluorescent dyes for cell labeling [5-6], biosensors for chromosomal mapping 
[7], and chemotherapy alternatives [8]. With continued improvement of quantum dot 
coatings to enhance biocompatibility, in vivo applications are just on the horizon. 
Because of their small size and demonstrated success in electronic and biological 
systems, quantum dots provide a model material for the creation of nano-scale  
neuroelectronic interfaces. 
In this chapter, the properties and applications of nanoparticles are reviewed. 
First, the motivation for the development of nano-scale bio-electronic systems is 
considered. Then, a brief description and history of the nanocomponents used in our 
work, semiconductor quantum dots, are supplied. Next, we examine the impact of size on 
material attributes. The requirements for quantum confinement, as well as the changes in 
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the energy band structures, are discussed. These are related to the resulting electrical and 
optical phenomena, and contrasted with the properties of bulk materials. Additionally, we 
discuss applications of nanoparticles in both electrical and biological contexts. Finally, 
we present our proposed system, and the mechanism of its interaction with the cell 
surface. 
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2.1 NANOCOMPONENTS AND NANOPARTICLES  
To produce electronic interfaces with individual cell receptors it is necessary to 
employ components at the nanometer length scale. Most existing devices are based on the 
microelectrode array platform, which includes micron-sized (~10 µm [9]) components. 
These devices are manufactured using photolithography techniques, and the current 
length scale limitation of this technology is ~90 nm. [10] Electrodes of this size are still 
almost an order of magnitude larger than the average ion channel (~10 nm [11]). 
Alternative patterning technologies, such as electron beam lithography (EBL), can 
produce electrodes of the correct dimension (e.g., as small as 10 nm). [12] However, EBL 
is a time consuming process, and is not well adapted to mass production. Furthermore, 
any patterned structure will have to address the difficulty of forming controlled interfaces 
between migrating cells and fixed electrode surfaces. [9] The number of electrodes 
required to ensure an interface through random cell placement could be quite large, and 
each would have to be individually addressed to a much larger electrical contact. For 
these reasons, optically addressable nanoparticles pose an attractive alternative to 
patterned electrode systems. 
Nanoparticles have many advantages over patterned devices. They are typically 
produced in solution and can be directly linked to cellular components. [5] They can also 
be absorbed or tethered to a substrate, forming thin films. [13] Additionally, 
nanoparticles can be manipulated non- invasively to produce photocurrent, photo- induced 
electric fields, or electro- luminescence. [2] All of these factors eliminate the need for 
fixed wires and contacts, rendering cell adhesion and migration minor concerns. For our 
experiments, we chose to examine the ability of a particular class of nanoparticle, 
semiconductor quantum dots, to form neuroelectronic interfaces.  
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Quantum dots are crystalline solids that typically average less than 10 nm in 
diameter. [1] Because of their small size, the particles exhibit quantum confinement; 
giving them several unique optical and electronic features (see Section 2.2 for more 
details). They display many attributes indicative of quantum mechanical principles, as 
opposed to bulk materials, which follow traditional Newtonian laws. Quantum dots can 
be made from a variety of materials including metals and semiconductors. [14] For our 
experiments, we examined two materials from the semiconductor class: Cadmium Sulfide 
(CdS) and Cadmium Telluride (CdTe). These were selected because of their documented 
electrical and optical properties. [1] Additionally, both materials can be excited optically 
in the UV or visible range of wavelengths, allowing for visualization of the cell interface 
using fluorescence microscopy. 
 
2.2 OPTICAL AND ELECTRONIC PROPERTIES OF QUANTUM DOTS 
2.2.1 A Brief History 
Quantum dots were initially discovered in 1981, during the development of 
materials for the photo-cleavage of water. [15] Bulk cadmium sulfide is known to be an 
ideal electrode material; however it experiences photocorrosion upon irradiation. It was 
believed that colloidal particles of cadmium sulfide, coated with a protective agent (i.e., 
RuO2), would be more resistant to corrosion. Therefore, a synthesis method was 
developed to produce colloidal CdS through aqueous precipitation. The resulting particles 
displayed unique properties not found in the bulk, including fluorescent emission. These 
properties were determined to be the result of quantum size effects, [16] and were found 
to be tunable by altering the size of the particle. [17-18] This provided a method for 
selecting excitation and emission wavelengths, and particle band gaps. 
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2.2.2 Quantum Confinement and Size Effects 
Quantum effects occur in colloidal nanoparticles for a number of reasons. Small 
particles can experience quantum confinement of the excited state. In bulk semiconductor 
materials, an excited electron leaves behind a positive charge in the crystal lattice, known 
as a hole. The excited electron, now in the conduction band, can be coupled with the hole 
in the valence band through Coulombic attractions (e.g., electrostatic attraction) to create 
an exciton, an electron-hole pair that are bound together (Figure 6A). In quantum 
mechanics, the positions of electrons and holes are described as wavefunctions, or 
probability distributions. The exciton has a certain size, determined by the combined 
probability distribution functions, and if this size exceeds the particle diameter, quantum 
confinement occurs (Figure 6B).  
Figure 6: Exciton 










(A) An excited electron in the conduction band is coupled to a vacancy (hole) in the 
valence band creating an exciton. (B) If the electron probability distribution of the 
exciton exceeds the nanoparticle diameter, then quantum confinement will result. The 
exciton probability distribution is forced to remain within the confines of the 
nanoparticle. 
 
The size limit for quantum confinement is given by the diameter of the bulk Bohr 













Nanoparticle Diameter  
 27 
can be approximated from a modified version of the De Broglie wavelength equation for 
a free electron (Equation 1), [21-22]   
   
 [Equation 1] 
          
where h is Planck’s constant, and m and v are the mass and velocity of the excited 
electron, respectively. Modification of this equation is required because bulk 
semiconductor materials do not contain truly free electrons; charge screening effects of 
neighboring atoms in the crystal lattice must be taken into account. This is accomplished 
by noting the symmetry of each lattice position. If we assume an infinite system, each 
position is equivalent. We can model a single position by utilizing the equations for free 
electron systems, but approximating the mass of an electron with me, the effective mass,  
which includes the averaged effects of attraction, repulsion, and shielding from 
neighboring atoms. [22] 
Nanocrystals contain many fewer atoms than found in the bulk, and as atoms are 
removed, charge screening effects are reduced. The effective mass declines, and the De 
Broglie wavelength can become uncharacteristically large, up to several nanometers. For 
cadmium sulfide and cadmium telluride, the materials we examined; these wavelengths 
are 5.5 [16] and 7.5 [23] nm, respectively. For particles that exhibit sizes smaller than this 
wavelength, the exciton “feels” restricted. Thus, the nanocrystal will display a band gap 
and associated optical and electrical features proportional to its size. 
 An additional feature of shrinking nanoparticle diameter is the formation of 
discrete bands within the potential energy diagram of the particle (Figure 7). Bulk 
semiconductor materials are characterized by bands of allowed potential energy values. 




h ==λ Broglie De
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electrons in the excited state may occupy any state in the conduction band (Figure 7A). 
The region between the two bands is forbidden. For an electron to be excited, it must 
absorb at least enough energy to be carried from the highest energy state in the valence 
band to the lowest energy state in the conduction band. Energies below this minimum 
value (i.e., the band gap) will not produce an excited state. However, a continuum of 
values greater than the band gap will produce an excited state. [24] 
When we examine a system consisting of only two atoms, the molecular orbitals 
formed create discrete potential energy states (Figure 7B). Electrons will only be excited 
if energy is absorbed in discrete quantities. Other values are not permitted and will not 
produce excited states. [25] Quantum dots occupy the interval between discrete and 
continuous energy levels (Figure 7C). [1] As the number of atoms in the particle is 
reduced, the potential energy bands split and shrink, eventually collapsing to the discrete 
values of the atomic state. Thus, electrons in quantum dots may be excited by energies in 
discrete intervals, rather than a continuum. 
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Figure 7: Potential Energy States and Particle Size.  
 
(A) Bulk materials have continuous energy bands, and absorb energy at a value greater 
than the band gap. (B) Molecular materials possess discrete energy levels and only absorb 
energy with certain values. Additionally, the band gap is greater than that of a bulk 
material as a result of shrinking and splitting of the energy bands. (C) Quantum dots lie 
between the extremes (A, B). They possess discrete energy bands and absorb energy in 
discrete intervals. The band gap is greater than that of a bulk material, but less than that 
of a molecular material. 
 
2.2.3 Electrical Properties Resulting from Quantum Confinement 
For bulk semiconductors, the band gap of a uniform material is fixed. However 
for quantum dot systems, splitting and shrinking of the bands produces an increase in 
band gap with decreasing particle size, approaching the value for an atomic system. Thus, 
gap energies are size dependant, and electrical properties that depend on this difference 
will display size dependence as well. One such property is electron transfer. [26] 
Electrons with no additional energy added prefer to move to lower energy states within a 
given material. Because there are no energy states in the band gap, the electron will decay 
until it reaches the lowest state in the conduction band, and then return to the valence 
band through another mechanism (i.e., electron-hole recombination, non-radiative energy 






























loss, etc.). [27] However, if the electron encounters a material with lower available 
energy states (i.e., values within the band gap); it can transfer its electron to that material 
(Figure 8). This process is dependant upon the band gap. As the band gap increases, 
excited electrons occupy higher energy levels, and can decay to a greater number of 
lower state values. As a result of size-tunable band gaps within the particle, electron 
transfer can be optimized to many materials. 
Figure 8: Electron Transfer and Band Gap 
Energy. 
If an excited electron in one material (A) 
encounters a second material (B) with a lower 





Another property resulting from small nanocrystal sizes is the presence of large 
excited state dipole moments. When an electron in a quantum dot is excited, the 
probability functions of both the electron and the hole are altered. [28] One possibility is 
the formation of a state where the wavefunctions of the electron and hole are concentric 
(Figure 9A). [29] This would result in radial symmetry producing a net dipole moment of 
0 Debye. However, it is also possible for the electron to get trapped at the particle surface 
(Figure 9B). This usually occurs as a result of defects in the crystal lattice (e.g., 
interstitial atoms, adsorbed species, dopants, etc.). Electron trapping results in a fixed 
charge separation, producing a dipole moment dependant on the size of the crystal (e.g., 
192 Debye for 4 nm CdSe [29]). Cadmium-based nanocrystals exhibit a mixing of these 
two states, with dipole moments of more modest, but still quite large values (~ 30 Debye 
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in electronic applications because each dipole moment has an associated electric field that 
can be used to influence ions outside of the particle (see Section 2.5). 
Figure 9: Formation of a Dipole Moment in the 





(A) Excited state exciton wavefunction for a perfect nanocrystal. (B) Excited state 
exciton wavefunction with a surface-trapped electron. Surface-trapping results in charge 
separation, producing a transient dipole moment. 
 
2.2.4 Optical Properties Resulting from Quantum Confinement 
Additionally, quantum confinement affects the optical properties of nanoparticles. 
The electrical and optical energies of the band gap are equivalent through the following 
conversion: [31] 
[Equation 2]  
 
where E is the band gap energy difference, h = Planck’s constant, ν = the frequency of 
the incident light, c = the speed of light, and λ = the wavelength of incident light. Thus, 
the energy difference of the band gap is inversely proportional to the wave length of 
incident light. Nanoparticles will only absorb light of wavelengths shorter than that 
determined by the band gap value. For example, CdS (bulk) has a band gap of 2.42 eV, 
which corresponds to a wavelength of 512 nm. [15] CdS begins to adsorb light at 512 nm 
and absorbs continuously into the UV (e.g., shorter wavelengths). As particle size 
declines, the band gap increases, and the absorbance onset shifts to shorter wavelengths 










Figure 10: Band Gap 











The band gap (eV) increases with decreasing nanoparticle size. Band gap is inversely 
related to absorbance onset (λ) through the relationship E=hc/λ. Therefore, smaller 
particles begin to absorb at shorter wavelengths. [32] 
 
The influence of particle size on optical properties is not limited to absorbance. 
Particle fluorescence is also a function of the band gap. After an electron is excited, some 
of its energy is lost to atomic vibrations, satisfying the second law of thermodynamics. 
Typically, this energy is converted to heat. When the electron decays into the ground 
state, it will emit light, or fluoresce, at a longer wavelength because of this energy loss 
(Figure 11A). [33] As the band gap decreases, a smaller amount of energy is dissipated 
through fluorescent emission to return to the ground state, and the wavelength of emitted 
light will shift to the red (Figure 11B). Because band gap is inversely proportional to 
nanocrystal size, large r nanocrystals display red-shifted emission. Additionally, the 
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Figure 11: Fluorescent 
Emission and Particle 
Band Gap.  
(A) Photon absorption 
creates an excited 
electron. This electron 
loses some energy to heat; 
then decays to ground, 
emitting a photon. The 
emitted photon has a 
longer wavelength than 
the absorbed photon 
because of the energy lost 
to heat. (B) As the band 
gap (e.g., ∆E) decreases, 
the particle will absorb at 
longer wavelengths. This 
will produce a 







Finally, nanoparticles can exhibit a unique type of fluorescent emission resulting 
from the trapping of an electron at the crystal surface. [34] When a defect is introduced 
into the crystal, it can introduce a potential energy state in the forbidden zone (Figure 12). 
Electrons that enter into this state will become trapped (Figure 9), as photonic emission 
from this level is forbidden by classical physics. However, quantum mechanics allows for 
emission from this state, albeit at a low probability, and the electron can eventually decay 
to the ground state through this mechanism. Because of this delay, the lifetime of an 
excited electron in a trapped state is significantly longer than that of an electron in an 
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between the absorbance wavelength and the emitted wavelength will be larger as a result 
of the energy lost in decaying to the trapped state. 











(A) After absorption of a photon at the band gap energy/wavelength, an excited electron 
loses some energy to vibration and recombines with the hole, emitting a photon at a 
slightly longer wavelength. (B) In a system with a trap, the electron first decays into the 
trap, and then recombines with the hole producing a photon at a longer wavelength than 
in (A). 
 
2.3 APPLICATIONS OF QUANTUM DOTS IN ELECTRONIC DEVICES  
Exceptional optical properties make quantum dots attractive components for 
integration into devices. One significant asset of quantum dots over traditional 
optoelectronic materials is that they exist in the solid state. Solids tend to be more 
compact, easily cooled, and allow for direct charge injection. [35] Additionally, quantum 
dots can interconvert light and electricity in a tunable manner dependant on crystal size, 
allowing for facile wavelength selection. This is a significant improvement over silicon-
based materials, which require modification of their chemical composition (i.e., doping) 
to alter optical properties. [35] Thus, researchers have experimented with quantum dots in 
lasers, LEDs, and photovoltaics. Most of these applications are still in early development; 
however, the benefits of quantum dot components are evident. Our proposed 
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neuroelectronic interface also converts optical energy into an electrical signal; thus, a 
study of these applications provides successful models for the development of our 
system. 
 
2.3.1 Quantum Dot Lasers  
The primary employment of quantum dots in optoelectronic devices has been for 
the development of lasers. [35] Lasers operate through stimulated light emission; as 
opposed to the spontaneous light emission discussed earlier (see Section 2.2.4). 
Spontaneous emission occurs when an electron decays from an excited state to the 
ground state, releasing a photon. However, if an excited electron is bombarded with a 
photon of the same wavelength as that emitted spontaneously, it may be encouraged to 
decay to the ground state and release a second photon (Figure 13A). Thus, one photon 
interacting with an electron can produce two photons of emitted light. Additionally, these 
two photons will be coherent (i.e., possess the same wavelength and phase) as a result of 
their interaction. Lasing occurs when these emitted photons can bombard other excited 
state electrons to produce a sustained chain reaction and amplification of coherent 
emitted light through stimulated emission. [36] 
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Figure 13: Spontaneous versus 
Stimulated Emission.  
(A) Spontaneous fluorescent emission 
occurs when an electron is excited from 
ground to valence and then decays 
spontaneously back to ground (left). 
Stimulated emission occurs when a 
previously excited electron absorbs a 
photon with the same energy. The 
electron decays, releasing two coherent 
photons with the same wavelength 
(right). (B) Bulk materials can absorb at 
multiple wavelengths, making it 
difficult to place electrons at the same 
energy level. (C) Quantum dots have 
narrower energy bands; therefore, it is 





In order for lasing to occur, there must be more electrons in the excited state than 
in the ground, and they must all occupy the same excited state. Otherwise different 
wavelengths of light will be required to stimulate electrons in each energy level (Figure 
13B), and lasing will be difficult to maintain. The main advantage of quantum dot lasers 
is that they posses fewer energy states than bulk materials, reducing the “spread” of 
electrons (Figure 13C). [2] It is thus much easier to create lasing. Additionally, quantum 
dots can be tuned to a specific emission wavelength by altering the size of the particle, 
and can be operated within a narrow excitation wavelength range. [35] All of these 































2.3.2 Quantum Dot Light Emitting Diodes 
A second optoelectronic device that utilizes quantum dots is the light emitting 
diode (LED). A diode is a material that contains positive charges on one side, and 
negative charges on the other. Under forward bias (voltage), the positive and negative 
charges meet in the center of the material, annihilating each other and producing emitted 
light. LEDs are important components used in many technologies, including display 
elements in cell phones and laptop computers. Currently, these devices are composed of 
microfabricated semiconductor materials that emit a fixed light wavelength based on their 
chemical composition. Quantum dots provide a novel alternative to these materials 
because emission wavelengths can be selected simply by changing the size of the particle. 
Additionally, because of their small size, quantum dots can easily be encapsulated into 
conducting organic polymers, allowing for the development of flexible displays. [37] 
These two advantages will allow for quantum dot LEDs to be utilized in many additional 
technologies. One exciting prospect is the replacement of incandescent lights with paper 
thin materials that could produce illumination at a variety of wavelengths and could be 
molded into any shape. [37] 
 
2.3.3 Quantum Dot Photovoltaics 
A third use of quantum dots in electronics is for the creation of advanced 
photovoltaics, or solar cells. Solar cells convert absorbed light energy into electrical 
current. Electrons in the material are excited by light absorption, which in turn produces a 
current that can be conducted away from the device. [2] The primary difficulty with 
photovoltaic devices is the efficient conversion of light to energy. Light with a 
wavelength below the value of the band gap will not be adsorbed, and is not converted to 
energy. Further, any electron excited with a photon greater than the band gap value, will 
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dissipate the extra energy as heat. Only the portion of energy corresponding to the band 
gap will produce a current. The advantage of quantum dot photovoltaics is that multiple 
particles can be incorporated into a single solar cell, and each particle can have a different 
band gap. [2] Thus, a solar cell can be constructed that is responsive to the entire 
spectrum of emitted solar light. 
 
2.3.4 Summary of Quantum Dot Electronic Devices 
The advantages of quantum dots in optoelectronic devices are significant. Their 
size-tunable emission wavelengths, continuous adsorption, and small sizes have already 
provided impetus for the development of lasers, LEDs, and solar cells. As improvements 
continue to be made in quantum dot synthesis and crystal structure, the optical properties 
of nanoparticles are enhanced. Thus, quantum dots increasingly become a viable and 
preferable alternative to microfabricated semiconductor materials. All of these 
applications establish the utility of quantum dots to interconvert light and energy, and 
pave the way for the development of future applications, including optically excited 
quantum dot-neuroelectronic devices.  
 
2.4 APPLICATIONS OF QUANTUM DOTS IN BIOLOGY 
Nanoparticles have also been explored in a number of biological uses. The first 
demonstration of their utility in a biological context occurred in 1998 by A.P. Alivisatos, 
et al. [5] and S. Nie, et al. [6] Both groups employed CdSe/ZnS quantum dots as 
fluorescent labels. Coupling the quantum dots directly to biorecognition molecules (e.g., 
antibodies, proteins), the particles could be targeted to particular parts of the cell, 
producing a fluorescent indicator. Fluorescent labeling is an important tool in biology 
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that is used to track the positions of entire cells, intracellular structures, and disease 
markers in tissue specimens. This application has become the primary biological use for 
quantum dots because of their advantageous optical characteristics.  
Quantum dots offer several enhancements over the organic fluorescent dyes that 
are typically used for biological labeling. Organic dyes can exhibit a low quantum yield, 
or brightness, because of molecular interactions with themselves, each other, and the 
solvent. Quantum dots are also susceptible to these limitations, but the particles may be 
passivated with protective insulating materials to produce quantum yields that are > 50%. 
[38] Another limitation of organic dyes is the loss of fluorescence that occurs when dye 
molecules react irreversibly with each other or the solvent, producing a non-fluorescent 
product. This process, known as photobleaching, can occur in aqueous solution on the 
order of minutes. [6] However, photobleaching in quantum dots is diminished, as the 
same passivating layer that enhances quantum yield also protects particles from external 
interactions. Most notably, passivation reduces photooxidation of the particle core, which 
can produce free ions (e.g., Cd2+ in our case) and eventually particle dissolution. [39] As 
a result of reduced photobleaching, quantum dots can exhibit continuous fluorescence for 
a time period an order of magnitude greater than organic fluorescent dyes. [6] 
Also, organic fluorescent dyes typically exhibit fixed, narrow excitation spectra. 
Fluorescent excitation spectra reflect absorbance spectra; and as discussed earlier, 
quantum dot absorbance is continuous after the size-tunable onset. Thus, quantum dots 
may be excited in a range of wavelengths selected by their size. Additionally, the 
emission bandwidth (e.g., wavelength range of emitted light) for nanoparticles can be 
particularly narrow (~20-30 nm) when compared with organic dyes (> 40 nm, often with 
a tail into red wavelengths). [5] This results from the shrinking and splitting of potential 
energy bands as particle size decreases (Figure 7). Photon emission can only occur from 
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an allowed energy state in the conduction band to an allowed energy state in the valence 
band. As the width of these bands decreases, the number of acceptable energy transitions 
declines and the range of emitted wavelengths are diminished. All of these properties 
have led to quantum dot applications in diverse biological fields, including biosensing, 
cellular labeling, and in vivo fluorescent detection and therapeutics. 
 
2.4.1 Quantum Dots Biosensors  
Biosensors detect molecules of biological significance through an optical or 
electrical signal produced upon analyte recognition. Although their initial use was 
primarily for disease detection and monitoring, there has been a recent resurgence in the 
detection of bio-warfare agents; and a great deal of federal funding has been directed to 
this purpose. [40] Most biosensors operate on the principle of molecular recognition. 
Antibodies, peptides, proteins, and DNA sequences all bind tightly to their target 
biomolecules with high specificity. [41] Dyes can be coupled to these recognition 
molecules to produce a fluorescent event when binding occurs. Quantum dot biosensors 
offer many benefits to those based on dye molecules. The surface of quantum dots can be 
easily altered, providing a facile route for conjugation to recognition molecules. [1] 
Additionally, their small size allows for incorporation into existing electronic devices. 
Several types of biosensors have been studied, but the most common utilize fluorescence 




2.4.1.1 FRET-Based Biosensors 
The simplest method for detection using fluorescent molecules is a system that 
produces an on or off signal upon binding. This can be accomplished using FRET. First, 
an electron in a fluorescent molecule is excited. Then, instead of decaying through 
photon emission, the energy in that electron is dissipated by transfer to a second 
molecule. This quenches the fluorescence of the first molecule. FRET is a distance 
dependant event. As the FRET donor and acceptor move away from each other, transfer 
no longer occurs and fluorescence in the donor is restored. [42] If a conformational 
change can be introduced upon analyte binding that separates the two molecules, a 
fluorescent on/off signal can be produced.  
This has been accomplished in a number of systems.  A combination of gold 
quantum dots (which do not fluoresce) and organic fluorophores have been utilized to 
create DNA sensors. [43] Gold quantum dots were bound to single stranded DNA 
sequences, which were terminated with fluorescent molecules, or fluorophores. The 
fluorophores formed an arched structure that interacted with the nanoparticle surface, 
quenching fluorescence (Figure 14). However, when the complement DNA was 
introduced, binding occurred and the conformation changed. The fluorophore migrated 
away from the quantum dot surface and its fluorescence was restored. This technique is 
very accurate, the mismatch of a single base pair in a 30 amino acid DNA sequence could 
be detected. [43] 
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Figure 14: Detection of DNA 







(A) Fluorophore-conjugated single stranded DNA is bound to a quantum dot, forming an 
arched structure with the nanoparticle surface. Fluorophore fluorescence is quenched 
through FRET with the nanoparticle. (B) When the complement DNA is added, the DNA 
structure changes, moving the fluorophore away from the nanoparticle and restoring 
fluorescence. 
 
A second, similar system utilized fluorescent CdSe/ZnS quantum dots to detect 
sugar binding. [44] The initial configuration contained cyclodextrin molecules conjugated 
to a non-fluorescent FRET acceptor. The cyclodextrin adhered to maltose (i.e., sugar) 
binding protein, which was present on the quantum dot surface. FRET between the 
nanoparticle and the acceptor molecule quenched quantum dot fluorescence. However, 
when maltose was introduced, the cyclodextrin was displaced, restoring fluorescence to 
the quantum dot. Although maltose sensing was demonstrated, these sensors could 
eventually be adapted to detect glucose, a crucial molecule to monitor in the management 
of diabetes. 
Finally, systems need not be hybrids, incorporating nanoparticles and fluorescent 
dyes; homogeneous systems have also been constructed. [45] Two types of CdTe 
quantum dots were bound to model proteins. Red-emitting quantum dots were conjugated 
to bovine serum albumin (BSA), while green-emitting quantum dots were conjugated to 
an antibody that binds BSA (i.e., anti-BSA). When the two quantum dots were incubated 
together, the green fluorescence was quenched, as excited electrons transferred their 












energy transferred from the green-emitting quantum dots was dissipated through the red-
emitting quantum dot.  
FRET-based quantum dot biosensors are elegant, and in theory can provide 
analyte detection of as few as 10 parts per trillion. [45] Additionally, the signal is easy to 
interpret: fluorescence indicates the presence of an analyte. FRET-based biosensors can 
also provide quantitative information, as fluorescent intensity can be correlated to the 
number of molecule binding events. Although FRET systems could be constructed 
entirely from fluorescent dye molecules, quantum dots provide an excellent alternative. 
They display high quantum yield; and their acceptor energy and emission wavelengths 
can be tailored by changing the size of the particle.  
 
2.4.1.2 Aggregation-Based Biosensors 
Another type of biosensor constructed using quantum dots is based on particle 
aggregation. Many biomolecules possess recognition sites for different binding targets. 
These biomolecules can be used to link quantum dots together. If one population of 
nanoparticles is conjugated to target A, and another to target B, when a biomolecule 
recognizing A and B is introduced, aggregation of the particles will result. Depending on 
the type of quantum dot, this can produce increased fluorescence or a change in color. 
CdSe/ZnS quantum dots have been used to identify DNA molecules with this technique. 
[46] Two types of 15 amino acid single stranded DNA were conjugated to the 
nanoparticle surface. When 30-amino acid DNA complementary to both sequences was 
introduced, aggregation of the nanoparticles occurred. This change could be easily 
visualized with a fluorescence microscope. A second system is based on gold quantum 
dots, which do not fluoresce, but change visible color upon aggregation. [47] Again two 
types of single stranded DNA were conjugated to nanoparticles. When the complement 
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was introduced, the color of the nanocrystal solution changed from red to blue as a result 
of particle aggregation.  
While these systems are functional, they are not as elegant as FRET-based 
biosensors. They require a greater quantity of analyte to produce detection, and the signal 
is not quantitative. However, they may offer improvements to biosensors constructed 
using fluorescent dyes because the nanocrystal surface chemistry can be easily altered, 
[1] aiding in bioconjugation. Quantum dot biosensors are still in early development, but 
already present a viable alternative to dye-based systems. With their unique optical 
properties, there is no doubt that they will continue to be utilized in these devices. 
 
2.4.2 Quantum Dot Fluorescent Labels for Cells 
The most prevalent biological use of quantum dots has been fluorescent labeling 
of cells. In this function, quantum dots are not only superior to fluorescent dyes, but have 
also extended the potential applications of fluorescent labels in biological systems. For 
example, they have been used to investigate the motion of biomolecules, detect cell 
phenotype, and study cell migration. In each of these uses, they present several 
enhancements over systems employing fluorescent dyes. Most importantly, their small 
size and high resistance to photobleaching have allowed quantum dots to be used in a 
number of high throughput systems with real- time monitoring, [48] a difficult feat with 
dye molecules. 
One new use of quantum dot labels has been the detection of single molecules 
within the cellular environment. Normally, single molecule tracking is accomplished 
using fluorescent beads (e.g., rhodamine on polystyrene) that can have sizes from tens of 
nanometers to a micron. [49] However, these beads cannot be used in all situations; in 
some cases, they cannot penetrate the confined spaces to be monitored. With their small 
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size, quantum dots can be employed to track and study the motion of molecules in these 
locations. For example, quantum dots have been used to investigate the movement of 
neurotransmitter receptors in the synaptic cleft. Researchers were able to study the 
diffusion dynamics of glycine receptors over several minutes, an achievement that would 
have been nearly impossible using fluorescent beads. [49] This technique has also been 
used to detect transferrin uptake, the transport of charged dye molecules, and 
oligonucleotide motion. [50] Thus, quantum dots have been shown to provide real-time 
monitoring of biomolecules in living cells. This approach can provide new insights into 
cell function and promote novel methods of disease treatment. 
 Another unique use of quantum dots is for the identification of particular cell 
types in a mixed population. This is critical for cancer detection, as well as drug 
screening. [48] Commonly, cells are distinguished by observation of phenotype or by 
fluorescently tagging uniquely expressed bio-markers. However, the implementation of 
these techniques has been difficult in practice. Phenotype distinction requires detailed 
inspection of individual cells and is difficult to automate, limiting its use in high-
throughput applications. On the other hand, fluorescent molecules must possess a wide 
range of distinct emission wavelengths to label all of the desired cell types in a 
population. The emission wavelengths of organic dyes are difficult to modify because 
they are determined by the composition of the material. Additionally, dyes can have large 
emission bandwidths, creating difficulty in distinguishing individual colors. Quantum 
dots, with their narrow emission bandwidths and size tunable fluorescence are ideal 
labels for cell detection. Multi-plexed imaging of cells has been demonstrated for up to 5 
different cell types, and could in theory be expanded to detect over 100 distinct types of 
cells. [48] This system was also used to provide monitoring in real time, with the 
simultaneous observation of calcium levels in three different cell types. High-throughput 
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identification of individual cells in a heterogeneous environment will improve cancer 
diagnosis, whereas real-time monitoring of biomolecule expression in different 
populations could provide new insights into drug metabolism and function. 
A final, notable use of quantum dots as cellular labels is in the study of cell 
motion. The detection of increased migration is important, especially when estimating the 
metastatic potential of cancer cells. Migrating cells can ingest molecules as they move 
over them, leaving behind a path known as a phagokinetic track. [51] In the past, 
phagokinetic tracks have been monitored using gold particles with diameters from 
microns to several hundred nanometers. However, these particles do not adhere well to 
the substrate, and their large size can perturb cell mobility. Because of their high 
resistance to photobleaching, quantum dots are the first fluorescent labels that have 
demonstrated the potential for detection of phagokinetic tracts. Additionally, they can be 
easily placed on the substrate and have sizes unlikely to affect cell mobility. In early 
experiments, quantum dots were able to distinguish between cancerous and non-
cancerous cells and remained luminescent for over one week. [51] 
The unique optical properties of quantum dots have not only produced superior 
fluorescent labels, but also have expanded the use of labeling technologies into new 
fields. To capitalize on the success of quantum dot labeling, two commercial companies, 
Quantum Dot Corporation (Hayward, CA) and Evident Technologies (Troy, NY), have 
both begun to produce nanoparticle–bioconjugates, making this techno logy easily 
accessible to biologists. With continuing improvements in biocompatibility and stability, 
quantum dot labels will continue to find use in new applications. 
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2.4.3 In Vivo Applications of Quantum Dot Labels 
The most exciting possibility for quantum dot labels has been their use in vivo. 
This is no small task. The penetration of excitation and emission light can be difficult in 
vivo, as tissue is transparent to light only in a limited spectral range, mostly at longer, 
infrared wavelengths. [52] Additionally, the metabolism and biocompatibility of 
nanocrystals in vivo have proven to be much more complicated than in single cells. The 
majority of nanoparticles used in biological applications have been based on a Cd–X 
structure, where X = tellurium, sulfur, or selenium. Cadmium is known to interfere with 
DNA mismatch repair [53], can inhibit certain types of neuronal firing [54], and is a 
known carcinogen [55]. Therefore, toxicity of the particles has been a major concern. 
Surface passivation can significantly reduce the risk of exposure to free cadmium, [56] 
and although the long-term effects of nanoparticle exposure have not yet been 
investigated; short-term in vivo studies do not demonstrate any acute effects.  [8, 57-62] 
Quantum dots have been utilized in a number of in vivo procedures that would not be 
possible with organic fluorescent dyes. Many of these take advantage of the longevity of 
their fluorescence, as a result of resistance to photobleaching; [57-60] while others 
exploit their electrical properties to deliver therapeutic treatment. [8, 61-62] 
One novel use of quantum dots in vivo has been to monitor embryogenesis. [57] 
When quantum dots were injected into frog (i.e., Xenopus) embryos, they were 
transferred from parent to daughter cells upon cell division. The particles maintained 
their fluorescence over many cell division cycles and did not appear to be toxic. They 
were used to track the movement of different structures in the embryonic frog, as the 
embryo matured to a tadpole. The use of fluorescent dyes in this system would have been 
very demanding because of high levels of photobleaching. Thus, the utilization of 
quantum dots presented a significant advance that allowed for long-term monitoring of 
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embryonic growth. Ultimately, this technique will allow developmental biologists to form 
a better understanding of growth in the early embryo and thus elucidate the nature of 
specific birth defects.  
Another use of quantum dots in vivo has been to image structures within the body. 
Currently, vasculature is visualized using fluorescent dextrans. Some of the most 
challenging regions to image with these molecules are skin and adipose (i.e., fat) tissue 
because of their high degree of light scattering. Using quantum dots in living mice, 
researchers were able to visualize capillaries several hundred micrometers below the 
surface of the skin. [58] Producing the same image with dextran dyes required five times 
as much power and was much less detailed. With their narrow bandwidths and high 
quantum yields, nanoparticles provide improved imaging capabilities to dextran dyes. 
Thus, quantum dots have been shown to present viable alternatives to current clinical 
practice. 
Quantum dots have also been used to track the in vivo motion of biomolecules and 
cellular structures over time. [59] Fluorescent dyes, with their high susceptibility to 
photo-bleaching, are difficult to use in this context. However, nanoparticles can be used 
to monitor the motion of proteins, peptides, antibodies, or therapeutic agents in real time. 
[59] For example, when quantum dots were conjugated to peptides that bound the lung 
and tumor vasculature, they could be visualized in vivo. [60] Eventually, these techniques 
could be used to improve drug delivery and understand biomolecule circulation in the 
body. 
Finally, quantum dots have been evidenced in limited therapeutic contexts. 
Quantum dots can be used to image and even penetrate cancer cells, through receptor-
mediated endocytosis. [62] Particles can be coupled to therapeutic agents, which are 
activated in the presence of light excitation. Gold nanoshells conjugated to recognition 
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molecules can be used to image tumors. [8] When they are optically excited they produce 
heat. Depending on the size of the nanoshell, heat production can be significant enough to 
kill the attached cells. Additional systems are envisioned that could release therapeutic 
agents, including chemotherapy drugs, upon light activation. [61] By only targeting the 
cells of interest, systems for localized drug delivery could significantly reduce the toxic 
effects of chemotherapy. These ideas take advantage of the combined electrical and 
optical properties of quantum dots, and serve as models toward the development of other 
combined optoelectronic systems, including neuroelectronic interfaces. 
 
2.4.4 Summary of Quantum Dot Biological Applications  
With their high quantum yields, resistance to photobleaching, narrow bandwidths, 
and size-tunable spectra, quantum dots have significant advantages over fluorescent dyes. 
This has made fluorescent labeling the primary application of quantum dots in biology. In 
this context, they have been demonstrated as biosensors, fluorescent labels for cells and 
tissue, and even as in vivo therapeutic agents. Many of these applications are not possible 
with fluorescent dyes. For example, quantum dots have been used for high-throughput 
and long-term imaging, techniques that are difficult to implement with fluorescent dyes. 
Additionally, combined systems that utilize both electrical and optical properties have 
been developed. These systems provide models for future development of 
neuroelectronic interfaces. As improvements in biocompatibility and optical properties 
continue to be made, quantum dots will find even more uses in biology. 
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2.5 PROPOSED QUANTUM DOT-NEURONAL RECEPTOR INTERFACE 
Our proposed system combines aspects of quantum dot optoelectronic devices and 
biological uses to create the first system capable of producing electrical interactions with 
cells. Specifically, we anticipate that electrical signals from the nanoparticle can 
modulate the behavior of neuronal voltage-gated ion channels. These channels are the 
primary mechanism of signal propagation in a neuron. They consist of four  repeated 
subunits containing six transmembrane spanning regions. These transmembrane regions 
include positively-charged alpha helices that are normally attracted to the negatively-
charged interior of the cell, producing a closed pore (Figure 15A). However, when the 
membrane experiences a localized change in voltage (Chapter 1, Section 1.1), the alpha 
helices move toward the exterior cell surface, opening the pore (Figure 15B). [63] 
Quantum dots could potentially be used to produce these local changes in membrane 
potential. 
Figure 15: Voltage-







(A) At rest, the positively charged alpha helices of the ion channel are attracted to the cell 
interior, closing the channel pore. (B) When a localized membrane depolarization occurs, 
the alpha helices move to the exterior cell surface, opening the pore and allowing ions to 
pass. 
 
There are several possible mechanisms for quantum dot electrical interaction with 
ion channels. For example, electron transfer has already been demonstrated between 
quantum dots and methylviologen [64-65], a biomolecule. However, we believe that the 
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which is a result of the optically-created transient dipole moment (Section 2.2.3). [28] If 
this electric field is strong enough, an induction response may elicit changes in the local 
cell potential (Figure 16). Previous groups have used induction to stimulate neurons and 
to measure existing signals, leading to microarray devices that communicate with the cell. 
[66] 
Figure 16: Nanoparticle Dipole Moment and Ion Channel 
Activation.  
The dipole moment of an optically excited nanoparticle 
(black) produces an electric field (arrows). That field may 
be strong enough to attract alpha helices in the ion channel 
(pink) to the membrane surface, opening the ion channel 
pore. This allows Na+ ions to enter the cell (green), 






Nanoparticle dipole moments result from charge separation between the electron 
and hole in the exciton (Section 2.2.3). This occurs primarily because of electron trapping 
at the nanoparticle surface. These dipole moments create an electric field and associated 
potential.[28] A simplistic view allows us to approximate the dipole as a point source 
(Figure 17A). The voltage between it and any given point is supplied by the following 
equation: [67] 
 
















where k is (4πεo)-1 = 8.98 x 109 N-m2/C2, p is the dipole moment in C-m (1 Debye = 
3.336 x 10-30 C-m), and r and θ are the distance and angle between the center of the 
dipole and the point of interest.  
However, this equation assumes that the separation of charges in the dipole (d) is 
much less than the distance of the dipole to the point of interest (r). This is not rigorously 
correct for our interface. The separation of charges in the dipole is approximately the 
diameter of the nanoparticle (i.e., 1-5 nm), while the ion channel may be as close as a few 
nanometers. Thus, a more appropriate means to determine the dipole voltage field treats 
each charge as a point source. With this method, the voltage between the dipole and point 




where k is (4πεo)-1 = 8.98 x 109 N-m2/C2, q is the charge of an electron = 1.602 x 10-19 C, 
and r+ and r- are the distances between the point of interest and the positive and negative 
charges of the dipole, respectively (Figure 17B). If we examine a point directly opposite 
one of the charged poles, this equation reduces to: 
 
[Equation 5]  
 
where k is (4πεo)-1 = 8.98 x 109 N-m2/C2, p is the dipole moment  in C-m (1 Debye = 
3.336 x 10-30 C-m), r is the separation distance from the center of the dipole to the point 































Figure 17: Calculating the Electrical Potential of a Dipole Moment. 
(A) If r >> d, the dipole is approximated as a point source. (B) If r ~ d, then we must 
represent each pole as a point source. 
 
Using this equation, we estimated the potential created by dipole moments from 
20-40 Debye at various separation distances. These dipole strengths represent similar 
magnitudes to published values (i.e., ~30 Debye [29]). Our calculations (Figure 18) 
showed that voltage potentials capable of stimulating ion channels (i.e., > 15 mV [6]) 
could be obtained for separation distances of ~ 10 nm or less, and measurable potentials 
(i.e. > ~ 5 mV) were produced at separation distances of ~ 15 nm or less. Many linker 
molecules (e.g., antibodies or peptides) can produce separation distances of this 




















Figure 18: Electric Dipole Potential. 
The potential of an electric dipole moment is plotted for values of ∆ = 20, ◊ = 30, and o 
= 40 Debye and nanoparticle sizes of 2 (dashed) and 5 (solid) nm. Higher dipole 
moments and smaller nanoparticle sizes produce a stronger potential. A potential of 15 
mV (bold line) is required to activate an ion channel. 
 
However, these results apply to interactions taking place in deionized water. 
Biological systems require a particular osmotic pressure, provided by ~150 mM saline 
[70], for survival. The addition of salt ions can produce a screening effect (Figure 19) that 
reduces the electric field strength of the dipole. This screening is described by the Debye 
Length, which is the distance required for the potential intensity to drop by a value of e. 











































EXPV pole  
 
where k is (4πεo)-1 = 8.98 x 109 N-m2/C2, p is the dipole moment  in C-m (1 Debye = 
3.336 x 10-30 C-m), r is the separation distance from the center of the dipole to the point 
of interest, rpole is the separation distance from the closest pole to the point of interest, and 
d is the separation of the positive and negative dipole charges. 
 
Figure 19: Charge Screening and the Nanoparticle Dipole 
Moment.  
The addition of normal saline (~150 mM), which is 
required for cell survival, produces a layer of salt ions 
between the dipole and the cell surface. This ion layer 
reduces the electric field of the dipole moment, decreasing 






When we include the effects of charge screening, the minimum separation 
distance required to create an action potential declines significantly (Figure 20). 
Distances of less than ~2 nm can theoretically produce an action potential, and distances 
of less than ~2.5 nm can create a measurable voltage change in the membrane. This 
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separation can be achieved with certain linker molecules (i.e., peptides [69]), but is 
difficult to produce. However, there are several mitigating factors that are not considered 
in this approximation. For example, we are estimating the field for one nanocrystal, but it 
is highly probably that multiple nanoparticles will be bound to a single ion channel. 
Depending on nanoparticle alignment, the collective dipole could be many times that of a 
single nanocrystal. Additionally, the cell membrane is not a static surface; it is a capacitor 
that separates internal negative charge from external positive charge (Figure 20). [73] 
These charges would be influenced by the presence of the dipole and could augment the 
potential. When we include these factors, it is quite possible that nanoparticles produce 
dipole moments of sufficient intensity to modulate neuronal ion channels. Through 
optimization of the most important limitations: the strength of the dipole moment, the 
size of the nanocrystal and its separation distance from the ion channel, we believe that a 





Figure 20: Electric Dipole Potential with Charge Screening. 
The potential of a screened electric dipole moment in normal saline (~150 mM) is plotted 
for values of ∆ = 20, ◊ = 30, and o = 40 Debye and nanoparticle sizes of 2 (dashed) and 
5 (solid) nanometers. A potential of 15 mV (bold line) is required to activate an ion 
channel.  
 
2.6 CONCLUSIONS  
Quantum dots, or nanocrystals, have many unique properties that result from their 
small size. The properties occur because of quantum confinement in the nanocrystal, 
which leads to a reduction in the density of potential energy states and a size-tunable 
band gap. Electrical and optical properties that result from these features include electron 




















wavelengths smaller than a size-tunable onset, size tunable emission wavelengths, and 
trapped-state emission. The combination of these properties has led to numerous 
applications in optoelectronics. Quantum dot lasers, light emitting diodes, and 
photovoltaics have all been investigated. However, the influence of quantum dots has not 
been limited to engineering; several significant biological technologies have been 
developed. Biosensing, monitoring of live cells, and in vivo imaging have all been 
demonstrated. These techniques rely upon the use of quantum dots primarily as 
fluorescent labels.  
Our interface would combine these two functionalities to create electrical systems 
that could modulate biological entities. Particularly, stimulation of neuronal ion channels 
could be provoked with the electric field produced by an optically excited nanoparticle. 
Our application represents the first system that combines these electrical and biological 
features. Future directions will likely lead to a greater integration of these two 
phenomena to create new classes of biological optoelectronic devices possessing the 
capability to interact with cells at increasingly smaller length scales. 
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Chapter 3: Quantum Dot Synthesis and Analysis2 
This chapter discusses selection criteria and synthesis methods for nanoparticles 
employed in the neuroelectronic interface. The motivation for our choice of cadmium–X 
quantum dots, where X = sulfur or tellurium, is presented. Next, we discuss synthesis 
methods for these particles: organic phase precursor decomposition and aqueous arrested 
precipitation. The advantages of each technique are discussed, and in particular, those 
factors impacting the development of the neuroelectronic interface.  
Then, we present our optimization and characterization of the aqueous method 
utilized in our work: arrested precipitation of CdCl2 and Na2S in the presence of a 
thiolated passivating ligand. We investigated this system thoroughly, studying the effects 
of the reactant ratios and concentrations; ligand concentration, length and charge; and 
reaction pH on the optical properties of the quantum dots produced. Altering each of 
these variables produced changes in the absorbance onset wavelength, which has been 
linked to nanocrystal size, and particle quantum yield. Most notably, we discovered that 
particles with intermediate sizes have the highest quantum yield (~15%). As quantum 
yield and particle size determine the conversion efficiency of optical input to electrical 
output, [1] they are critical variables in the development of neuroelectronic interfaces. 
                                                 
2 Portions of this material have been submitted for publication to Journal of Colloids and Surfaces A. 
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3.1 MATERIALS SELECTION 
The selection of a specific material for any quantum dot application is crucial, as 
it determines the optical and electrical properties of the particle. [2] Our system requires 
high quantum yields and resistance to photobleaching, along with biocompatibility. High 
quantum yields (i.e., conversion of absorbed photons into emitted photons) are important 
because they are related to the number of particles in the excited dipole state. [3] Hence, a 
high percentage of the particles will be available to interact with the nerve membrane. 
Photobleaching not only reduces our ability to detect particles from their fluorescent 
signal, but can quench the dipole state entirely.  [2] Therefore, resistance to 
photobleaching is a critical component of a long-term neuroelectronic interface. Finally, 
particles must be water-soluble and non-toxic to living neurons. 
The majority of previous biological systems have utilized cadmium-based 
nanoparticles. Most commonly cadmium selenide (CdSe) has been explored, although 
cadmium sulfide (CdS) and cadmium telluride (CdTe) have also been studied. [4] 
Cadmium-based particles are a good selection for biological systems because their 
excitation and emission wavelengths lie in the UV-visible region of the spectrum. This is 
the area typically employed for organic fluorescent dyes; therefore, most biological 
equipment (i.e., fluorescence microscopes, microplate readers, etc.) operates in this 
wavelength range. [For further discussion of cadmium toxicity see Chapter 5, Section 
5.1.2] Although metallic particles (i.e., gold and silver) have been used for a limited 
number of applications (e.g., biosensing, in vivo therapeutics); they do not fluoresce and 
produce undesirable quantities of heat. [5] Therefore, they are not suited to the 
development of neuroelectronic interfaces. Thus, to create a system that could be readily 
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reproduced in biological laboratories, we selected two types of cadmium-based particles 
for analysis: CdS and CdTe particles.  
 
3.2 PARTICLE SYNTHESES  
In addition to selecting a particle material, the method of synthesis is of great 
importance. Synthesis techniques for quantum dots have advanced significantly since 
their  discovery in the early 1980’s. [6] Methods have shifted from arrested precipitation 
in aqueous solution to precursor decomposition in organic solution. [7] The majority of 
changes were instituted in order to improve nanoparticle quantum yield, resistance to 
photobleaching, and size distribution. Nanoparticles synthesized with current techniques 
can exhibit quantum yields >50%, [8] fluorescence that can last for hours under 
continuous excitation, [9] and size distributions as narrow as 5%. [7] 
These improvements arose largely from the introduction of a new synthesis 
method: precursor decomposition at high temperature. [7] Prior to this time, nanoparticles 
were produced primarily at room temperature, a condition that does not permit adequate 
annealing of defects on the nanoparticle surface. Defects are undesirable because they 
can serve as traps for excited electrons, increasing the probability of electron decay 
through vibration, as opposed to fluorescent emission. The introduction of high 
temperatures not only addressed this problem, but also allowed for controlled 
nanoparticle growth and nucleation, thus limiting the size distribution. All of these 
improvements provide desirable increases in quantum yield and photostability.  
However, these particles are produced in organic solvents that are not compatible 
with biological systems. Thus, additional steps are required to confer water-solubility. 
This can be accomplished by altering the surface chemistry of the nanoparticle, either 
through exchanging the capping ligand or by coating the particle with a water-soluble 
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shell. These techniques have both been used to create particles that have been 
demonstrated in biological labeling. [9-10] However, the process for transferring particles 
into water can be time-consuming and requires equipment outside the reach of most 
biological laboratories.  
 
3.2.1 Organic Synthesis Methods for Cadmium–Based Quantum Dots 
3.2.1.1 Synthesis with Dimethyl Cadmium in Trioctylphosphine 
The organic syntheses currently used for cadmium-based nanoparticle production 
are primarily based on a technique, pioneered by Murray, et al., [7] which produces 
trioctylphosphine oxide (TOPO)–capped CdSe nanoparticles. Briefly, dimethyl cadmium 
and selenium shot are each placed in a solution of trioctylphosphine (TOP) in a glove 
box. [A variation of this procedure uses tributylphosphine (TBP) instead of TOP. [11]] 
Next, a solution TOPO is degassed at 200ºC under vacuum for 20 minutes, melting the 
TOPO and removing oxygen. Then, the solution temperature is raised to 300ºC under 
argon. When temperature has been reached, the cadmium and selenium solutions are 
combined into one syringe, quickly removed from the glove box, and injected into the hot 
TOPO solution. The temperature declines to ~180ºC upon injection, but is gradually 
raised to 230-260ºC.  
 Particle size is controlled largely through the final temperature, with higher 
temperatures leading to larger particles. Additionally, TOPO molecules coordinate with 
the surface of the nanoparticle limiting its growth. Depending on the reaction time and 
final temperature, particles from 1-11 nm may be produced. [7] Optical characteristics are 
favorable, with excitation wavelengths tunable across the visible spectra (i.e., from 400-
700 nm) and emission wavelengths that are red-shifted ~10 nm from excitation.  [7] The 
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small magnitude of the shift between emission and excitation wavelengths indicates that 
emission does not occur from deep surface trap states, and that the crystal contains few 
electronic defects. The quantum yield of these particles is ~10%. [7]  
 These traits make CdSe quantum dots that are produced using this method 
appealing choices for the development of neuroelectronic interfaces. However, there are 
several difficulties to their direct use. First, particles are produced in TOP and are TOPO-
capped. They are soluble in chloroform and other organic solvents, but not in alcohols or 
aqueous solution.  [7] Further, TOPO is a weakly bound ligand and can disassociate from 
the particle over time, and TOPO is toxic to cells. [12] The loss of ligand coverage can 
expose the core of the particle to oxidative attack, limiting quantum yield and producing 
photobleaching. [13] Further, the synthesis requires the use of a glove box and Schlenk 
line, not common equipment in biological laboratories, and exposure to extremely toxic 
chemicals that can be explosive (i.e., dimethyl cadmium and TOPO).  
 
3.2.1.2 Synthesis with Cadmium Oxide in Trioctylphosphine and Tetradecylphosphonic 
Acid 
 A common variation of the standard method, developed by Peng, et al., [14] 
replaces dimethyl cadmium with cadmium oxide (CdO) as a precursor. Additionally, 
TOPO ligands are augmented with tetradecylphosphonic acid (TDPA) or 
hexylphosphonic acid (HPA); both of which bind strongly to the cadmium core. Briefly, 
CdO, TOPO, and either TDPA or HPA are heated above 60ºC (the melting point of 
TOPO). Additionally, selenium shot is placed in TOP and heated above 150ºC (to 
produce dissolution). The TOPO solution is degassed for several hours. Next, the 
temperature of the CdO solution is raised to 340ºC. Then, the temperature of both 
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solutions is lowered:  to 300ºC for CdO and to 120ºC for Se. Finally, the Se is injected 
into the hot CdO solution, producing nanoparticles.  
 These variations reduce exposure to toxic agents and produce high quality 
particles. [14] CdO is much less toxic than dimethyl cadmium and does not require the 
use of a glove box. Additionally, the optical properties of the previous synthesis are 
improved or retained. Emission wavelengths are minimally shifted from absorption, 
indicating a high quality crystal surface, and quantum yield is improved to as much as 
20%. [14] However, a Schlenk line is required for particle production; and although 
reaction temperatures are reduced, they are > 200ºC. Particles are not soluble in water 
and partially capped with TOPO. Thus, despite the reduced toxicity of this method, it is 
still not ideal for use in creating neuroelectronic interfaces. 
 
3.2.1.3 Core-Shell Syntheses 
The particles made from the organic syntheses described above are often modified 
with a shell of a wider band gap material (i.e., more insulating material). This change 
protects the particle core from photooxidation and surface reactions and further confines 
the exciton. Additionally, a shell can be used to confine potentially toxic cadmium ions 
on the surface of the particle to the interior. The majority of the particles used in 
biological applications contain a shell, with the most common material being zinc sulfide 
(ZnS). [4] ZnS is an ideal shell material as it is substantially less toxic than cadmium, 
possesses a larger band gap than CdSe, and does not easily form alloys with CdSe. [8, 13] 
The production of core-shell particles is based in large part on the standard 
organic methods. [8] Solutions of dimethyl cadmium and selenium shot are prepared in 
TOP, as described before. However, dimethyl zinc is also prepared, along with bis 
(trimethylsilyl) sulfide (a sulfur source), in a separate TOP solution. [Alternatively 
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diethyl zinc has also been used as a zinc source. [15]] Particles are produced as described 
previously, except that injection occurs at 350ºC, instead of 300ºC. The temperature after 
Cd/Se injection is allowed to decline to 300ºC, at which time the Zn/S solution is injected 
in 5 aliquots over 20 s intervals. The injection of small aliquots over time allows the 
temperature to be held fairly constant during this period. The ratio of Zn solution to Cd 
solution is ~1:4. 
 Core-shell particles offer many benefits over those produced with standard 
organic methods. The quantum yield is substantially increased, from 20% for CdSe to 
50% for CdSe/ZnS. [8] Additionally, CdSe normally presents a tail in the emission band 
toward red wavelengths, but this tail is eliminated with capped particles. Otherwise, 
particles exhibit spectra that would be expected from uncapped CdSe, indicating that the 
core is largely unaffected by the presence of the ZnS shell, which averages less than a 
nanometer in thickness. Instead, improvements in quantum yield and bandwidth likely 
result from the reduction of surface traps in the CdSe core. Further, the presence of a 
shell protects the core particle from photooxidation and reduces the likelihood of 
cadmium dissolution at the particle surface. Thus, CdSe/ZnS capped particles are stable 
for months, even in the presence of oxygen and are less toxic than uncapped particles.  
[13]  
Nonetheless, core-shell particles are still not ideal for neuroelectronic interfaces. 
The final product contains TOPO ligands on the surface, which are insoluble in water and 
toxic. Additionally, the chemistry involved can be complex and requires equipment that 
is outside the reach of most biological laboratories. However, the most important 
limitation to the use of core-shell particles in neuroelectronic interfaces is the effect of the 
shell on the particle dipole moment. Unless the shell is epitaxially aligned with the core, 
it would not participate fully in the formation of a dipole moment. [16] Thus, it would 
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have some insulating properties. With a Debye length of ~1 nm, [17] even a thin shell 
could significantly reduce electrical interactions with the neuron. Although core-shell 
particles may make excellent biological labels, they are not ideal for systems requiring 
electrical interactions. 
 
3.2.2 Water-Soluble Particles Produced Using an Organic Synthesis 
Organic particles have many advantages to their use in biological applications, 
and in particular neuroelectronic interfaces. They possess high quantum yields and good 
resistance to photobleaching. [8] Both of these qualities present the potential for a high 
conversion of optical energy into an electrical signal, a requirement for optically 
activated neuroelectronic devices. The main limitation of organic particles is their lack of 
water solubility. Several techniques have been offered to confer water solubility, but all 
rely on modification of the nanoparticle surface. This can be accomplished by altering the 
nature of the passivating ligands or augmenting the crystal with a shell material that is 
biocompatible.  
 
3.2.2.1 Ligand Exchange 
The most common method for producing water-soluble particles using an organic 
synthesis includes an additional post-processing step known as ligand exchange. During 
ligand exchange, the existing chemical surface coating of the particle is replaced with one 
that can alter the solubility of the colloid. [18] There are a number of variations in the 
ligand exchange technique; however the basic premise remains the same. First, particles 
are dried to remove unreacted ligand and the organic solvent. This can be accomplished 
using either a rotary evaporator or precipitation in a counter-solvent. In the case of 
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TOPO-capped particles, the addition of anhydrous methanol will cause flocculation of the 
particles; and centrifugation can be used for separation.  [7] Next, the particles are 
introduced into a solution containing a gross excess of the new ligand. After an 
incubation of several hours, exchange occurs. Exchange can be confirmed by altered 
solubility of the particles, or through analytical techniques like FTIR (Fourier Transfer 
Infrared Spectroscopy) and XPS (X-ray Photoelectron Spectroscopy).  
The most common ligand exchange used to produce biologically compatible 
quantum dots exchanges TOPO, bound to CdSe/ZnS core-shell particles, for 
mercaptoacetic acid (MAA=HS-CH2-COOH). [9, 18] The binding of MAA occurs 
through the sulfur group at the molecule’s terminus, which adheres to Zn atoms on the 
ZnS coating.  [18] The carboxyl end of MAA provides water solubility. In addition to 
MAA, a number of other thiolated chemicals have been examined, including 
mercaptopropionic acid (MPA= HS-(CH2)2-COOH), mercaptoethylamine (MEA, HS-
(CH2)2-NH2), and β-mercaptoethanol (MBE, HS-CH2-CHOH). In fact, any molecule 
which binds to the surface of the particle and is water-soluble can be used, thus allowing 
for a range of surface chemistries that can be explored.  
This technique allows researchers to use high-quality particles produced with an 
organic synthesis in a biological context, and addresses many of the limitations of an 
organic process alone. However, there are still some disadvantages. For example, the 
initial synthesis of CdSe/ZnS particles requires access to a Schlenk line and possibly a 
glove box. Exposure to toxic and potentially explosive chemicals still occurs. 
Additionally, ligand exchange is a long, multi-step process spanning as many as three 
days. The particles are only stable for 1-3 weeks; [18] indicating possible loss of ligand 
coverage over time. If the ligands are toxic (i.e., MBE [19]) or bioactive (MEA [20]), 
desorption can have deleterious effects on the cells in contact with the particles. Despite 
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these concerns, this technique could be used to produce particles for a neuroelectronic 
interface. Nonetheless, there are other techniques that can be used to make particles more 
quickly, and that are more accessible to a biological audience.  
 
3.2.2.2 Additional Surface Coatings 
Another method to create water-soluble nanoparticles alters the surface by 
applying a biocompatible shell material. An example of this technique, developed by 
Alivisatos, et al., [10, 21] coats TOPO-capped CdSe/ZnS particles with silica, although 
any TOPO-capped particle could be used. The particles are created using the standard 
method. Then, they are precipitated in anhydrous methanol, dried, and re-dissolved in 
mercaptopropyltris(methyloxy)silane (MPS) to which tetramethylammonium hydroxide 
(TMAH) has been added. The pH of the mixture is altered to pH 10 and the entire 
contents are placed under nitrogen at 60ºC. Additional MPS and TMAH are added, along 
with (trihydroxysilyl)propyl methylphosphonate (to provide stability in water) and the 
cycle is repeated. The silanization reaction is quenched using chlorotrimethylsilane. 
Finally, the solution is stirred under nitrogen for several days, and filtered using a 
combination of rotary evaporation, dialysis, and centrifugation.  
Silica-coated particles meet several of the criteria for biological applications. For 
example, the advantageous optical properties of the particle core remain largely 
unchanged. Despite a silica shell averaging 2-5 nm in thickness, emission wavelengths 
are similar to uncoated CdSe/ZnS. [21] Quantum yields average 5-20%, and are 60-80% 
of the original values. [10, 21] Unlike particles that undergo ligand exchange, silica 
coated nanocrystals exhibit stability for months, with little loss of quantum yield. [10, 21] 
Additionally, biomolecules can be readily conjugated to silica using well-established 
techniques developed for chromatography. However, despite all of these advantages, 
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these particles are not ideally suited for neuroelectronic interfaces. Silica shells are 
insulating and increase the separation distance of the cell and the particle by several 
nanometers. Given a Debye length of ~1 nm, [17] this can reduce electronic interactions 
significantly. Thus, additional strategies must be pursued. 
 
3.2.3 Aqueous Synthesis Methods for Cadmium–Based Quantum Dots 
 An obvious route to water-soluble nanocrystals is their production in aqueous 
solvents. Nanocrystal synthesis in water occurs through a process known as arrested 
precipitation. For example, the solubility constant of CdS in water is ~10-29, [22] 
indicating that the bulk material is relatively insoluble. If a water-soluble thiol is added to 
the reaction mixture, some cadmium ions complex with this chemical. As crystal growth 
occurs, it is hindered by the steric presence of the thiol compounds. Eventually, free 
sulfur anions cannot overcome the steric forces of the thiol and particle growth is 
terminated. If the surface is well passivated with water-soluble thiol ligands, the crystals 
can remain suspended in water. This process is controlled by many factors, including the 
reactant ratios, the thiolated ligand in question, and the pH of the reacting mixture; all of 
which contribute to nanoparticle size and uniformity. [23] 
Aqueous syntheses are very flexible. A variety of materials can be used as 
reactants. The first CdS nanocrystals were produced using Cd(SO4) as a cadmium source 
[6], although Cd(ClO 4)2 [24] and CdCl2 [23] have also been used. Sulfur can be 
introduced through a variety of mechanisms, and (NH4)2S [6], Na2S [24], and H2S [25] 
have all been investigated. Thiolated ligands investigated range widely, including MAA, 
MPA, MEA, and MBE. [23, 26-27] Although thiolated ligands are used most commonly, 
any ligand that binds to Cd2+ ions and promotes water solubility of the particle may be 
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employed. Initially, polymers, such as maleic hydride/styrene, [6] silicon dioxide sol, [24]  
and polyphosphate, [25] served this purpose. 
Nanoparticles produced using aqueous syntheses offer many benefits for 
biological studies. For example, they have the unique ability of being manufactured using 
simple bench-top chemistry, requiring only a fume hood. These requirements can be 
easily met by most biological laboratories. Additionally, particle surfaces may be readily 
altered through the use of thiolated biomolecules, or by performing post-synthetic 
conjugation chemistry on a ligand functional group. The main limitations of this 
procedure are the reduced optical properties and large particle size distribution. Particle 
quantum yields average only ~10-15%, [28-29] and the majority of emission occurs 
through trapped states, meaning that the emission bandwidth can be very large. [30] The 
size distribution is an issue because it can increase with time, developing a tail at larger 
sizes, indicating particle instability. [31] This is likely a result of Ostwald ripening, the 
growth of larger particles at the expense of the thermodynamically less stable smaller 
ones. [27] However, we have observed that only solutions of larger particles exhibit this 
behavior; solutions containing smaller particles (i.e., ~3 nm and less) can be stable in 
aqueous solution for months. Thus, the particles can exhibit remarkable stability, 
comparable only to silica-capped CdSe/ZnS. [10, 21] Although these factors could be 
limiting for other technologies, particles created through aqueous methods are suitable for 
use in neuroelectronic interfaces. 
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 3.3 SYNTHESIS SELECTION AND CHARACTERIZATION 
3.3.1 Synthesis Selection 
Direct aqueous-phase synthesis of semiconductor nanocrystals with a high 
photoluminescence (PL) quantum yield provides a convenient, economic, and 
environmentally friendly alternative to the labor- intensive method of organic-phase 
synthesis followed by ligand exchange CdS nanocrystals, created using arrested 
precipitation in aqueous media, represent one such system with properties suitable for 
neuroelectronic interfaces. They can be manufactured quickly, using readily available 
laboratory equipment, and with minimal exposure to toxic chemicals. Additionally, CdS 
nanocrystals can be both fabricated and functionalized with biomolecules in a single 
synthetic step. 
 Although there are some limitations in their optical properties, these are not 
problematic for their use in neuroelectronic interfaces. For example, it is true that 
quantum yields are substantially lower than those for core-shell systems (e.g., CdSe/ ZnS: 
quantum yields ~50% [8]); however, core-shell particles are not ideal for this application 
as a result of the possible insulating nature of the shell. Thus, quantum yields are low 
(~15% [29]), but compare well with other available systems (e.g., CdSe averages ~20%  
[7]).  
Also, trapped state emission, the other major limiting factor, is less important in 
neuroelectronic interfaces. Trapped state emission indicates the presence of trapped 
electrons at crystal defect sites. The presence of a trap can permit electrons to decay 
through non-radiative methods (e.g., crystal vibrations). This would be reflected in a 
reduced quantum yield for the particle. However, trapped states can also increase the 
lifetime of the exciton, [2] thus increasing the amount of time that the particle is in the 
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transient dipole moment state. In this case, trapped state emission is an advantage for 
neuroelectronic interfaces.  
Finally, CdS possesses a relatively large band gap (i.e., 2.42 eV [6]). PL emission 
is limited to the upper energy half of the visible spectrum, requiring UV or blue (350 to 
425 nm) excitation wavelengths, which could damage the cells. However, this 
wavelength range is often used for labeling applications, particularly those employing the 
organic dye DAPI (λexc=350, e.g., Molecular Probes, D-1306), which binds cellular 
nuclear components. Thus, CdS nanocrystals are comparable to commercially available 
organic dyes and other semiconductor nanocrystals (e.g., CdSe, CdTe) and provide a 
suitable system for the development of neuroelectronic interfaces. 
 
3.3.2 Motivation for Synthesis Characterization 
Our ongoing efforts to use aqueous CdS nanocrystals conjugated to biomolecular 
recognition components [29] for the development of neuroelectronic interfaces has 
revealed that subtle variations in synthesis parameters, such as pH, concentration and 
ligand length, lead to unpredictable differences in PL emission wavelength, quantum 
yield and dispersibility. Despite the fact that many studies have examined the aqueous 
arrested precipitation of CdS nanocrystals using thiolate [26, 32-33] and phosphate [30] 
terminated ligands, we found that the key synthetic parameters controlling the particle 
size and PL quantum yield were not adequately identified. Here, we report a systematic 
study of the effects of reactant concentration, Cd:S mole ratios, Cd:ligand mole ratios, 
ligand chain length, pH, and ligand R group on the nanocrystal size and PL for CdS 
nanocrystals synthesized by aqueous-phase arrested precipitation. The acid/base 
equilibrium of free ligands is coupled to ligand surface adsorption, Cd-thiolate complex 
formation, and CdS precipitation. By decoupling the effects of pH and concentration, we 
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obtained a predictive understanding of nanocrystal growth, which will allow us to 
produce controlled, reproducible nanocrystal populations for use in the neuroelectronic 
interface. 
 
3.3.3 Materials and Methods  
The absorbance and PL spectra of CdS nanocrystals produced under conditions of 
altered reactant concentrations, reactant and ligand ratios, ligand length, pH, and ligand R 
group were measured and evaluated. All chemicals were used as received from either 
Sigma-Aldrich or Fluka Chemical Companies and all water was doubly distilled and 
deionized.  
 
3.3.3.1 Standard CdS Nanocrystal Synthesis 
As a standard case, mercaptoacetic acid-stabilized CdS nanocrystals were 
synthesized by the methods developed by Feng, et al. [34] 50 µL mercaptoacetic acid 
(MAA, HOOCHCH2SH) (Fluka) were added to 10 mL of 5 mM CdCl2 (Sigma) for a 
final MAA concentration of 55 mM and pH of 2.15-2.30. The pH was raised by drop 
wise addition of concentrated 10 M NaOH to pH 4.5, and then incremented further 
through drop wise addition of 1 M NaOH to a final pH of 7.0 ± 0.05 (total addition ~600 
 µL 1 M equivalents). 10 mL of 2 mM Na2S⋅9H2O (Sigma) solution were added to this 
solution with rapid stirring, which raises the pH to ~8.2. The reaction mixture was stirred 
for 4 hours prior to analysis. Table I summarizes the reaction conditions and variables 
examined in this study.  
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Table I: Experimental Synthesis Conditions Examined 







Control MAA 5 55 2 pH1 = 7 
Concentration MAA 1-20 11-220 0.4-9.5 pH1 = 7 
Ratio MAA 5 55 0.5-20 pH1 = 7, 
pH2 = 8.2 
Ligand Conc. MAA 5 1-500 2 pH1 = 7, 
pH2 = 8.2 
Ligand Length -OH terminated4 10 98.5 10 pH1 = 7, 
pH2 = 8.2 
pH MAA 5 55 2 pH1 = 5-11, 
pH2 = 8.2 
Ligand R 
Group 
MAA, MBE, MEA 5 55 2 pH1 = 3-11 
1 pH before Na2S addition, pH after Na2S addition fluctuates freely 
2 pH after Na2S addition, held constant through drop wise 1 M HCl or 1 M NaOH 
addition 
3 All reactions were carried out in a total volume of 20mL. 
4 HS(CH)xOH, with x = 2, 3, 4, 6. 
  
3.3.3.2 Reactant Concentration 
Overall reactant concentration was examined by carrying out particle growth in a 
total volume of 20 mL with constant molar ratios of [CdCl2]:[Na2S]=2.5 and 
[MAA]:[CdCl2]=11. CdCl2 concentrations ranged from 1 to 20 mM, with corresponding 
MAA addition ranging from 11 to 220 µL. In these experiments, the pH was raised to 7 
using NaOH prior to Na2S addition.  
 
3.3.3.3 Cadmium:Sulfur Ratio 
The [CdCl2]:[Na2S] molar ratios were altered, while [MAA]:[CdCl2] = 11 was 
kept constant. Two classes of experiments were performed with initial pH (prior to Na2S 
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addition) = 7.0 and (1) reaction pH fluctuates freely and (2) reaction pH (after Na2S 
addition) = 8.2. The reaction pH was adjusted to 8.2 using rapid drop wise addition of 1 
M NaOH or 1 M HCl. These experimental conditions were selected to differentiate the 
effect of pH changes from that produced by the variable alone. 
 
3.3.3.4 Ligand Concentration 
The [MAA]:[CdCl2] molar ratio was altered from 0.2 to 100, while holding the 
[CdCl2]:[Na2S] ratio constant at 2.5. MAA was added to 10 mL of 5 mM CdCl2 to 
achieve the desired [MAA]:[CdCl2] ratio. After MAA addition, the pH was raised to 7.0 
by drop wise addition of 10 M and 1 M NaOH. In some of the experiments, the reaction 
pH was adjusted to 8.2 after Na2S was added, using drop wise addition of either 1 M 
NaOH or 1 M HCl. 
 
3.3.3.5 Ligand Chain Length  
Ligand chain length was investigated using –OH terminated ligands. Alcohol 
terminated ligands were selected because a wide range of chain lengths, from 2 to 6 
carbons long, were commercially available, which was not the case for carboxyl-
terminated ligands. We examined β-mercaptoethanol (2-mer, HS(CH2)2OH) (Sigma), 3-
mercaptopropanol (3-mer, HS(CH2)3OH) (Sigma), 4-mercapto-1-butanol (4-mer, 
HS(CH2)4OH) (Sigma), and 6-mercapto-1-hexanol (6-mer, HS(CH2)6OH) (Fluka). For 
these experiments, the CdCl2 and Na2S concentrations were modified from the standard 
conditions, as the –OH ligands produced CdS nanocrystals with significantly blue-shifted 
absorbance that did not fluoresce. 10 mM CdCl2, [CdCl2]:[Na2S]=1, and 
[MAA]:[CdCl2]=9.85 were used for the reactions. The pH was raised to 7.0 with NaOH 
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solution after adding capping ligand, and prior to Na2S addition. In some cases, the pH 
was adjusted to 8.2 after sulfide addition by drop wise addition of either 1 M NaOH or 1 
M HCl. 
 
3.3.3.6 pH Adjustment 
50  µL MAA was added to 10 mL of 5 mM CdCl2 solution following the standard 
procedure. 10 M and 1 M NaOH were added to obtain the desired initial pH value, 
ranging from 5 to 11, prior to Na2S addition. In one set of experiments, the reaction pH 
after adding the Na2S solution was adjusted to 8.2 by drop wise addition of either 1 M 
NaOH or 1 M HCl. 
 
3.3.3.7 Ligand R Group 
Three different capping ligands were explored: MAA, MBE, and β-
mercaptoethylamine hydrochloride (MEA, HSCH2CH2NH2⋅HCl, Fluka). MAA is an acid, 
MBE is neutral, and MEA is a base. Each ligand was added to 10 mL of 5 mM CdCl2 
solution as per the standard preparation to a final concentration of 55 mM 
([Ligand]:[CdCl2]=11). After ligand addition, the pH was raised to values ranging from 3 
to 11 by adding 10 M and 1 M NaOH. 10 mL of 2 mM Na2S⋅9H2O (Sigma) solution were 
added to this solution with rapid stirring.  
 
3.3.3.8 Absorbance and Photoluminescence Spectroscopy  
Room temperature absorbance spectra of CdS nanocrystals dispersed in DI-H2O 
were obtained using a Beckman DU500 spectrophotometer (Beckman Coulter, Fullerton, 
CA). Room temperature PL spectroscopy was performed using a Quanta Master Model C 
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Cuvette-based scanning spectrofluorometer (Photon Technology International, 
Lawrenceville, NJ) with a Xenon lamp source and monochromator scanning. Bandpass 
filters were set to 4 nm. Spectra were obtained from CdS nanocrystals dispersed in water 
with optical densities adjusted to 0.1 at the excitation wavelength in standard quartz 
cuvettes. PL quantum yield was measured using a quinine sulfide standard (QY= 0.55, 
λexc=366) in 0.5 M H2SO4. The room temperature PL quantum yield of CdSe 
nanocrystals obtained from Evident Technologies (Troy, NY)  dispersed in toluene was 
measured using carboxytetramethylrhodamine (TAMRA) as a standard in methanol 
(QY=0.68, λexc=543). 
 
3.3.4 Results and Discussion 
MAA-stabilized CdS nanocrystals were synthesized through aqueous-phase 
arrested precipitation. Nanocrystals created using the standard procedure luminesce at 
366 nm with a quantum yield of 15%. This quantum yield compares well with 
commercially available CdSe nanocrystals (Evident Technologies) that we found to emit 
with PL quantum yields of 1.2% and reported values of ~20%. [7] Changes in optical 
properties resulting from altered reactant concentration, Cd:S and Cd:ligand mole ratios, 




Table II: Summary of Experimental Synthesis Results 
Variable Abs. Edge PL Peak λ PL Intensity4 
⇑ Conc. NC3 NC NC 
⇑ Ratio ⇓ 1,2 ⇓ 1,2 Max at 2:1, 4:11,2 




Max. at 55, 100 mM1,2 
⇑ Ligand Length ⇓ 1,2 ⇓ 1,2 ⇓ 1 
⇑ 2 




Max. at pH 71,2 
Ligand R Group Varied with pH N/A* Max. for MAA, MEA* 
(NC) =No Change 
*N/A. No fluorescence occurred for MBE samples. 
1Reaction pH fluctuates freely 
2Reaction pH = 8.2 
3Peak energy is unchanged; intensity increases 
4OD=0.1, Control (see Table I) quantum yield = 15%. 
 
3.3.4.1 Overall Reactant Concentration 
Figures 21A-B show absorbance and PL emission spectra for CdS nanocrystals 
synthesized with the standard Cd:S and MAA:Cd mole ratios of 2:1 and 11:1, 
respectively, at different overall reactant concentrations. In these experiments, the 
solution pH did not vary appreciably from 8.2 after Na2S addition. Increased overall 
reactant concentration increased the absorbance; however, the exciton peak energy did 
not vary significantly (Figure 21C). The spectra indicate that nanocrystal number density 
increases with more reactant, while the particle size distribution does not change. 
Additionally, the PL emission peak energy did not vary with overall concentration 
(Figure 21B), providing further support that nanocrystals of the same size are formed in 
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each preparation. Furthermore, increasing particle concentration in the synthesis does not 
significantly alter the PL quantum yield (Figure 21D).   
Figure 21: Absorbance and Excitation 












Room temperature (A) absorbance spectra and (B) PL emission spectra (λexc=366 nm, 
OD=0.1) for aqueous CdS nanocrystals synthesized with increasing [CdCl2] while 
maintaining the Cd:S and MAA:Cd mole ratios of 2.5 and 11, respectively. (C) The 
exciton peak energies observed in the absorbance spectra and (D) the PL intensity 
averaged over 3 experiments (OD=0.1 for all samples). Exciton peak energy remains 
approximately constant as overall reactant concentration is increased, whereas PL 
intensity experiences a slight decline at higher concentration.  
 
Although CdS nanocrystals synthesized at different overall reactant 
concentrations exhibit similar optical properties and size, the dispersion stability was 
significantly higher for nanocrystals produced at lower concentrations. Particles created 
at higher concentrations (e.g., 15 mM, 20 mM) generally precipitated within one week. 
Decreased stability most likely results from higher ionic solution strength and increased 
particle proximity. As reactant concentration increases, additional Na+ and Cl- ions are 
available to screen the repulsive charge between more closely-packed carboxyl-coated 
nanocrystals  a combination which results in particle aggregation and precipitation. 
Dispersion stability is a concern for biological labeling applications, as less-soluble 




3.3.4.2 Cd:S Ratio 
The [CdCl2]:[Na2S] was varied from 10:1 to 1:4. For these experiments, the stock 
CdCl2/MAA solution was prepared according to the standard procedure, with a solution 
pH adjusted to 7.0 prior to Na2S addition. Figures 22A-D shows absorbance and PL 
spectra of the CdS nanocrystals. The relationship between the absorbance onset and CdS 
nanocrystal size is well studied and can be used as a measure of particle diameter. [35] 
Increasing Cd:S ratio decreases the particle size (Figures 22A,B,E). These results are 
consistent with past findings in the literature. [28, 36-37] To ensure that these 
observations were not related to solution pH variations, nanocrystals were also 
synthesized by adjusting the pH to 8.2 after Na2S addition (Figures 22B and 22D). This 
final pH readjustment did not change the nanocrystal optical properties. 
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Figure 22: Absorbance and Excitation Spectra for Increased Cd:S Ratio.  
Room temperature (A,B) absorbance and (C,D) PL emission spectra (λexc=exciton peak, 
OD=0.1) for aqueous CdS nanocrystals synthesized with different [CdCl2]:[Na2S] mole 
ratios. For these experiments, [CdCl2]=5 mM, [MAA]:[CdCl2]=11, and the pH is adjusted 
to 7.0 prior to Na2S addition. In one set of experiments (B,D), the pH was also adjusted to 
8.2 after Na2S addition. (E) Absorbance onset averaged over 3 preparations as a function 
of [CdCl2]:[Na2S] ratio for the samples with pH adjusted to 8.2 after Na2S addition. For 
reference, the band gap energy of bulk CdS is identified with a dotted line. The curve fit 
in (E) is a logarithmic fit to the data points (R2 = 0.956, λonset = -55 ln(Cd:S ratio) + 486). 
(F) PL emission peak intensity (OD=0.1 for all samples) plotted as a function of 
[CdCl2]:[Na2S] ratio. Nanocrystals formed with [CdCl2]:[Na2S]>6 and [CdCl2]:[Na2S]<1 




The decrease in size with increasing [CdCl2]:[Na2S] results from competition 
between MAA and SH- anions (Na2S exists primarily as SH- for the pH range 



















SH- condenses with Cd2+ ions or Cd dangling bonds on the nanocrystal surface to 
produce CdS, whereas RSH terminates nanocrystals surfaces or stabilizes new nuclei by 
forming Cd-SR complexes. As [Na2S] increases, more SH- becomes available for CdS 
formation and particle growth. As [CdCl2] increases, a greater proportion of Cd atoms are 
available for surface reaction with the capping ligand  a situation resulting in the 
stabilization of smaller particles. An insoluble precipitate with bulk spectral properties 
forms below a lower Cd:S limit (1:1), whereas at the upper end of Cd:S ratios (Cd:S > 
6:1), particles that formed did not fluoresce and exhibited significantly blue-shifted 
absorbance. Nosaka [23] proposed that these high Cd:S ratios yield molecular clusters, as 
opposed to nanocrystals with bulk crystal structure. The PL intensity is also a strong 
function of Cd:S ratio (Figure 22F), with maximum emission occurring for Cd:S ratio 
ranging between 2 and 4 and absorbance onsets that correspond to a size of ~2 nm. [35]  
This appears to indicate that surface passivation is best for mid-size (or mid-spectral) 
CdS nanocrystals. The presence of a size-specific maximum in PL intensity has been 
observed before in several other systems, including CdTe [39], CdSe [39-41], InAs [39], 
and CdS [28, 42-43]. 
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3.3.4.3 Ligand Concentration 
 MAA-stabilized CdS nanocrystals were synthesized at different [CdCl2]:[MAA] 
ratios, with [CdCl2]=5 mM and [CdCl2]:[Na2S]=2. The pH was raised to 7.0 after adding 
MAA to the CdCl2 solution, and prior to Na2S addition. In one set of experiments, the 
reaction pH was not controlled; and in a separate set of experiments, the pH was adjusted 
to 8.2 after sulfide addition. As seen in the absorbance and PL spectra in Figures 23A-D, 
when the reaction pH was not readjusted to 8.2 after sulfide addition, the ligand 
concentration had little effect on the nanocrystal size for the majority of the conditions 
tested. Slight increases in size were seen at the highest ligand concentration (500 mM), 
and insoluble bulk material formed at the lowest concentration (1 mM). These 
observations are consistent with previously reported results for MAA-stabilized CdS 
nanocrystals.  [34] However, when the reaction pH was adjusted to 8.2 after Na2S 
addition, a small increase in particle size occurred with increasing ligand concentration 
(Figures 23B, D, E). Prior to adjustment, the reaction pH ranged from 7 (for 10:1) to 10 
(for 1:4). 
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Figure 23: Absorbance and Excitation Spectra for Increased Ligand Concentrations. 
Representative room temperature (A, B) absorbance and (C, D) PL emission 
(λexc=exciton peak, OD=0.1) spectra of aqueous CdS nanocrystals synthesized with 
different [MAA] concentration. For these reactions, [CdCl2]=5 mM; and [MAA]=55 mM, 
corresponding to [MAA]:[CdCl2]=11. The pH was set to 7.0 prior to Na2S addition. The 
spectra in (B) and (D) correspond to particle growth experiments where the pH was also 
adjusted to 8.2 after sulfide addition. (E) The absorbance onset of nanocrystals 
synthesized with pH adjusted to 8.2 plotted as a function of ligand concentration on a 
semi- log plot, fitted to a logarithmic curve: (R2 = 0.97, λonset  = 8.24 ln([MAA (mM)]) + 
396). (F) PL intensity (OD=0.1 for all samples) as a function of ligand concentration for 
reaction pH adjusted to 8.2 (semi- log plot). PL intensity was maximum for the range, 55 
mM<[MAA]<100 mM.  
 
The observed increase in particle size with increasing ligand concentration is 
consistent with only one study in the literature. In that study, increased oleic acid 
concentration in octadecene [44] gave rise to larger CdS particles. The majority of work 
examining the effect of ligand concentration on particle size has found that increasing 
ligand concentration either decreased particle size (β-mercaptoethanol-stabilized CdS) 
[26-27, 45] or had little effect (CdS nanocrystals stabilized with β-mercaptoethanol (high 
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concentration), sodium hexametaphosphate, ethylene glycol, and ethanol). [27] One 
would expect that nanocrystal size would decrease with increased ligand concentration, to 
be consistent with the proposed competitive binding mechanism [26, 38] between RSH 
and SH-. However, pH also plays a critical role in particle growth, as it determines the 
equilibrium species and concentrations of all the reactants. In fact, it is possible that some 
of the trends reported earlier in the literature occurred in part as a result of changes in 
reaction pH (e.g., addition of more acidic ligand lowers reaction pH) and not because of 
increases in ligand concentration.  
The PL and absorbance spectra both follow similar trends with ligand 
concentration. Without adjusting pH after sulfide addition, the PL peak energy is not 
affected by the [MAA]:[CdCl2] ratio (Figure 23C); however, the PL intensity varies 
considerably for both adjusted and unadjusted pH after sulfide addition. The maximum 
PL intensity was found for [MAA] in the range of 55 to 100 mM (Figure 23F), 
concentrations that produce particles in the 2 nm size range. This corresponds to 
[MAA]:[Na2S] ratios ranging from 22:1 to 44:1—the same ratios that gave rise to the 
highest PL emission intensity in the [Cd]:[S] experiments shown in Figure 22. Although 
the particle size is not affected by changes in ligand concentration (when pH is not 
adjusted), the PL quantum yield can change by almost an order of magnitude.    
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3.3.4.4 Ligand Length  
CdS nanocrystals were synthesized in the presence of HS(CH2)xOH with varying 
hydrocarbon chain length, x=2, 3, 4, and 6. For these reactions, [CdCl2]=10 mM, 
[CdCl2]:[Na2S]=1, and [HS(CH2)xOH]:[CdCl2]=9.85. The pH was raised to 7.0 prior to 
Na2S addition. In one set of experiments, the pH was adjusted to 8.2 after Na2S was 
added. Figure 24A-D shows the absorbance and PL emission spectra of the CdS 
nanocrystals synthesized using ligands of varying chain length. The 6mer produced a 
white insoluble precipitate—most likely due to the formation of an insoluble hydrophobic 
Cd-SR complex [8]—and is therefore not included in the spectra. Increasing chain length 
led to decreased particle size, as found in a previous study (Figures 24A,B). [7] The trend 
is more dramatic without the pH readjustment after sulfide addition (Figure 24A). 
Consistent with suggestions by others, [7, 46] it appears that the added bulkiness 
associated with the longer ligands leads to slightly smaller nanocrystals. Similar results 
have also been observed in a number of nanocrystal materials synthesized in both organic 
and aqueous phases, including CdSe, CdTe, CdS [7], Ag [47], InP, InAs [48]. 
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Figure 24: Absorbance and Excitation Spectra for Increased Ligand Length. 
Room temperature (A,B) absorbance and (C,D) PL emission spectra (λexc=exciton peak, 
OD=0.1) for aqueous CdS nanocrystals stabilized by HS(CH2)xOH ligands with varying 
hydrocarbon chain length, x. The nanocrystals were synthesized with [CdCl2]=10 mM, 
[CdCl2]:[Na2S]=1, and [Ligand]:[CdCl2]=9.85. In one set of experiments (B,D), the pH 
was adjusted to 8.2 after adding Na2S. (B, Inset) Three experiment average of absorbance 
onset plotted against ligand chain length for the samples adjusted to 8.2 after adding 
Na2S. The curve corresponds to a linear fit of the data (R2 = 0.99, λonset  = -50.6(Ligand 
Length) + 647.) PL intensity (OD=0.1 for all samples) plotted versus ligand chain length 
for CdS nanocrystals formed without (E) and with (F) pH readjustment to 8.2 for three 
experiments. 
 
The longer chain length capping ligand also shifts the PL emission peak to the 
blue, as expected based on the absorbance spectra (Figures 24C, 4D). Without readjusting 
the pH after adding the sulfide reagent, the CdS nanocrystals show quantum yield 
efficiencies that decrease with increasing chain length (Figure 24E). On the other hand, 
when the pH was adjusted to 8.2, the PL intensity increased with increasing chain length 
(Figures 24F). These trends appear to be related to the particle size differences rather than 
the ligand length. When PL intensity is correlated to nanoparticle size, we see that a 
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maximum in PL intensity occurs for particles with similar sizes, ~2 nm (Figure 24A, 
2mer; Figure 24B, 4mer).  
 
3.3.4.5 pH Effects 
MAA-stabilized CdS nanocrystals were synthesized at different solution pH 
values prior to Na2S addition. The pH was varied between 5 and 11 prior to adding Na2S, 
because pH values less than 4.5 led to the formation of insoluble CdCl2/MAA complexes 
[34, 49] and the pH of Na2S solutions exhibit an upper pH limit of 12. The exciton and 
PL emission peak wavelengths monotonically shift to the blue with decreased pH 
(Figures 25A, C), which is consistent with previous findings in the literature. [23, 50] The 
exciton peak wavelength varies sigmoidally with the pH prior to sulfide addition (Figure 
25E) and parabolically with the pH after sulfide addition (Figure 25F). The sigmoidal 
trend resembles a titration curve for Na2S (pKa = 6.90 [51]), further indicating that SH- 
anions mediate nanocrystal formation. 
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Figure 25: Absorbance and Excitation Spectra for Increased Reaction pH. 
Room temperature (A, B) absorbance and (C,D) PL emission spectra (λexc=exciton peak, 
OD=0.1) for aqueous CdS nanocrystals synthesized at different solution pH prior to Na2S 
addition. The nanocrystals were synthesized with [CdCl2]=5 mM, [CdCl2]:[Na2S]=2, 
[MAA]:[CdCl2]=11. The pH was adjusted to 8.2 after sulfide addition for the samples 
with absorbance and PL plotted in (B) and (D). (E) Exciton peak energy plotted as a 
function of pH prior to sulfide addition—the curve is a sigmoidal fit to the data: R2 = 
0.955, λpeak = 0.347(pH)3 – 9.27(pH)2 + 88.3(pH) + 78.1. (F) Exciton peak energy plotted 
as a function of solution pH after Na2S addition—the labels above the data points are the 
pH values prior to Na2S addition and the curve is a parabolic fit to the data: R2 = 0.989, 
λpeak = -1.47(pH)2 + 38.7(pH) + 142.5. PL intensity (OD=0.1 for all samples) plotted 
against the solution pH before (G) and after (H) Na2S addition. In (H), each data point is 




Again, the PL emission spectra exhibit a peak in intensity in the mid-size, or mid-
spectral range, whereas the peak energy increases with declining pH (Figures 25G-H). 
Interestingly, CdS nanocrystals synthesized at a solution pH of 7.0 (prior to sulfide 
addition) exhibited a large standard deviation in PL intensity, perhaps as a result of the 
competition for the formation of different Cd-SR complexes in this pH range. 
Nanocrystals synthesized at different initial pH, but with the pH adjusted to 8.2 after 
Na2S addition, exhibited identical absorbance and PL curves. This indicates that the 
reaction pH, and not the pH prior to Na2S addition, is the pH that determines the size. 
The pH dependent size shift of the nanocrystals also depends on the ligand 
concentration.  The sigmoidal pH versus exciton energy curve shown in Figure 25E shifts 
to lower pH values with increasing ligand concentration (data not shown). Thus, when 
using a solution of 220 mM MAA for the capping ligand, it is necessary to decrease 
reaction pH by 2 units to produce nanocrystals with similar spectroscopic properties to 
those created with 55 mM MAA. This is in part because the pH required to dissolve the 
precipitate formed upon MAA addition to CdCl2 solution is also a function of ligand 
concentration, with solutions of higher [MAA] dissolving at lower pH (e.g., pH 3 for 220 
mM MAA vs. pH 4.5 for 55 mM MAA).  
 
3.3.4.6 Ligand R Group 
 Previous studies [23, 37] have reported increasing particle size with decreasing 
pH for basic ligands (i.e., polyphosphate, mercaptoethylamine hydrochloride (MEA)). 
Upon further exploration, we found that the relationship between the pH and size is more 
complicated than a simple monotonic increase or decrease, especially for CdS 
nanoparticles stabilized with basic or neutral ligands. Figure 26A shows the exciton peak 
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energy for CdS nanocrystals synthesized using three different thiolate ligands containing 
acidic (i.e., -COOH (MAA)), neutral (-CH2OH (MBE)), and basic (–CH2NH2 (MEA)) R 
groups. The nanocrystals were grown using standard solution conditions, with variation 
of the pH prior to Na2S addition ranging between 3 and 10 for MBE and MEA and 5 to 
11 for MAA. 
Figure 26:  Effects of Altered Ligand Charge. 
(A) Exciton peak energy plotted as a function of 
ligand R group: (♦) MBE; (<) MEA; and (o) 
MAA. (B) The negative log of the total 
concentration for all soluble free Cd2+ and Cd 
complexes formed in an excess of Na2S is plotted 
versus pH. (C) The negative log of concentration for 
individual soluble Cd species present in an excess of 
Na2S is plotted versus pH. [Plots in B and C are 
adapted from J. Ste-Marie, A.E. Torma, A.O. 










 At low pH (<5), the peak absorbance energies for neutral MBE and basic MEA 
stabilized nanocrystals exhibit the same trend. In the mid-pH range (5 to 8), basic MEA 
and acidic MAA-stabilized particles show similar peak energy dependence on pH. At 
high pH (>8), the peak energy increases with increasing solution pH for acidic MAA and 
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neutral MBE stabilized particles; whereas, the peak energy of MEA-stabilized 
nanocrystals decreases with increasing pH.  Taking into account the charge of the 
functional group on each ligand, the pH-dependence of the nanocrystal size appears to 
correlate with R group acidity/alkalinity. At low pH the “unique” curve is the acidic 
ligand, in the median pH range it is the neutral ligand, and at high pH it is the basic 
ligand.  
Further, the “W”-shaped pH curve for the neutral MBE ligand is strikingly similar 
to the pH-dependent solubility curve for Cd-S complexes reported in the literature 
(Figure 26B-C). [51] Although, Figures 26B-C describe water-soluble Cd-S species 
formed in the presence of excess Na2S and not Cd-RSH, the complexes formed by 
ligands appear to be qualitatively similar. These complexes play an important role in the 
formation of CdS particles. Since free Cd2+ only appears at pH lower than 2.0 (Figure 
26C), CdS nanocrystal formation must be mediated by Cd-thiol species. The ligand R 
group can modulate the concentration and nature of these Cd-thiol complexes and thereby 
influence particle formation.   
For example, between pH 5 and 10, two Cd-thiol species are seen: Cd(HS)3- and 
Cd(HS)4-2, with a maximum concentration of both near pH 7. We believe that these Cd-
thiol species play a critical role in crystal growth for several reasons. First, MBE capped 
nanocrystals display a local maxima in size at pH 6-7. Also, MAA-coated particles 
synthesized in this pH region (i.e., pH 6-7, Figure 25G) exhibit maximum PL intensity. 
Finally, molecular studies show that Cd-HSR complexes formed in the process of 
nanocrystal growth generally demonstrate Cd coordination numbers of 3, 4, or their 
multiples. [52-54] Based on our data and these observations, we propose that Cd(HS)3- 
and Cd(HS)4-2 and Cd(HSR)x2-x based complexes are the most likely intermediates for 
CdS nanocrystal formation. Thus, the maximum concentration of these intermediates at 
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pH 7 corresponds to the observed increase in MBE particle size and MAA PL intensity 
around pH 6-7. As these concentrations decline, MBE particle size also declines, 
reaching a minimum around pH 7-8.  
The presence of a charged R group (e.g., MAA, MEA) could alter the interactions 
between the ligand and Cd2+ producing deviations from the behavior of the neutral ligand 
described above. It is particularly notable that both the acidic and basic curves resemble 
that of MBE (neutral), except in the region where the ligand would be charged. Thus, the 
Cd-thiol complexes present in solution before Na2S addition are a major factor in 
determining particle size, and the presence of charged R groups will influence Cd-HSR 
complex formation. However, these complexes are not the sole determinant of particle  
size; competition between the capping ligand and SH- for Cd surface binding also plays a 
role, as evidenced in the ratio experiment. 
 
3.3.5 Summary of Synthesis Characterization 
The effects of reactant concentration, Cd:S and Cd:ligand mole ratios, ligand 
length, pH, and R group chemistry on the optical properties of CdS nanocrystals 
synthesized by aqueous-phase arrested precipitation were analyzed (Table II). For the 
majority of variables examined, a size-dependant PL intensity maximum occurs at 
intermediate particle sizes (i.e., absorbance onset = 430 nm, diameter ~ 2 nm). This 
implies that as the PL emission peak is adjusted to produce tunable fluorescence, 
quantum yield may be sacrificed. The PL intensity is linked to particle surface quality,  
[39-40, 43] which is dependent upon the nanocrystal growth mechanism. We believe that 
optimal surface quality occurs from growth mediated by selected Cd-thiol nucleating 
complexes. Because these complexes appear to be present only under certain synthesis 
conditions (e.g., pH 6-8, Figure 26C), which are linked to a particular nanocrystal size 
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and emission wavelength, the ability to manipulate the location of the PL intensity 
maximum by tuning synthetic conditions can potentially be limited. 
This is extremely important for the development of bio-labels because the ability 
to produce particles with a variety of narrow bandwidth emission wavelengths is desired 
for viewing multiple labeled components of a cell in a single image. Although the decline 
in PL intensity that occurs at these varied wavelengths may not be substantial enough to 
inhibit visualization with a microscope, it is relevant to consider this effect when 
designing particles for these applications. An alternative approach is to tune the color of 
the qdot by altering composition, either through varying the semiconductor (e.g., CdSe, 
CdTe [7]) or by adding dopants (e.g., Mg [45], Cu [55], Zn [56]). Additionally, capping 
the particles with a material of larger band gap can significantly improve quantum yields 
by enhanced exciton confinement, but even in this case, the epitaxial interfacing at the 
surface must be optimized. [7] 
 
3.3.6 Relevance to Neuroelectronic Interfaces 
Based on these results, CdS quantum dots produced using an aqueous synthesis 
display characteristics that are favorable to the development of neuroelectronic interfaces. 
Particles with high quantum yields (~15%) can be created reproducibly by controlling the 
reactant ratios and reaction pH. Particles can be capped with a variety of ligands, 
including acids, bases, and neutral molecules. This allows for a range of surface 
conjugation strategies that could be used to link particles to the cell receptor of interest. 
Additionally, a variety of particle sizes can be produced, allowing for modulation of the 
magnitude of the transient dipole moment; and hence the electric field to which the cell is 
exposed. Thus, through characterization of the arrested precipitation of CdS in aqueous 
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media, a thorough understanding of the relationship between synthesis conditions and the 
relevant physical properties of the resultant quantum dots was obtained. 
 
3.4 CONCLUSIONS  
Cadmium-based semiconductor nanocrystals offer many benefits to the 
development of neuroelectronic interfaces. Although metallic and other semiconductor 
materials could be used, cadmium-based particles provide high quantum yields with 
excitation and emission wavelengths in the UV and visible regions of the spectra. 
Additionally, these particles have been used in other biological applications, 
demonstrating their compatibility with aqueous media and living components. There are 
several synthesis strategies for producing these particles. Organic syntheses provide the 
best optoelectronic properties (e.g., high quantum yield, resistance to photobleaching); 
however, these particles are not water-soluble and are made from toxic materials. 
Although several strategies exist for producing water-soluble particles from an organic 
synthesis, aqueous routes offer a convenient, non-toxic alternative to nanocrystal 
production. The main limitations of nanoparticles produced using an aqueous synthesis 
are lower quantum yields and trapped state emission. However, these factors are not 
crucial to the development of a neuroelectronic interface. Quantum yields for aqueous 
particles compare well with the usable organic systems, and trapped state emission may 
in fact lengthen the transient dipole moment state, increasing the time of electrical contact 
with the nerve cell.  
Our initial efforts to utilize these particles evidenced a lack of reproducibility in 
the optical properties. Through systematic analysis of nanocrystal synthesis conditions, 
we were able to determine the critical factors in nanoparticle production. Increased 
reactant concentrations do not alter the nanoparticle size or emission wavelength, but can 
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affect quantum yield and stability in water. Reactant and ligand ratios, ligand length, and 
pH control particle emission wavelength and quantum yield. Finally, the charge of the 
ligand can alter the emission wavelength and quantum yield, especially for the reaction 
pH values in which the molecule is charged. We also discovered that regardless of the 
synthesis variable altered, particle quantum yield is size-dependant, with a maximum at 
intermediate sizes (~2 nm). This may represent a thermodynamic preference for 
nanocrystal growth from certain molecular precursors: clusters of Cd- ligand with ligand 
coordination numbers of 3, 4, or their multiples. These results allow us to create 
reproducible nanoparticles with a range of sizes and optical characteristics; thus 
providing us with several options to implement in a neuroelectronic interface. 
 103 
 
3.5 REFERENCES  
 
1. T.J. Bukowski and J.H. Simmons. “Quantum Dot Research: Current State and Future 
Prospects.” Crit. Rev. Solid State Mat. Sci. 27(3): 119, 2002. 
2. A.P. Alivisatos. “Perspectives on the Physical Chemistry of Semiconductor 
Nanocrystals.” J. Phys. Chem. 100: 13226, 1996. 
3. Y. Wang and N. Herron. “Nanometer-Sized Semiconductor Clusters: Materials 
Synthesis, Quantum Size Effects, and Photophysical Properties.” J. Phys. Chem. 
95: 525, 1991. 
4. W.C.W. Chan, D.J. Maxwell, X. Gao, R.E. Bailey, M. Han, and S. Nie. “Luminescent 
Quantum Dots for Multiplexed Biological Detection and Imaging.” Curr. Opin. 
Biotech. 13: 40, 2002. 
5. C. Loo, A. Lin, L. Hirsch, M.H. Lee, J. Barton, N. Halas, J. West, and R. Drezek. 
“Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer.” Tech. 
Cancer Res. Treat. 3(1): 33, 2004. 
6. K. Kalyanasundaram, E. Borgarello, D. Duonghong, and M. Grätzel. “Cleavage of 
Water by Visible-Light Irradiation of Colloidal CdS Solutions: Inhibition of 
Photocorrosion by RuO2” Angew. Chem. Int. Ed. Engl. 20(11): 987-988, 1981. 
7. C.B. Murray, D.J. Norris, and M.G. Bawendi. “Synthesis and Characterization of 
Nearly Monodisperse CdE (E = S, Se, Te) Semiconductor Nanocrystallites.” J. 
Am. Chem. Soc. 115: 8706, 1993. 
8. M.A. Hines and P. Guyot-Sionnest. “Synthesis and Characterization of Strongly 
Luminescing ZnS-Capped CdSe Nanocrystals.” J. Phys. Chem. 100: 468, 1996. 
9. W.C.W. Chan and S. Nie. “Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic 
Detection.” Science 281: 2016, 1998. 
10. M. Bruchez, Jr., M. Moronne, P. Gin, S. Weiss, and A.P. Alivisatos. “Semiconductor 
Nanocrystals as Fluorescent Biological Labels.” Science 281: 2013, 1998. 
11. J.E. Bowen Katari, V.L. Colvin, and A.P. Alivisatos. “X-ray Photoelectron 
Spectroscopy of CdSe Nanocrystals with Applications to Studies of the 
Nanocrystal Surface.” J. Phys. Chem. 98: 4109, 1994. 
 104 
12. Tri-octyl phosphine Oxide MSDS Product Number 223301, version 1.5, 6/28/2004, 
from Sigma Aldrich. 
13. A.M. Derfus, W.C.W. Chan, and S.N. Bhatia. “Probing the Cytotoxicity of 
Semiconductor Quantum Dots.” Nano Lett. 4(1): 11, 2004. 
14. Z.A. Peng and X. Peng. “Formation of High-Quality CdTe, CdSe, and CdS 
Nanocrystals Using CdO as Precursor.” J. Am. Chem. Soc. 123: 183, 2001. 
15. B.O. Dabbousi, J. Rodriquez-Viejo, F.V. Mikulec, J.R. Heine, H. Mattoussi, R. Ober, 
K.F. Jensen, and M.G. Bawendi. “(CdSe)ZnS Core-Shell Quantum Dots: 
Synthesis and Characterization of a Size Series of Highly Luminescent 
Nanocrystallites.” J. Phys. Chem. B 101: 9463, 1997.  
16. Personal Communication from Fred Mikeluc, Innovalight, Austin, Texas, June 29, 
2004. 
17. P. Bongrand. “Adhesion of Cells,” in Handbook of Biological Physics, vol. 1, R. 
Lipowsky and E. Sackmann, Eds., Elsevier, Amsterdam: 1995, p. 767. 
18. W.C.W. Chan, T.L. Prendergast, M. Jain, and S. Nie. “One-Step Conjugation of 
Biomolecules to Luminescent Nanocrystals,” in Molecular Imaging: Reporters, 
Dyes, Markers, and Instrumentation, Darryl J. Bornhop, Kai Licha, Eds., 
Proceedings of SPIE., vol. 3924, 2000, p. 2. 
19. β-Mercaptoethanol MSDS Product Number M7522, version 1.12, 4/6/2004, from 
Sigma Aldrich. 
20. J.A. Schneider, B. Katz, and R.B. Melles. “Update on Nephropathic Cystinosis.” 
Pediatr. Nephrol. 4(6): 645, 1990. 
21. D. Gerion, F. Pinnand, S.C. Williams, W.J. Parak, D. Zanchet, S. Weiss, and A.P. 
Alivisatos. “Synthesis and Properties of Biocompatible Water-Soluble Silica-
Coated CdSe/ZnS Semiconductor Quantum Dots.” J. Phys. Chem. B 105: 8861, 
2001. 
22. R.C. Weast and M.J. Astle, Eds., CRC Handbook of Chemistry and Physics, 60th Ed. 
CRC Press, Boca Raton, Florida: 1979, p. B-220. 
23. Y. Nosaka, N. Ohta, T. Fukuyama, and N. Fujii. “Size Control of Ultrasmall CdS 
Particles in Aqueous Solution by Using Various Thiols.” J. Col. Interface Sci. 
155: 23, 1993. 
24. A. Henglein. “Photo-Degradation and Fluorescence of Colloidal Cadmium Sulfide in 
Aqueous Solution.” Ber. Bunsenges. Phys. Chem. 86: 301, 1982. 
 105 
25. A. Eychmüller, A. Hässelbarth, L. Katsikas, and H. Weller. “Fluorescence 
Mechanism of Highly Monodisperse Q-Sized CdS Colloids.” J. Luminescence. 
48-49: 745, 1991. 
26. Y. Nosaka, K. Yamaguchi, H. Miyama, and H. Hayashi. “Preparation of Size-
Controlled CdS Colloids in Water and Their Optical Properties.” Chem. Lett. 4: 
605, 1988. 
27. K. Kundu, A.A. Khosravi, S.K. Kulkarni, and P. Singh. “Synthesis and Study of 
Organically Capped Ultra Small Clusters of Cadmium Sulphide.” J. Mat. Sci. 32: 
245, 1997. 
28. A. Hässelbarth, A. Eychmüller, and H. Weller. “Detection of Shallow Electron Traps 
in Quantum Sized CdS by Fluorescence Quenching Experiments.” Chem. Phys. 
Lett. 203(2-3): 271, 1993. 
29. J.O. Winter, T.Y. Liu, B.A. Korgel, and C.E. Schmidt. “Recognition Molecule 
Directed Interfacing Between Semiconductor Quantum Dots and Nerve Cells.” 
Adv. Mat. 13: 1673, 2001. 
30. A. Fojtik, H. Weller, U. Koch, and A. Henglein. “Photo-Chemistry of Colloidal Metal 
Sulfides 8. Photo-Physics of Extremely Small CdS Particles: Q-State CdS and 
Magic Agglomeration Numbers.” Ber. Bunsenges. Phys. Chem. 88: 969, 1984. 
31. R. Rossetti, J.L. Ellison, J.M. Gibson, and L.E. Brus. “Size Effects in the Excited 
Electronic States of Small Colloidal CdS Crystallites.” J. Phys. Chem. 80(9): 
4464, 1984 
32. Y. Nosaka, H. Shigeno, and T. Ikeuchi. “Formation Steps of CdS Clusters in Aqueous 
Solution Containing 2-mercaptoethanol.” Surf. Rev. Let. 3:1209, 1996. 
33. D. Hayes, O.I. Micic, M.T. Nenadovic, V. Swayambunathan, and D. Meisel.  
“Radiolytic Production and Properties of Ultrasmall CdS Particles.” J. Phys. 
Chem. 93: 4603, 1989. 
34. H.M. Chen, X.F. Huang, L. Xu, J. Xu, K.J. Chen, and D. Feng. Superlattices and 
Microstructures. “Self-Assembly and Photoluminescence of CdS-Mercaptoacetic 
Clusters with Internal Structures.” 27: 1, 2000. 
35. H. Weller, H.M. Schmidt, U. Koch, A. Fojtik, S. Baral, A. Henglein, W. Kunath, K. 
Weiss, and E. Dieman. “Photochemistry of Semiconductor Colloids. 14. 
Photochemistry of Colloidal Semiconductors-Onset of Light Absorption as a 
Function of Size of Extremely Small CdS Particles.” Chem. Phys. Lett. 124: 557, 
1986. 
 106 
36. N. Herron, Y. Wang, and H. Eckert. “Synthesis and Characterization of Surface-
Capped, Size-Quantized CdS Clusters – Chemical Control of Cluster Size.” J. 
Am. Chem. Soc. 112: 1322, 1990.  
37. H. Weller. “Colloidal Semiconductor Q-Particles – Chemistry in the Transition 
Region Between Solid-State and Molecules.” Angew. Chem. Int. Ed. Engl. 32: 
41, 1993. 
38. V. Swayambunathan, D. Hayes, K.H. Schmidt, Y.X. Liao, and D. Meisel. “Thiol 
Surface Complexation of Growing CdS Clusters.” J. Am. Chem. Soc. 112: 3831, 
1990. 
39. D.V. Talapin, A.L. Rogach, E.V. Shevchenko, A. Kornowski, M. Haase, and H. 
Weller. “Dynamic Distribution of Growth Rates within the Ensembles of 
Colloidal II-VI and III-V Semiconductor Nanocrystals as a Factor Governing 
Their Photoluminescence Efficiency.” J. Am. Chem. Soc. 124: 5782, 2002. 
40. C. de Mello Donegá, S.G. Hickey, S.F. Wuister, D. Vanmaekelbergh, and A. 
Meijerink. “Single-Step Synthesis to Control the Photoluminescence Quantum 
Yield and Size Dispersion of CdSe Nanocrystals.” J. Phys. Chem. B. 107: 489, 
2003. 
41. L. Qu and X. Peng. “Control of Photoluminescence Properties of CdSe Nanocrystals 
in Growth.” J. Am. Chem. Soc. 124: 2049, 2002. 
42. G.R. Bradburn, T.J. Trentler, S.C. Goel, W.E. Buhro, and J.M. Jean. “Dependence of 
Quantum Yield from the Deep Trap States of CdS Nanoparticles on Particle-Size 
and Capping Group.” 210th ACS National Meeting, PHYS-322 (Pt. 2): Chicago, 
1995.  
43. D.V. Bavykin, E.N. Savinov, and V.N. Parmon. “Specific Features of Luminescence 
of Q-CdS Colloids with Different Sizes.” Russ. Chem. Bul. 47: 629, 1998. 
44. Y.W. William and X.  Peng. “Formation of High-Quality CdS and Other II-VI 
Semiconductor Nanocrystals in Noncoordinating Solvents: Tunable Reactivity of 
Monomers.” Angew. Chem. Int. Ed. 41: 2368, 2002. 
45. A.A. Khosravi, M. Kundu, B.A. Kuruvilla, G.S. Shekhawat, R.P. Gupta, A.K. 
Sharma, P.D. Vyas, and S.K. Kulkarni. “Manganese-Doped Zing-Sulfide 
Nanoparticles by Aqueous Method.” Appl. Phys. Lett. 67: 2506, 1995. 
46. C. Barglik-Chory, E. Dieman, A.F. Münster, H. Strohm, C. Remenyi, and G. Müller. 
“Influence of Synthesis Parameters on the growth of CdS Nanoparticles in 
Colloidal Solution and Determination of Growth Kinetics using Karhunen-Loeve 
Decomposition.” Chem. Phys. Lett. 374: 319, 2003. 
 107 
47. P. Shah, S. Husain, K.P. Johnston, and B.A. Korgel. “Role of Steric Stabilization on 
the Arrested Growth of Silver Nanocrystals in Supercritical Carbon Dioxide.” J. 
Phys. Chem. B. 106: 12178, 2002. 
48. D. Battaglia and X. Peng, Nano. Lett. “Formation of High Quality InP and InAs 
Nanocrystals in a Noncoordinating Solvent.” Nano Lett. 2: 1027, 2002. 
49. V.L. Colvin, A.N. Goldstein, and A.P. Alivisatos. “Semiconductor Nanocrystals 
Covalently Bound to Metal-Surfaces with Self-Assembled Monolayers.” J. Am. 
Chem. Soc. 114: 5221, 1992. 
50. L. Spanhel, M. Haase, H. Weller, and A. Henglein. “Photochemistry of Colloidal 
Semiconductors. 20. Surface Modification and Stability of Strong Luminescing 
CdS Particles.” J. Am. Chem. Soc. 109: 5649, 1987. 
51. J. Ste-Marie, A.E. Torma, and A.O. Gübeli. “The Stability of Thiocomplexes and 
Solubility Products of Metal Sulphides.” Can. J. Chem. 42: 662, 1964. 
52. Y. Nosaka, H. Shigeno, and T. Ikeuchi. “Formation of Polynuclear Cadmium-
Thiolate Complexes and CdS Clusters in Aqueous-Solution Studied by Means of 
Stopped-Flow and NMR Spectroscopies.” J. Phys. Chem. 99: 8317, 1995. 
53. H.-B. Bürgi. “Stereochemistry of Polynuclear Cadmium (II) Thioglycolates: Crystal 
Structure of Cadmium (II) Bisthioglycolate.” Helv. Chim. Acta. 57: 515, 1974. 
54. V.S. Gurin. “Large Clusters with Cadmium Sulfide Cores: Simulation of Thiolate 
Ligands on the Surface by ab initio MO LCAO Calculation.” Surf. Rev. Lett. 7: 
161, 2000. 
55. J.M. Huang and C.J. Murphy. Materials Research Society Luminescent Materials 
Symposium; San Francisco, 1999, pp. 33. 
56. P.J. Sebastian. “ZnCdS Films for Solar Cell and Photodetector Applications 
Deposited by in situ Chemical Doping of CdS with Zn.” Adv. Mat. Opt. Elec. 5: 
269, 1995.  
 108 
Chapter 4: Quantum Dot Bioconjugation and Directed Cell Binding3 
The formation of interfaces with individual neuronal ion channels requires 
nanoparticle binding in close proximity to channel proteins. Although this could be 
accomplished through non-specific binding, a more promising method utilizes the native 
biorecognition capabilities of proteins and peptides to adhere to targets on the cell 
surface. [1] Several strategies have already been developed to conjugate these recognition 
molecules to fluorescent dyes, [2] and these strategies can be directly applied to 
nanocrystals. Previous to our studies, quantum dots had been conjugated to both proteins 
[3] and antibodies [4], although only proteins had been used with living systems. Here, 
we describe our efforts to develop additional methods to produce targeted cell binding 
with quantum dots. 
Using CdS quantum dots, we have conjugated antibodies and peptides to 
nanoparticle surfaces for targeted cell binding. As a model system, we investigated the 
ability of these nanoparticles to bind integrins (e.g., extracellular matrix receptors [5]) on 
the cell surface. Antibody binding to the quantum dot surface was confirmed using UV-
visible absorbance spectroscopy, while peptide binding was verified using UV-visible 
absorbance spectroscopy, fluorescence anisotropy and Fourier transform infrared 
spectroscopy (FTIR). Finally, both nanoparticle-conjugates were attached to cells, 
establishing the ability of quantum dots to form controlled interfaces with cell surfaces. 
Although these results represent a model system, they can be extrapolated to a variety of 
cell surface receptors, including ion channels. Thus, these strategies have the potential to 
                                                 
3 Portions of this material have been previously published in the following reference: J.O. Winter, T.Y. 
Liu, B.A. Korgel, C.E. Schmidt. “Recognition Molecule Directed Interfacing Between 
Semiconductor Quantum Dots and Nerve Cells.” Advanced Materials  13: 1673, 2001. 
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create controlled neuroelectronic interfaces between nanocrystals and neuronal ion 
channels. 
 
4.1 FORMATION OF MOLECULAR–CELL INTERFACES  
Present neuroelectronic devices establish contact through the direct or random 
placement of cells over device electrodes. [6] However, the small size of nanoparticles 
precludes this approach for binding cell receptors controllably. Additional strategies are 
needed to bring nanoparticles into the proximity of cell surface receptors. Several 
techniques have already been developed to link fluorescent molecules and microbeads to 
various parts of the cell. [2] At the time of this work, two of these strategies had been 
employed to bind nanocrystals to proteins [3] and antibodies. [4] These and other methods 
can potentially be applied to the development of controlled neuroelectronic interfaces.  
 
4.1.1 Requirements for Forming Receptor–Scale Neuroelectronic Interfaces 
Quantum dots average 1-10 nm in diameter, [7] and the average cell surface 
receptor is 10 nm. [8] However, the cell body is typically 10-30 microns in size. [9] 
Although several methods of controlled placement exist for entire cells (e.g., 
micropositioners), none have nanometer scale resolution.  [6] Thus, precise electrical 
connections cannot be established by situating receptors over individual quantum dots. 
Biorecognition techniques provide an alternative strategy that allows direct presentation 
of nanoparticles to cells. In this method, nanoparticles are coupled to molecules that 
recognize and bind receptors on the cell surface. Nanocrystal-conjugates are then exposed 
to cells in solution, and are capable of forming precise interfaces with their receptor 
targets.  
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These techniques are well-established, as biorecognition has been used 
extensively to link other small molecules with selected cell components. [2] However, to 
develop active electronic interfaces between nanoparticles and cells, two additional 
factors must be considered. First, the conjugation of a biorecognition molecule to the 
nanocrystal must not interfere with its optoelectronic properties. Second, it is crucial that 
the distance between the nanoparticle and the cell surface receptor be minimized. This is 
because the nanoparticle electric field, which interacts with ion channels in the cell 
membrane, decays as a function of separation distance (Chapter 2, Section 2.5). Standard 
biorecognition techniques, combined with modification of the nanocrystal surface, can be 
combined to meet both of these needs. 
 
4.1.2 Biomolecular Recognition 
Biorecognition describes the strong and highly specific binding that exists 
between a receptor and its ligand target. This binding is not completely understood, but is 
believed to arise from a combination of electrostatic attractions, hydrogen bonding, and 
hydrophobic/hydrophilic interactions. [1] The cumulative interaction of these forces, 
which are individually weak, produces tight binding. Additionally, this affinity is unique 
to the ligand and its analogs, as only molecules with a certain conformation can access 
the binding site and form the appropriate bonds. Thus, the interfaces formed through 
biomolecular recognition are highly specific and controlled.  
A number of molecules have been identified as biorecognition elements, and can 
be used to connect small molecules to components of the cell. Typically, these fall into 
three classes: antibodies, proteins, and peptides. [1] Antibodies recognize components 
that are foreign to their host system, and can be produced for almost any cellular 
component. A wide range of antibodies are commercially available, and their large size 
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and high number of functional groups allow for ready conjugation to many surfaces. 
Antibodies are by far the most commonly used biorecognition element in conjugate 
chemistry. [10] However, when antibodies cannot be applied, alternatives such as 
proteins and peptides may be employed. Because protein or peptide binding will produce 
a cellular response, these methods are often utilized to impose a specific cellular function 
(e.g., receptor-mediated endocytosis [4]) to the attached molecule. Proteins can be linked 
to these molecules through chemistry techniques, the success of which depends widely on 
the nature of the protein employed. For applications where an entire protein might be too 
large or expensive, protein fragments, known as peptides, can be employed. Peptides can 
be synthesized with additional amino acids to allow for conjugation to a chosen molecule. 
 
4.1.3 Conjugation Strategies Using Biorecognition Molecules 
Several different chemistry strategies have been developed to link recognition 
molecules to surfaces. [11] The majority of these techniques rely upon the presence of 
primary amines and carboxylic acid residues, common functional groups in antibodies 
and proteins. For many materials, conjugation to these groups is straightforward. 
However, if there are no or only a few functional groups that can be chemically linked to 
amines or carboxyl groups, modification of the material’s structure may be required. One 
advantage of quantum dots is that their surfaces can be readily modified through ligand 
selection, and their conjugation to biorecognition molecules is not limited to a particular 
functional chemistry. Thus, nanoparticles can draw upon the full range of previously 
developed conjugation techniques. Two of the most frequently used methods are 
described below as examples. 
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4.1.3.1 Carbodiimide Conjugation 
By far the most commonly employed approach for establishing links between 
proteins and other molecules is carbodiimide chemistry [12]. This method produces 
amide bonds (i.e., -CO-NH2-) between free amines and carboxylic acid groups with no 
additional elements contributed to the molecule (Figure 27). Briefly, carboxylic acids are 
activated using EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) to produce a urea 
intermediate. Then, this complex reacts with primary amines to produce an amide bond 
and an isourea by-product. This technique is highly effective; however, it has many 
limitations. The most common problem associated with EDC chemistry is the direct 
relationship between cross- linking efficiency and yield. When the EDC concentration is 
increased more protein is attached to the material of interest. However, additional, 
unintended bonds may also form between conjugates, creating networks of agglomerated 
molecules. Extreme care must be taken to ensure near unimolecular attachment, and the 
amount of protein that can be incorporated without aggregation is low. 
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Figure 27: Carbodiimide Conjugation Chemistry.  
(A) Carboxylic acid residues are activated with EDC. (B) This complex reacts with 
primary amines to produce amide bonds and isourea. [Adapted from Figure 106, G.T. 
Hermanson. Bioconjugate Techniques. Academic Press, San Diego: 1996, p. 171.] 
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4.1.3.2 Avidin-Biotin Interactions and Conjugation 
A second commonly used approach to link proteins to a surface employs avidin 
and biotin [13], two naturally occurring proteins that display a remarkable affinity for 
each other. Conjugation of avidin to one molecule and biotin to the other can be used to 
produce tight binding between two unrelated components. This approach is frequently 
coupled with antibody binding to create systems that can recognize almost any cellular 
protein. A large variety of biotinylated antibodies are commercially available for this 
purpose. Conjugation of biotin to a surface is straightforward, and frequently occurs 
through reaction of a commercially available, activated biotin molecule (i.e., 
biotinamidocaproic acid 3-sulfo-N-hydroxysuccinimide ester) with primary amines. 
Conjugation of avidin can be accomplished through many mechanisms, the most 
common utilizing primary amines in both the avidin molecule and the material of interest. 
In this method, free amines in avidin are activated with 2- iminothiolane to produce a 
sulfhydryl (-SH) leaving group (Figure 28). Then, the surface in question is modified to 
contain maleimides using SMCC (succinylimidyl-4-(N-maleimidomethyl)cyclohexane–
1-carboxylate). This reaction proceeds through primary amines on the material surface 
and the NHS group (N-hydroxylsuccinyl group) of the SMCC molecule. Finally, the –SH 
group of avidin reacts with maleimides in the SMCC-conjugated material to produce a 
thioether bond. As both components initially contain amines, this reaction can also occur 





Figure 28: Streptavidin and Avidin Conjugation Chemistry. 
(A) Avidin (light gray) is activated with 2- iminothiolane, producing an activated thiol 
complex. (B) The molecule of interest (dark gray) reacts with SMCC to produce a free 
NHS molecule and an activated maleimide complex. (C) The activated thiol-avidin 
complex and the activated SMCC-conjugate react, creating an avidin-conjugate. 
[Adapted from Figures 158 and 363, G.T. Hermanson. Bioconjugate Techniques. 





















































4.2 PREVIOUSLY EMPLOYED CONJUGATION STRATEGIES FOR QUANTUM DOTS 
At the initiation of our work, there were only two significant publications 
describing quantum dots in a biological setting, [3-4] and both of these papers 
investigated nanoparticles as potential biolabels. Quantum yield is the main consideration 
for this use, and the particles employed were created us ing the highly luminescent (e.g., 
quantum yields ~ 50% [14]) core-shell synthesis. This synthesis produces TOPO-capped 
particles in organic solution. Thus, additional processing was introduced to provide water 
solubility and to attach biomolecules. Conjugation strategies, such as those described 
above, were some of the first approaches utilized for biofunctionalization of these 
quantum dots. 
 
4.2.1 Biofunctionalization of Silica-Coated Nanocrystals 
The first paper, by Alivisatos, et al., [3] utilized CdSe-CdS core-shell 
nanocrystals. Particles were enclosed in a silica shell, which not only conferred water-
solubility on the particle, but also provided functional groups for bioconjugation. This 
was accomplished through variation of the silanization agent employed. For example, 
trimethoxysilylpropyl urea ((CH3O)3-Si-(CH2)3NH-CO-NH2) and 3-aminopropyl 
trimethoxysilane ((CH3O)3-Si-(CH2)3NH2) both introduce positively charged amine 
residues onto the particle surface. This modification can be exploited to produce cell 
labeling through either electrostatic or specific interactions. 
To demonstrate non-specific binding, the silica coating was modified with 
trimethoxysilylpropyl urea (urea = NH2-C-NH3+ at neutral pH), which binds negatively 
charged acetate groups (-CH2-COO- at neutral pH) in the cell nucleus. Nanocrystal 
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binding was displayed at the nucleus, as evidenced through fluorescence microscopy 
measurements. Binding was suppressed with the addition of a negatively-charged reagent 
or sodium dodecylsulfate (SDS), indicating that it was mediated primarily through non-
specific electrostatic interactions. 
To demonstrate specific binding, biotin was conjugated to the nanocrystal surface 
(Section 4.1.3.2). First, the silica coating of the nanocrystal was modified to include 
primary amines using 3-aminopropyltrimethoxysilane. Then, biotinamidocaproic acid 3-
sulfo-N-hydroxysuccinimide ester was introduced. The NHS ester group of the activated 
biotin reacts quickly with primary amines to produce amide bonds, linking the 
nanocrystals to biotin molecules. To produce interfacing between these conjugates and 
cells, a complicated duel-biotin/streptavidin system was used. The cells were exposed to 
a separate solution of biotinylated-phalloidin, which adhered to F-actin filaments in the 
cytoskeleton. Then, streptavidin was introduced, binding the biotin component of biotin-
phalloidin. Finally, cells were incubated with the biotinylated-nanocrystals, which bound 
to the phalloidin-biotin-streptavidin complexes at avidin sites. Using this system, specific 
nanoparticle binding of F-actin filaments was produced. 
 
4.2.2 Biofunctiona lization of Mercaptoacetic Acid-Coated Nanocrystals 
The second paper, by S. Nie, et al., [4] used a slightly different approach to 
investigate CdSe-ZnS core-shell particles as potential biolabels. Particles were altered 
through mercaptoacetic acid ligand exchange, placing carboxyl groups on the surface. 
Using EDC (i.e., carbodiimide chemistry, Section 4.1.3.1), those carboxyl groups were 
conjugated to the reactive  amines of IgG antibodies and transferrin, a surface protein that 
promotes uptake of iron molecules through receptor-mediated endocytosis. Because 
aggregation is a side-effect of EDC chemistry, conjugates were examined with 
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transmission electron microscopy and were found to be primarily single particles. 
Additionally, fluorescence optical microscopy confirmed that conjugated particles 
maintain their initial optical properties.  
To demonstrate biorecognition, IgG conjugates were shown to aggregate in the 
presence of a specific polyclonal antibody known to bind IgG fragments. These particles 
were not, however, examined with living cells. On the other hand, transferrin-conjugated 
particles were incubated with living cells. Transferrin-conjugated particles were found in 
intracellular vesicles, as would be expected following receptor-mediated endocytosis.  
 
4.2.3 Summary of Previous Quantum Dot Strategies and Applicability to the 
Neuroelectronic Interface 
Although the previously used techniques are highly successful for biolabeling 
applications, many limitations exist to their application in a neuroelectronic interface. 
Quantum dot binding was achieved through non-specific interactions  [3] or through 
secondary binding to molecular receptors. [3-4] Neither of these strategies can produce 
the specificity or close-proximity binding required for the neuroelectronic interface. Non-
specific interactions (e.g., positively charged molecules binding nuclear proteins) can 
provide disperse labeling over large portions of the cell membrane, and may even 
produce connections with ion channels. However, they do not provide the control to 
interface nanoparticles with a chosen receptor of interest. Alternatively, indirect 
attachment methods (i.e., avidin-biotin systems and 2º antibodies), while specific, give 
rise to significant cell-quantum dot separation distances, on the order of 30 nm, [15]  
reducing electrical contact. Furthermore, at the initiation of our work, only intracellular 
labeling had been demonstrated with living cells. Thus, new methods were needed to 
produce close proximity binding to targeted receptors on the extracellular surface. 
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4.3 RECEPTOR-NANOPARTICLE INTERFACES USING RECOGNITION MOLECULES 
4.3.1 Strategies for Creating Quantum Dot–Receptor Interfaces 
A limited number of biorecognition molecules can produce separation distances 
of less than 10 nanometers between their conjugates and cells. In fact, the majority of 
proteins are several nanometers in size. For example, a single antibody is approximately 
15 nm in diameter. [16] Considering that the Debye screening length for biological saline 
is on the order of 1 nm, [17] this distance is too large to allow for direct nanoparticle 
influence on the cell membrane potential. Both of the nanocrystal conjugation 
technologies discussed previously utilize large protein molecules (Sections 4.2.2 and 
4.2.3), producing untenable separation distances. [3-4] Thus, we developed two 
additional routes to interface the receptors of living neurons with semiconductor quantum 
dots. The first employs known antibody-antigen recognition and the second, a new 
approach, utilizes peptide recognition groups. 
 
4.3.1.1 Antibody-Based Approach 
The first method expands the quantum dot-antibody conjugation chemistry 
demonstrated by Nie, et al. [4] to create more intimate cell connections. As discussed 
above, antibodies themselves are too large to create neuroelectronic interfaces; however, 
an alternative is to use antibody Fab fragments, the smallest portion of an antibody that 
retains its binding capability. These fragments are ~5 nm in diameter. [16] Fab fragments 
are commercially available for many cell targets, and can be created using papain 
digestion. [18] Although antibodies have been demonstrated previously by Nie, et al. [4]  
to link quantum dots to biomolecules, this work did not demonstrate cell compatibility. 
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Additionally, the particles studied were not produced using aqueous methods. Instead, 
organic CdSe-ZnS TOPO-capped quantum dots were made water-soluble through a 
complicated ligand exchange process. Thus, we expanded this method to bind particles 
manufactured using aqueous synthesis and demonstrated connections to living cells. 
As a model system, we conjugated aqueous CdS quantum dots to IgG secondary 
antibodies using the technique described by Nie, et al.  [4] (Figure 29A). IgG antibodies 
recognize and bind a variety of primary antibodies that are specific to targets on the cell 
surface. In particular, we chose to investigate integrins (i.e., extracellular matrix receptors 
on the cell surface) because of their abundance and documented expression pattern. [19] 
Integrins are not electrically active, but expansion of this technique to ion channels is 
straightforward through selection of the appropriate antibody. Although this system 
produces a large separation distance (~30 nm [15]), it demonstrates the utility of antibody 
intermediates for quantum dot-cell interfacing. Ultimately, this method could be 
expanded to include Fab fragments, which possess a more appropriate size for the 
neuroelectronic interface. Thus, the model system is not ideal for neuroelectronic 
interface creation, but can be easily altered to create components of the proper 
dimensions and binding capabilities. 
 
4.3.1.2 Peptide-Based Approach 
In addition to the antibody method, a second, novel approach utilizing peptides 
was developed (Figure 29B). Biorecognition peptides are protein fragments that promote 
attachment of bulk protein to the active site. The advantage of employing peptides, as 
opposed to the whole protein molecule, is their large reduction in scale. The minimum 
peptide length for recognition depends on the protein selected, but can be as short as 3-5 
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amino acids (e.g., 1-1.5 nm). [20-21] Additionally, peptides can be manufactured to 
almost any length, with each amino acid roughly corresponding to 3 angstroms (0.3 nm) 
for a straight chain conformation. [22] Thus, the separation distance between the particle 
and the cell surface can be tuned through altering the length of the peptide. Their small 
size and tunable length make peptides ideal alternatives to large conjugation molecules. 
For our model system, we investigated aqueous CdS nanoparticles and selected 
peptides. In particular, we chose to investigate peptides containing some of the shortest 
sequences necessary for recognition, RGDS [20] and YIGSR, [21] which bind to integrin 
receptors. These sequences bind the same receptor class as the antibody-based method, 
allowing for direct comparison between the two techniques. Peptides were linked to the 
quantum dot through a novel approach: thiolated ligand binding using cysteine residues. 
They were used as sole passivating agents and in combination with mercaptoacetic acid, a 
traditional ligand. In this method, peptide attachment to the quantum dot surface occurs 
during synthesis, providing a single-step technique for nanocrystal synthesis and 
bioconjugation. Although our model system binds to integrins, which are not electrically 
active, it can be expanded to include ion channels. Given these advantages, peptide 
bioconjugation presents a superior approach for forming close-range interfaces between 
semiconductor quantum dots and cellular receptors. 
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Figure 29: Recognition Molecule-Directed Interfacing Between Quantum Dots and Nerve 
Cells. 
(A) Antibody Technique. A primary antibody binds to specific cell surface receptors. 
Multiple secondary antibodies bind to the primary antibody. Quantum dots are attached 
to the secondary antibody through amine bonds. The expected separation distance 
between the quantum dot and the cell is ~30 nm [15] assuming no crosslinking of 
secondary antibodies and a linear attachment. Actual distances may be smaller. (B) 
Peptide Technique. Peptide recognition sequences bind to specific cell surface receptors. 
These sequences are embedded in the capping layer of the quantum dots producing 
primary attachment. Based on stoichiomentric and chemical considerations, a monolayer 
of peptide and mercaptoacetic acid is expected. The maximum expected separation 






4.3.1.3 Summary of Quantum Dot–Recognition Molecule Approaches 
Unlike previous methods, our approaches are capable of creating extremely close 
connections between quantum dots at cell receptors. Additionally, these connections are 
localized to the specific receptor of interest. Given the commercial availability of 
antibodies, a wide variety of receptors may be investigated at separation distances of ~5 
nm. Although peptides are not as widely available as antibodies, the peptide approach 
could theoretically produce separation distances of 1 nm or less. Thus, these techniques 
are the first to allow for electrical interactions between the receptors of living cells and 
nano-scale inorganic particles. Although our interest is the development of a 
neuroelectronic interface, these methods could be used to study a myriad of other 
processes, including ox-redox reactions, mitochondrial respiration, and cell metabolism. 
 
4.3.2 Materials and Methods  
4.3.2.1 Synthesis of CdS Quantum Dots (and Peptide-Coated CdS Dots) 
 Dots were synthesized using previously published methods. [23] Briefly,  
carboxyl-stabilized CdS nanocrystals were produced through arrested precipitation at 
room temperature in aqueous solution. Mercaptoacetic acid served as the colloidal 
stabilizer. All chemicals were used as obtained from Sigma Chemical Co. (St. Louis, 
MO). Nanocrystals were prepared from a stirred solution of 0.009 g CdCl2 (5 mM) in 10 
ml of pure distilled, deionized water. Then, 200  µL of mercaptoacetic acid were added to 
the solution (220 mM MAA) lowering the pH to ~2.00. The pH was raised to 7 with 
concentrated NaOH (~1760 µL 1 M equivalents); and 10 ml of 2.5 mM Na2S•9H2O 
(0.00575 g) were added, raising the final pH to ~8.13. The solution turned yellow shortly 
 124 
after sulfide addition due to CdS nanocrystal formation, which was qualitatively 
confirmed using a UV lamp to observe fluorescence.  
Three types of peptide-coated quantum dots were produced: RGD-quantum dots, 
RGD/MAA-quantum dots, and YIGSR/MAA-quantum dots. The specific peptides 
utilized were Acetyl-CGGGRGDS and CDPGYIGSR. Both peptides were synthesized 
and purified at the University of Texas Protein Microanalysis facility and were used as 
supplied. For RGD-quantum dots, RGD peptide was added at 10 mM (i.e., 8 mg/mL 
CdCl2) to the CdCl2 solution in place of MAA. For RGD/MAA- and YIGSR/MAA- 
quantum dots, peptide was added at 0.6 mM (i.e., 0.5 mg/mL for RGD and 0.65 mg/mL 
for YIGSR) to the CdCl2 solution in addition to the 220 mM MAA. Quantum dots 
containing a control sequence, CGGGRVDS, were also synthesized following the 
procedure for RGD/MAA-nanoparticles. This sequence, which does not bind the cell, 
[20] was used to demonstrate the specificity of peptide binding. Final incorporation rates 
of the peptides were not measured explicitly, but incorporation was qualitatively 
confirmed using analytical techniques. 
 
4.3.2.2 Conjugation of Quantum Dots to IgG Antibody 
Goat IgG antibody (Jackson Immunochemistry) was covalently linked to CdS 
quantum dots at the carboxyl terminus of the quantum dot capping ligand (i.e., MAA). 
Antibody was added to MES (2-(N-Morpholino)ethanesulfonic acid, Sigma) 50 mM 
buffer at a concentration of 0.3 mg/ml. Then, an equal volume of 1.2 µM (post-synthesis  
concentration diluted by a factor of 6) quantum dots was added to the solution. After a 15 
minute incubation period, EDC (1-Ethyl-3-(3-Dimethylaminopropyl)-Carbodiimide 
Hydrochloride, Sigma) was added at 4 mg/ml. Next, the pH was adjusted to pH 6.5 ± 0.2. 
Following two hours in an orbital shaker, the reaction was quenched using glycine at 7.5 
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mg/ml. Conjugated quantum dots were isolated via repeated centrifugation (3000 g) and 
stored in 10 mM phosphate buffered saline (PBS, Table III) at pH 7.4.  
 
Table III: 10 mM Phosphate Buffered Saline (PBS) 
Component1 Concentration 
Sodium Phosphate Monobasic 0.131 g 
Sodium Phosphate Dibasic 0.575 g 
Sodium Chloride 4.5 g 
Distilled, De- ionized Water 500 mL 
 1All components were purchased from Fisher 
 
Control experiments exposing quantum dots to antibody without EDC revealed 
noticeable physisorption of IgG on quantum dots, as evidenced by pellet formation 
during centrifugation. However, absorbance measurements of these nanocrystals revealed 
substantially less IgG bind ing than in the presence of EDC. Additionally, when the pH of 
the nanoparticle solution was raised above 6.5, the physisorbed antibody dissociated from 
the nanocrystals, as evidenced by the inability to form a pellet at high pH. Therefore, 
prior to all nerve cell labeling experiments, the nanocrystals were transferred to 1 ml of 
PBS (pH 7.4). As a result of EDC-induced crosslinking, some agglomeration of particles 
occurred; however, the aggregates were eliminated through sterile filtration. Remaining 
aggregates were small enough to remain suspended in solution.  
 
4.3.2.3 Absorbance Measurements 
Absorbance spectra of antibody-quantum dot conjugates were used to confirm 
antibody binding. Measurements were collected using a Beckman DU500 series 
spectrophotometer. Unmodified antibody and quantum dot spectra were collected as 
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standards and compared to the antibody-quantum dot conjugates. Additionally, MAA-
quantum dots, RGD/MAA-quantum dots, and RGD-quantum dots were all examined to 
determine the degree of peptide binding. All measurements were acquired at optical 
densities less than 1. 
 
4.3.2.4 Fluorescence Anisotropy 
Fluorescence anisotropy is commonly employed to confirm the attachment of 
biomolecules to fluorescent species. The technique uses polarized light to obtain the 
solution tumbling rate for a fluorescent compound. Larger molecules display slower 
tumbling rates, thus conjugates can be distinguished from unmodified quantum dots. 
Anisotropy measurements were collected with a Sim Aminco Bowman Series 2 
Luminescent Spectrophotometer with  λexc=400 and λem=600. Measurements were 
repeated ten times for each sample. 
 
4.3.2.5 Fourier Transform Infrared Spectroscopy (FTIR) Measurements 
FTIR spectroscopy was used to confirm peptide conjugation to the nanocrystal 
surface. Quantum dots were obtained as a solid through the addition of a 1-propanol anti-
solvent and centrifugation. Approximately 10 mg of this solid were mixed with an excess 
of potassium bromide (KBr) and pressed into a transparent pellet. Pellets were analyzed 
using a Thermo Mattson Affinity Gold FTIR with Winfirst Software in a nitrogen 
atmosphere. Measurements were not collected until the concentration of water and CO2 in 
the chamber were negligible (~30 minutes), as determined by FTIR baseline spectra. As a 
control, 10 mg of dry peptide were also pelleted and evaluated under the same conditions.  
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4.3.2.6 Cell Culture  
SK-N-SH neuroblastoma cells (American Type Culture Collection #HTB-11) 
were cultured in DMEM cell culture medium (Sigma) with 10% fetal bovine serum (FBS, 
Gibco) and 1% penicillin-streptomycin (pen-strep, Gibco). Cells were plated at densities 
of 1:8 and passaged every 6 days. Medium was changed every 2 days. Cells with passage 
numbers greater than 20 were discarded. SK-N-SH cells exhibit both neuronal and 
fibroblast morphologies. [24] Dense cultures produce the neuronal morphology; plating 
densities were selected to maximize this morphology. 
 
4.3.2.7 CdS Morbidity Studies  
To establish the cytocompatibility of CdS quantum dots, particles were added to 
culture medium and exposed to cells for one passage period. Cells were incubated with 
CdS dots at concentrations of 3x10-11, 1.5x10-11, and 0.75x10-11 M in DMEM cell culture 
medium with FBS and pen-strep added. These concentrations reflect multiples of the 
relative number of quantum dots added to the cells in the attachment procedure, up to ten 
times in excess. After adjustment to biocompatible salt concentrations (9 g/L), cell death 
did not occur with CdS quantum dot addition. Cells were studied for five days, 
monitoring proliferation and attachment. No differences from controls were observed. 
 
4.3.2.8 Attachment of Quantum Dot Complexes to Cells 
 Quantum dot complexes were attached to cells using standard immunocytology 
techniques. [1] Briefly, cells were placed on 22x22 mm no. 1 thickness coverslips using 
imaging chambers (Sigma, Cat. No. Z36,585-4) to retain fluid. Cells were cultured at 
densities of 1 x 104 cells/mL in DMEM medium (Sigma) at 37 ºC and 5% CO2 in sterile 
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conditions. After the cells reached ~70% confluency (~2 days), they were washed with 
Dulbecco’s PBS (DPBS, Table IV) Then, the cells were blocked with 5% Bovine Serum 
Albumin in DPBS (BSA-DPBS,) for one hour at 4ºC. Following blocking, cells were 
washed with DPBS.  
For antibody attachment (Figure 29A), primary antibody (anti-CD51, Accurate 
Chemical) was added at 10 µg/ml in BSA-DPBS and incubated for 30 minutes at 4ºC. 
Cells were washed three times with DPBS. Then, antibody-quantum dot conjugate was 
added to cells filling the imaging chamber (~1 ml/chamber). Cells were incubated for 30 
minutes at 4ºC then washed with DPBS three times.  
For peptide attachment (Figure 29B), peptide-quantum dot conjugates were first 
modified to pH 7.4 and dispersed in DPBS. The pH was adjusted using 1M and 0.1 M 
NaOH or HCl, as required. DPBS suspensions were obtained through either the addition 
of powdered DPBS salts, resuspension in DPBS following anti-solvent addition and 
centrifugation, or dilution with an equal volume of 2X DPBS. The best results occurred 
with 2X DPBS dilutions. The imaging chamber was filled with peptide-quantum dot 
conjugate solution (~1 ml/chamber), and cells were incubated for 30 minutes at 4ºC. 
Then, cells were washed three times with DPBS.  
Following staining with either antibody- or peptide-conjugates, cells were stored 
in DPBS at 4ºC until observation. Imaging chambers were sealed with a 25 x 25 mm no. 
1 square coverslip. 
 129 
 
Table IV: Dulbecco’s Phosphate Buffered Saline (DPBS) 
Component1 Concentration 
Potassium Chloride 0.100 g 
Calcium Chloride 0.050 g 
Magnesium Chloride * 6 H2O 0.050 g 
Potassium Phosphate Monobasic 0.100 g 
Sodium Phosphate Dibasic 0.575 g 
Sodium Chloride 4 g 
Distilled, De- ionized Water 500 mL 
 1All components were purchased from Fisher 
 
4.3.2.9 Fluorescence Microscopy 
Fluorescence and phase contrast images were obtained using an Olympus IX70 
inverted microscope with a mercury arc lamp and UV (λexc=330-385) and wideband blue 
(λexc=450-480) filter sets. Images were collected immediately after formation of the 
quantum dot-cell interfaces, employing a 100X objective with oil immersion. The use of 
coverslips, in conjunction with imaging chambers, eliminated the requirement of sample 
inversion. All images were collected with an exposure time of 496 ms. Some images 
were modified for brightness and contrast using Adobe Photoshop version 5.5. 
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4.3.3 Results and Discussion 
4.3.3.1 CdS Nanocrystal Synthesis and Cytocompatibility 
Cadmium sulfide (CdS) quantum dots (Figure 30A) were selected for these 
studies because of their straightforward single-step preparation,  [26] which was easily 
modified for recognition molecule addition. The synthesis yields nanocrystals coated 
with exposed carboxyl groups on the particle surface that provide water solubility and 
convenient linking sites for amine-terminated antibodies. [12] The CdS quantum dots 
exhibit robust photoluminescence (PL) in visible wavelengths with photoluminescence 
excitation energies (PLE) just above those that induce cell damage (Figures 30B, C). To 
confirm that CdS quantum dots could be used successfully in conjunction with living 
cells, cells were exposed to quantum dot concentrations up to ten times in excess of that 
applied during labeling for five days. Cells were monitored for attachment and 
proliferation. No differences were seen from controls, suggesting that quantum dots were 
not toxic to cells over this time frame.  
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Figure 30: Properties of CdS 
Quantum Dots Employed for 
Bioconjugation Studies.  
(A) TEM of CdS Quantum Dots. 
The nanocrystals have an average 
diameter of 30 Å with a 3.1 Å 
lattice spacing characteristic of 
wurtzite CdS. Scale bar = 1 nm. 
(B) Room temperature 
photoluminescence, PL, (λexc=400 
nm) and photoluminescence 
excitation, PLE, (λem= 600 nm) 
spectra of CdS quantum dots 
dispersed at pH 7.4 in phosphate 
buffered saline (PBS).  
(C) Room temperature absorbance 
spectrum of an aqueous dispersion 
of CdS quantum dots. The exciton 
peak at 380 nm (3.6 eV) 
corresponds to an average particle 







4.3.3.2 Quantum Dot–Neuron Interfaces Using Antibody Recognition 
To extend previous nanoparticle-conjugate work [3,4] to the receptors of living 
neurons, quantum dots were attached to SK-N-SH neuroblastoma cells (American Type 
Culture Collection #HTB-11) using an indirect immunofluorescence approach without 
fixation. [24] Antibody-nanoparticle conjugates were produced through the covalent 
linkage of nanoparticle surface carboxyl groups to Immunoglobulin G (IgG) secondary 
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antibodies (2ºAb) using EDC chemistry. [12] Attachment of IgG 2ºAbs to quantum dots 
was confirmed through UV-visible absorbance spectroscopy (Figure 31). Quantum dot-
IgG conjugates exhibit absorbance peaks indicative of both antibody and quantum dots; 





Figure 31: Room Temperature Absorbance Spectra of CdS Quantum Dots and CdS-
Antibody Complexes.  
IgG absorbs at 280 nm (squares). After binding IgG, the quantum dot absorbance 
spectrum (dashed) exhibits this feature, which is absent in bare quantum dots (solid). 
(Inset) CdS quantum dots bound to IgG (dashed) exhibit the same exciton peak as bare 
quantum dots (solid) at 380 nm. All materials were dispersed in PBS buffer (pH 7.4). 
 
 These conjugates were then attached to SK-N-SH neuroblastoma cells using a 
two-antibody method. The human neuronal SK-N-SH cell line was selected because they 
are the closest approximation to the primary cells that will ultimately be used in a 
neuroelectronic interface. In the two-antibody approach, a primary antibody (1ºAb), 
targeting the αv portion of integrin receptors (anti-CD51, Accurate Chemical) was 
attached to the cell surface. The integrin αv subunit binds both vitronectin and fibronectin 
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in the form of αvβ1 and αvβ3 complexes. It was chosen as the attachment site because of 
its location on the exterior of the cell [28] and the high expression levels of the αvβ1 
complex in the SK-N-SH cell type. [24] Following primary antibody exposure, quantum 
dot-IgG 2ºAb conjugates were exposed to 1°Ab-labeled SK-N-SH cells (Figure 29A).  
Attachment of the antibody complexes to the cells was verified through phase 
contrast and fluorescence optical microscopy images (Figure 32A and 32B respectively). 
Controls establishing the location of the αv subunits on the SK-N-SH nerve cells were 
performed in a series of separate experiments (Figure 32C) using IgG 2ºAb attached to a 
common fluorescent dye, Alexa-488 (Molecular Probes), and compared with published 
results. [19] Quantum dot-IgG conjugates and Ab-Alexa-488 controls demonstrate 
binding only on the cell exterior, where integrin proteins are located. [28] Without 1oAb 
tagging of the cell, no observable binding of IgG/CdS quantum dots occurred (Figure 
32D). Also, bare quantum dots (i.e., quantum dots coated with carboxyl groups only) did 
not attach to the cells (Figure 32E). These results further confirm that antibodies mediate 












Figure 32: Quantum 
Dot Attachment to 
Neurons Using 
Antibody Binding 
Techniques.   
 
(A) Phase contrast and (B) fluorescence (λexc=330-385 nm) optical microscopy images of 
SK-N-SH human neuroblastoma cells labeled with CdS quantum dots. Quantum dots 
were functionalized with IgG 2°Abs that bind anti-αv integrin subunit 1° Abs. In (B,D,E) 
the blue color is the native autofluorescence of the cytoplasm of the cell—common in 
near UV excitation. (B) The yellow/orange color is CdS quantum dot luminescence. (C) 
Fluorescence image (λexc=450-480 nm) of control labeled with anti-αv 1ºAb and Alexa-
488 conjugated-IgG 2ºAb. Green fluorescence shows location of integrin receptors. (D,E) 
Fluorescence images ((λexc=330-385 nm) of controls incubated with (D) 2º antibody-














4.3.3.3 Quantum Dot–Neuron Interfaces Using Peptide Recognition 
To reduce quantum dot-neuron separation distances beyond those achieved with 
the antibody method, peptide recognition molecules were attached to the CdS quantum 
dots. Two peptide sequences known to bind integrins were selected for further study. One 
of these peptides, RGD (Arg-Gly-Asp), binds the αvβ1 and αvβ3 integrins studied in our 
antibody model system, and was used for direct comparison. [20] The actual sequence 
used, CGGGRGDS, included the tetramer, RGDS, which has been found to adhere to the 
receptor more effectively than the trimer. [29] A terminal cysteine residue was added to 
attach the RGDS recognition group to the particle surface through its exposed atoms. The 
three intermediate glycines are intended to serve as molecular spacers, potentially 
reducing steric hindrance to cell binding that could result from the mercaptoacetic acid 
groups and the nanocrystal itself (Figure 29B). A second integrin binding sequence, the 
naturally occurring laminin peptide CDPGYIGSR, [21] was also studied for comparison. 
This sequence binds α4β1 integrin receptors through the YIGSR pentapeptide, while the 
terminal cysteine residue allows for attachment to the nanoparticle surface. 
CdS nanocrystals were synthesized through a single-step arrested precipitation in 
the presence of peptide. Because of cost limitations and their blue fluorescence, quantum 
dots that utilize only peptide as a ligand are not practical for final implementation in a 
neuroelectronic interface. Therefore, three types of nanoparticles were created. To 
demonstrate cell binding, RGD/MAA-quantum dots and YIGSR/MAA-quantum dots 
containing only small amounts of peptide were developed; while RGD-quantum dots 
were created to verify peptide incorporation onto the nanoparticle surface.  
Peptide was added to the CdCl2 precursor solution either at 10 mM concentration 
(RGD-quantum dots) or in a 0.6:220 molar ratio with MAA (RGD/MAA- and 
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YIGSR/MAA-quantum dots). The addition of MAA to RGD/MAA- and YIGSR/MAA-
conjugates stabilizes the quantum dot size and prevents unwanted particle aggregation, 
while the peptide groups supply sites for cell surface receptor binding. Both MAA and 
the peptide bind CdS particle surfaces through sulfur atoms, creating either disulfide 
bonds or additional CdS bonds. There are no additional binding molecules exposed, and 
no chemical activators added. For peptide/MAA-quantum dots, peptide is added in a low 
stoichiometric ratio; and a monolayer is expected to form. Additional peptide ratios were 
not examined, but since peptide and mercaptoacetic acid compete for binding sites, it is 
expected that a minimum value for binding exists. 
The resulting nanocrystals exhibit absorbance and PL spectra similar in shape but 
blue-shifted from those of quantum dots made without peptide (Figure 33). This is 
expected because our previous studies (Chapter 3, section 3.3.4.4) demonstrated that 
increased ligand length results in smaller (i.e., blue-shifted) particles as a result of ligand 
steric hindrance to nanocrystal growth. As the concentration of peptide is increased, this 
effect is more pronounced, indicating additional peptide binding. 
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dots (dashed) are blue 




peptide (triangles vs. 
dashed) evidence a 
more pronounced shift 
in the absorbance 
edge. 
 
To further confirm peptide conjugation, RGD/MAA-quantum dots were examined 
using anisotropic fluorescence spectroscopy (or tumbling fluorescence spectroscopy), 
which measures changes in fluorescence polarization that result from differing rotational 
rates in solution. [30] Heavier molecules rotate less frequently, and therefore exhibit 
more anisotropy in their fluorescence. Quantum dots functionalized with CGGGRGDS 
peptide demonstrated statistically higher anisotropy than mercaptoacetic acid-coated 
quantum dots (p<0.0001, Figure 34) indicating peptide attachment. 




















Figure 34: Fluorescence Anisotropy of CdS Quantum Dots.  
Peptide-quantum dot conjugates demonstrate a greater degree of anisotropy than bare 
quantum dots (i.e., quantum dots coated with only mercaptoacetic acid). This occurs due 
to the bulkier size of the CGGGRGDS peptide. Peptide-quantum dot complexes 
displayed an anisotropy of (1.16 ± 0.3) x 10-2 polarization units, versus (5.17 ± 4.79) x 
10-3 polarization units for the bare quantum dots (p<0.0001), confirming peptide 
attachment to the quantum dots (p<0.0001). [N=10] 
 
Additionally, peptide binding was confirmed using Fourier transform infrared 
spectroscopy (FTIR). This technique evaluates the atomic vibrations of a molecule in the 
infrared spectrum. Results can be compared to standards or known spectra to determine 
the composition of a molecule. As MAA molecules would provide additional vibrations 
in the spectra, FTIR spectra were collected for RGD-quantum dots. These results were 
compared to a control consisting of CGGGRGDS peptide powder (Figure 35). The 
spectra for the peptide control and the RGD-quantum dots overlap, as would be expected 
for peptide-conjugated nanocrystals. For example, amide II and III peaks indicative of 




























Vibrations specific to the nanocrystal occur at lower wavenumbers, beyond the sensitivity 
of most IR instruments, and are therefore not evidenced in the spectrum. [32] 
Figure 35: FTIR of 
RGD-Quantum Dots. 
FTIR spectra of 
powdered peptide 
(black) and RGD-
quantum dots (red) 
demonstrate similar 
peaks, indicating the 
presence of peptide 










The combined results of absorbance, anisotropy, and FTIR confirm peptide 
binding to the nanoparticle surface. This binding appears to occur in proportion to the 
amount of peptide added, as the absorbance onset is further blue-shifted (i.e., smaller 
particles) for increased peptide quantities. Although we did not investigate additional 
peptide ratios, these results confirm the ability to control the amount of peptide bound to 
the nanocrystal surface. Thus, peptide conjugation to quantum dots not only occurs, but is 
tunable depending on the concentration of peptide added to CdCl2 solution.  
The procedure for attaching peptide-coated quantum dots to the cell resembles 
that used for the antibody labeling method, [24] the key difference being that only a 
primary incubation was needed, as peptide-coated quantum dots do not require an 
























exposed to cells to produce quantum dot-receptor interfaces. RGD-quantum dots were not 
used as their blue-fluorescence cannot be distinguished from the native autofluorescence 
of the cell. Brightfield and fluorescence microscopy images of the cells following 
exposure to RGD/MAA-quantum dots (Figures 36A and 36B, respectively) demonstrate 
nanoparticle binding. A yellow/orange layer of CdS quantum dots coats the blue 
autofluorescent cell. The quantum dots surround the exterior of the cell as expected, 






Figure 36: Quantum Dot Attachment to Neurons Using Peptide Binding Techniques.    
(A) Brightfield and (B) fluorescence (λexc=330-385 nm) optical microscopy images of 
SK-N-SH human neuroblastoma cells. CdS quantum dots conjugated to CGGGRGDS 
peptide and MAA ligands are on the surface of the cell. In (B), the blue color is the native 
autofluorescence of the cytoplasm of the cell—common in near UV excitation—and the 
yellow/orange color is CdS quantum dot luminescence.  
 
To further confirm the ability of peptides to form quantum dot–neuronal receptor 
interfaces, YIGSR/MAA-quantum dots were exposed to cells (Figure 37). YIGSR 
binding was similar to that of the RGD peptide. Fluorescence was localized to the cell 







Figure 37: YIGSR-Quantum Dot Labeling of Neuroblastoma 
Cells. 
Fluorescence (λexc=330-385 nm) optical microscopy image 
of SK-N-SH human neuroblastoma cells labeled with CdS 
quantum dots functionalized with CDPGYIGSR peptide and 
MAA. The blue color is the native autofluorescence of the 
cytoplasm of the cell—common in near UV excitation—and 
the yellow color is CdS quantum dot luminescence.  
 
 
Compared to nerve cells labeled with IgG-functionalized quantum dots (Figure 
32B), peptide-coated quantum dots (Figure 36B, Figure 37) experience significantly 
lower aggregation. Antibody- labeled quantum dots were more susceptible to aggregation 
than the peptide-quantum dot conjugates because of multiple secondary antibody binding 
and chemically induced cross- linking. This resulted in increased steric hindrance and 
clustering compared to the peptide approach. Both antibody- and peptide-conjugated 
quantum dot solutions demonstrate the same initial PL spectra intensity and are applied at 
the same concentration. 
Therefore, we conclude that the reduced overall luminescence intensity from the 
peptide-coated quantum dots compared to the antibody-labeled quantum dots results from 
primary, specific binding (i.e., lower signal amplification), and not from differing 
material properties of the quantum dots. To ensure that the peptide sequences indeed 
recognize specific receptors on the cell surface, peptide/MAA-quantum dots were 
synthesized with a non-binding control peptide sequence, [20] CGGGRVDS, and then 
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4.3.4 Summary of Peptide and Antibody Quantum Dot Conjugation 
We have attached semiconductor quantum dots to living neurons utilizing both 
antibody and peptide recognition molecules. Unlike previous work interfacing nerve cells 
and electronic materials, [6] these techniques do not require directed neuronal growth. 
Instead, the electronic materials are brought to specific cell surface targets on the nerve. 
Furthermore, peptide recognition molecules provide nanometer-scale control over the 
targeting and separation distance between the quantum dot and the cell. Antibody 
methods could be adapted to produce similar separation distances using Fab fragments. 
[16, 18]  
Although these techniques were demonstrated using integrin-binding as a model 
system, the methods can be adapted to neuronal ion channels. Antibodies for a variety of 
ion channels are available commercially, and can be treated to create Fab fragments. [18] 
Additionally, if suitable antibodies are not available for the desired ion channel, they may 
be manufactured directly. [33] To ensure proper interface formation, the antibody 
selected must bind the cell on the extracellular surface, and must not inhibit or activate 
the ion channel under study.  
Expansion of the peptide method to ion channels is slightly more difficult than 
with the antibody system. The majority of known ion channel binding peptides affect the 
function of the channel. [34-37] However, two possibilities may allow for peptide use. 
Binding peptides that do not inhibit channel function could be identified using phage 
display techniques, [38] or the ion channel itself could be genetically modified to express 
a molecule with a known peptide binding sequence. [39] Either of these techniques would 
allow for close-proximity binding to ion channels. 
The ability to design devices with specific, known attachment sites and 
controllable nanometer- length separation distances opens the door to developing future 
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bioelectronic devices. These techniques can be adapted to bind ion channels, enabling the 
development of receptor-scale neuroelectronic interfaces. Additionally, previous work 
(i.e., Chan and Nie  [4]) has demonstrated the capacity of quantum dot complexes to enter 
the interior of the cell. Thus, it is possible to utilize optically activated quantum dots as 
intracellular probes to study internal electrochemical reactions. The future of 
bioelectronic devices hinges upon the ability to make controlled, specific interfaces, such 
as those described here, between biological components and semiconductor devices.  
 
4.4 ADDITIONAL CONJUGATION STRATEGIES  
Since the completion of this work, two promising additional strategies have been 
published for close-range nanoparticle-cell interfacing. [40-42] The first of these 
strategies is an extension of our work, relying on peptides to produce quantum dot-
receptor binding. Our technique is ideal for water-soluble systems, adding peptides as 
passivating ligands during the initial synthesis. However, it is not compatible with 
organic media, as peptides are generally hydrophilic. To adapt our process to organic 
particles, Ruoslahti, et al. [40] introduced a passive ligand exchange that relies on the 
sulfur groups of thiolated peptides to produce nanocrystal binding. This technique 
exchanges peptides for TOPO ligands through overnight incubation in pH 7.4 phosphate-
buffered saline (PBS). Nanocrystals altered using this method maintain all the benefits of 
peptide modification described for our process and could be employed to develop 
neuroelectronic interfaces. 
A second technique, developed by two separate groups, uses the natural 
electrostatic interactions of proteins to produce nanoparticle-receptor interfaces. In one 
variation of this approach, [41] negatively-charged lipoic acid capped-quantum dots (-
COO- terminal) are attached to positively-charged leucine-zipper fusion proteins (surface 
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–NH3+ exposed) through electrostatic interactions. The leucine zipper proteins were 
genetically modified to be expressed in combination with the target biorecognition 
molecule, in this case maltose binding protein (MBP). Conjugation did not interfere with 
enzyme function, as evidenced by the ability of the complexes to bind maltose sugars.  
A second variation of this approach [42] utilizes bacterially derived cohesin 
protein to produce nanocrystal self-assembly. Cohesin protein is used by bacteria to 
construct cellusome complexes (i.e., a cellulose binding complex on the bacteria surface). 
When this protein was incubated with quantum dots, it resulted in quantum dot 
incorporation into protein-nanoparticle compounds. Through conjugation of other 
proteins or peptides to cohesin, this technique could be used to produce nanocrystal-
receptor binding.  
Both of these variations capitalize on the specific binding that occurs between 
proteins and their target molecules. Additionally, both strategies can be applied to a wide 
range of molecules of varying lengths, thus providing control of the neuroelectronic 
interface separation distance. Although demonstrated on organic particles (i.e., CdSe-
ZnS); these methods could be adapted to aqueous syntheses, and are therefore versatile. 
The main limitation of these techniques is that they both require genetically engineered 
molecules, which may be difficult to obtain.  
 
4.5 CONCLUSIONS  
Previously, laboratories have attempted micron-scale neuroelectronic interfaces 
using patterned semiconductor device structures with biocompatible features to favor 
neuron growth in desired locations. [43-48] This approach meets two major challenges: 
(a) reproducible neuron/device interfacing is difficult due to uncontrollable neuronal 
growth; and (b) the relatively large separation between the cell and the device (on the 
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order of 100 nm [49]) leads to poor electronic coupling. [50-51] These devices operate 
primarily through induction (Chapter 1, Section 1.1), the movement of separated charges. 
Coulomb’s law, describing the field between separated charges, is dependant on the 
inverse of the radius squared. Thus, to achieve high fields, small separation distances are 
desired.  
Patterning a surface with the nanometer-size features needed to interface 
electronic materials with specific cellular receptors is impossible using current 
technologies. [6, 52] Furthermore, the location of such receptors is varied, unpredictable, 
and dynamic from cell-to-cell. Semiconductor quantum dots attached to biological 
recognition molecules with short length scales can be positioned within nanometers of the 
cell surface, and direct attachment to the receptor of interest eliminates the need to 
control cell growth on a substratum. Thus, quantum dots provide a “smart” approach: 
wiring neurons directly with electronic structures through designated cell surface 
receptors.  
The interfacing of materials and cells using bio-recognition molecules, such as 
antibodies and peptides, has been investigated extensively. Recognition molecules have 
even been utilized to link quantum dots to certain cell structures and proteins. [3-4] 
However, none of these systems is capable of interacting electrically with living cells to 
provide stimulation. Our approach represents one of the first systems that can both attach 
a material to the cell and optimize parameters that enhance electrical interactions, 
particularly at the nanometer scale. 
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Chapter 5: Optimization of Directed Quantum Dot-Cell Binding and 
Non-Specific Binding Alternatives4 
As discussed in the previous chapter (Chapter 4), biorecognition molecule-
directed binding produces nanometer-scale connections between quantum dots and 
cellular receptors, addressing many of the issues in receptor-based neuroelectronic 
interface design. However, substantial challenges remain. The development of 
neuroelectronic devices requires primary, harvested neurons that can be integrated into 
components lasting up to several months. Previous work has not established the  ability of 
quantum dot–cell attachments to meet this requirement.  
We examined the ability of biorecognition techniques to produce stable, non-toxic 
connections between primary cells and CdS or CdTe quantum dots. CdTe particles 
exhibited greater cell toxicity than CdS, most likely because of free Cd2+ ions released 
through surface oxidation. Additionally, we researched the role of endocytosis in junction 
longevity, and determined that attachment to fixed receptors is required for maximum 
stability. As an alternative system, we investigated non-specific binding to cellular 
surfaces. Particle synthesis conditions were shown to play a large role in non-specific 
binding, particular those combinations which decreased ligand coverage on particle 
surfaces. However, endocytosis also occurred in non-specific cellular attachments.  
Therefore, we developed a fixed system, using poly-D-lysine- or mercaptosilane- 
modified substrates, to produce tethered-nanoparticle films. Both films displayed some 
stability in cell culture medium and were able to promote cell growth. Here, we present 
these three possible methods for the formation of neuroelectronic interfaces.  
                                                 
4 Portions of this material have been previously published in the following reference:  J.O. Winter, C.E. 
Schmidt, B.A. Korgel. Proceedings of the 2003 Fall MRS Meeting. Quantum Dots: Nanoparticles, and 
Nanowires. P. Guyot-Sionnest, N.J. Halas, H. Mattoussi, Z.L. Wang, U. Woggon, eds. 789: N.6.1, 2004.  
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5.1 REQUIREMENTS FOR LONG-TERM NEUROELECTRONIC INTERFACES  
The quantum dot-cell binding methods developed in Chapter 4, address many of 
the limitations in forming controlled interfaces between cell receptors and electronics. 
However, challenges to practical implementation remain. Typically, neuroelectronic 
interfaces are formed using primary neurons harvested from the brain or spinal cord. [1] 
These cells do not divide, and can therefore be integrated into devices lasting up to 
several months. Additionally, these cells are more sensitive to environmental conditions, 
and are more reflective of the in vivo atmosphere. [2] For a functional receptor-based 
interface, electrical components must create controlled, long-lasting connections at the 
nanometer-scale. Quantum dot-receptor binding has yet to meet these conditions. Here, 
we discuss the requirements for receptor-based neuroelectronic interfaces and the 
limitations of existing quantum dot–cell attachment methods. 
 
5.1.1 Cell Type  
Neuroelectronic interfaces are designed to serve as prosthetic devices, laboratory 
models of neuron signaling, or computational systems. [1] Most interfaces are developed 
or implemented ex vivo, using cultured cells. In prosthetic devices, ex vivo systems 
approximate in vivo conditions, whereas in laboratory models and computational systems, 
ex vivo systems provide a controlled environment for scientific questioning. Each of these 
applications requires cells that are plastic (e.g., capable of altering and forming new 
neuron-neuron connections) and non-proliferating. Also, certain uses (e.g., prosthetics, 
biosensors) necessitate that cells can survive for long periods of time in culture. 
Immortalized, cultured cells do not meet these requirements. The mechanisms that 
produce immortal cells introduce changes that can alter ion channel expression and the 
ability to fire action potentials. [3-5] Additionally, immortal cells continue to divide; 
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disrupting attachment to the device and requiring periodic transfer to a new growth 
substrate. [2] 
Current neuroelectronic interfaces are manufactured using primary cells, taken 
directly from tissue. [1] Typically, this tissue is derived from the spinal cord or brain; and 
the most commonly employed cell types are hippocampal cells, cortical cells, and dorsal 
root ganglia. To preserve plasticity, cells are often isolated from embryonic, neo-natal, or 
juvenile animals. These cells maintain the ability to form and alter neuronal connections 
in culture. [6-8] Additionally, primary cells do not divide and can be cultured for up to 
several months. Thus, primary cells meet all the requirements of interface design.  
Few researchers have examined quantum dots in living systems, and the majority 
of these investigations have used immortal, cultured cell lines. [9] The only study 
employing primary cells examined liver cells (i.e., hepatocytes) and not neurons. [10] 
Primary cells are much more sensitive to culture conditions than immortal cells. [2] 
Therefore, binding techniques that are compatible with immortal cells may require 
adaptation for primary culture systems. Further, primary cells are isolated from tissue, 
which results in associated debris. In our previous studies, we have observed that 
quantum dots adhere to dead, immortal cells, producing a fluorescence signal 
considerably brighter than that of directed binding. Debris may serve as a target for non-
specific binding,  obscuring biorecognition-mediated adhesion. Additional work is 
required to establish the feasibility of using quantum dots to form interfaces with 
primary, neuronal cultures. 
 
5.1.2 Toxicity 
Several groups have reported using quantum dots in living systems with no ill 
effects. [11-16] However, in the one study that specifically examined interactions 
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between semiconductor quantum dots and primary cells, [10] the cells utilized (i.e., 
hepatocytes) exhibited marked cell death in the presence of nanocrystals under certain 
conditions. This was attributed to the release of free Cd2+ ions following oxidation of the 
particle core. Cd2+ ions have well-established health risks, [17] and have been the chief 
concern in quantum dot toxicity. However, recent reports have  implicated other nano-
scale particulates in lung-toxicity [18] and oxidative stress in the brain. [19] Although 
these effects may be reduced by the presence of a suitable surface coating, [10, 20] these 
insulating layers may interfere with the operation of neuroelectronic interfaces. Thus, a 
careful study of nanoparticle toxicity on primary cells is required to identify those 
particles that may be employed in a neuroelectronic device. Briefly, we review the 
available data for toxicity of nanoparticulates and cadmium-based compounds. 
 
5.1.2.1 Nanoparticulate Toxicity 
Very few studies have examined the potential health risks of nanoparticles and 
other nano-sized materials. However, there is limited evidence that risks are present, 
particularly through inhalation. A recently published study demonstrated that inhaled 
carbon nanotubes can produce asbestos- like lesions in the lung. [18] Among the highest 
dose group, the mortality rate was 55% [N=9] after only 7 days of exposure. Although 
these results were for pulmonary tissue, a separate set of studies examining carbon [19, 
21-22], graphite [22], and  iridium [23] particulates established the ability of 
nanomaterials to damage other tissues, including the immune system [21] and brain [19, 
22]. Particle effects on the brain included an increase in lipid peroxidation and damage to 
lipid-rich tissues. [19] The most troubling finding of these studies is that particle 
clearance proceeds slowly. A low level (i.e., 6% in lung) of particulates remained in 
tissue a full six months after exposure. [23]  
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 However, it is unclear if these results will apply to semiconductor quantum dots. 
Most of these investigations examined toxicity through inhalation, but quantum dots are 
produced in solution-phase. A more likely route of exposure is through ingestion or skin 
contact. [20] To date, only a single study [10] has confirmed that quantum dots may be 
cytotoxic to cells when presented in aqueous solution. Additionally, the materials studied 
(i.e., carbon particulates and nanotubes) bear little similarity to quantum dots other than 
size, but there are indications that nanoparticle toxicity is not necessarily a function of 
composition. The most certain fact is that a full understanding of the effects of quantum 
dot exposure via any route has yet to be established. To develop viable neuroelectronic 
interfaces, thorough knowledge of quantum dot toxicity must be obtained. 
 
5.1.2.2 Cadmium Exposure 
One of the greatest concerns for the biocompatibility of semiconductor quantum 
dots is the well-established toxicity of cadmium, a key component of most particles. 
Cadmium is a known carcinogen, and has been linked to lung, testicular, adrenal, liver, 
and kidney cancer. [24] Although the exact mechanism of carcinogenicity is not 
understood, cadmium has been shown to interfere with DNA mismatch repair. [25] It also 
binds strongly to the sulfhydryl groups of mitochondrial proteins, [26] and this is the 
believed source of toxicity observed for the primary hepatocytes studied previously. [10] 
Additionally, cadmium is a commonly used blocking agent in patch-clamp studies that 
interferes with neuronal firing. [27] 
A number of groups have employed quantum dots in vitro and in vivo without 
noticeable cell damage; [11-16] however, none of these studies specifically examined 
cadmium toxicity. A single study [10] has measured cadmium levels in vitro suggesting 
that significant release occurred with nanoparticle oxidation, resulting in cell death. It is 
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well known that nanoparticles are susceptible to oxidation and photooxidation, [10, 28-
32] particularly with UV exposure. Reaction of oxygen with group VI elements (e.g., S, 
Se, Te) produces oxides, [30] that can disassociate from the particle surface. Free Cd 
atoms are left behind and may eventually enter solution. In these published studies, free 
cadmium levels were elevated for poorly-capped particles and particles exposed to 
prolonged UV excitation.  [10] 
Given all of these factors, the stability of the nanoparticle core is of great concern 
in the development of the neuroelectronic interface. Modifying particles with a strongly-
bound passivating ligand, an inorganic layer (e.g., ZnS), or a polymer coating can 
increase particle stability by preventing the entry of oxygen. [10, 20] All of the reports on 
quantum dot use for living systems utilize some coating of this nature. [11-16] However, 
these techniques have limited application in the neuroelectronic interface. Coatings can 
reduce nanoparticle electrical signals by producing an insulating layer or increasing the 
separation distance between the particle and the receptor. Thus, the development of a 
non-toxic, yet electrically active, nanoparticle system for neuroelectronic interface 
development is challenging. 
 
5.1.3 Longevity of the Interface: Endocytosis 
Adaptability to primary cells and biocompatibility remain the main requirements 
for neuroelectronic interface development. However, it is also important that the interface 
have a useful lifetime, preferably on the order of weeks or months. If the chief location of 
nanoparticle attachment is the cell membrane, this is a point of concern. Cells recycle 
their membrane and membrane-bound receptors regularly through a process known as 
endocytosis. [33] 
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Quantum dots bound to cell surfaces may be internalized through the endocytotic 
pathway, limiting interface longevity. In fact, several groups have exploited a particular 
type of endocytosis (i.e., receptor-mediated endocytosis) specifically for the purpose of 
introducing quantum dots to the interior of the cell. [10, 14, 34-35] Endocytosis can be 
suppressed by performing experiments at low temperature. [36] However, neurons do not 
experience normal signal propagation at low temperature, [37] and endocytosis resumes 
rapidly when cells are warmed to physiological temperatures. Further, endocytosis is not 
limited to receptor-bound ligands; non-specifically bound nanoparticles have also been 
internalized. [12, 38-39] 
Internalization could limit the use of biorecognition methods in forming long-term 
neuroelectronic interfaces. Only those molecules which bind fixed receptors or those 
recycled at a very low rate (i.e., lactoferrin receptor) would create long-term connections. 
The primary proteins targeted for binding (i.e., ion channels) are regulated on the 
membrane surface. [40] However, this process occurs slowly, and direct binding to ion 
channels should not pose a problem for interface longevity. Nonetheless, in cases where 
such binding is not permitted, an alternative method of stable interface formation will be 
required. 
 
5.1.4 Motivation for Examining Biorecognition-Directed Quantum Dot–Neuron 
Interfacing and Development of Alternatives 
Our previous work (Chapter 4) demonstrated the ability of biorecognition 
molecules to form controlled interfaces with cell surface receptors. Specifically, we 
utilized antibodies and peptides to bind quantum dots to the integrin receptors of SK-N-
SH neuroblastoma cells. This system has two major limitations to implementation in a 
neuroelectronic interface. First, the cells examined were immortal, cancer cells. Thus, 
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they do not engage in normal signal propagation and divide continuously, significant 
impediments to the development of a device. [2-5] The second challenge is that the 
antibodies and peptides used, anti-CD51 and RGDS respectively, can be internalized 
through receptor-mediated endocytosis, [41-42] minimizing long-term stability. 
The ability of quantum dots to form long-term interfaces with the cell surface has 
not been thoroughly explored. Quantum dots have been employed in living systems, [11-
16] but their potential toxicity is not well understood. Previous research is confined 
mainly to applications using immortal, cultured cell lines or in vivo studies of short 
duration. In either case, long-term toxic effects would be unlikely to surface during the 
course of these studies. A single study has investigated quantum dot toxicity to primary 
cells, [10] which are more sensitive to environmental conditions. [2] A direct relationship 
between cadmium released from the nanoparticle surface and cell death was established. 
Additionally, the stability of quantum dot-neuron interfaces is not well-explored. It is 
known that internalized particles can persist for several weeks; [14] however, 
nanoparticles bound to cell surfaces may be subject to endocytosis.  
Here we present our efforts to produce long-term, stable interfaces between 
quantum dots and cell surface receptors. We investigated the toxicity of both CdS and 
CdTe particles to primary, neuronal cells. We also examined the role of endocytosis for 
both receptor-bound and non-specifically adherent quantum dots. Finally, we developed 
three separate methods to produce nanoparticle interfaces with the cell surface and 
characterized the long-term stability of each junction. 
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5.2 MATERIALS AND M ETHODS 
5.2.1 Quantum Dot Synthesis 
5.2.1.1 CdS Synthesis 
Standard and peptide-bound CdS quantum dots were synthesized as described 
previously (Chapter 3, Section 3.3.3.1 and Chapter 4, Section 4.3.2.1). Briefly, a solution 
of 55 mM mercaptoacetic acid was created in 5 mM aqueous CdCl2. The pH was raised 
to 7 using NaOH (~ 600 µL of 1 M equivalents), and 2 mM aqueous Na2S * 9H2O was 
added. Nanocrystals formed immediately and continued to grow for up to four hours after 
sulfur addition.  
For peptide-conjugated nanoparticles, peptide was added to the CdCl2 solution at 
10 mM or, in combination with 55 mM MAA, at 0.6 mM. Additionally, the reaction pH 
was increased to 12, producing green-yellow nanocrystals that could be distinguished 
from blue cellular autofluorescence. Otherwise, synthesis proceeded as described. For the 
non-specific binding studies, synthesis reactant concentrations and ratios, ligand 
concentration, and pH values were varied. Table V describes these changes in detail. For 
tethered quantum dot films, CdCl2 concentrations from 2-20 mM were examined while 
maintaining constant Cd:S ratio, and with reaction pH values of 7 or 11. 
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Table V: Particle Synthesis Conditions for Non-Specific Binding Studies. 
Parameter1 Ligand [CdCl2] (mM) [Ligand] (mM) [Na2S] (mM) pH2 
Control MAA 5 55 2 pH = 7 
pH MAA 5 55 2 pH = 5-11 
Ratio MAA 5 55 0.83-5 pH = 7 
Ligand Conc. MAA 5 10-500 2 pH = 7 
Concentration MAA 2-20 22-220 0.8-8 pH = 7 
1 All reactions were carried out in a total volume of 20mL. 
2 pH before Na2S addition. 
 
5.2.1.2 CdTe Synthesis 
CdTe particles were produced using the synthesis method developed by Peng, et 
al. [43] with the modifications of Donegá, et al. [44] Cadmium oxide (CdO, Aldrich) 
precursor (0.056 g) was placed in a 50 mL, 14/20, three-neck round bottom flask 
equipped with an RTD port, along with 0.230 g of tetradecylphosphonic acid (TDPA, 
Alfa Aesar) and 3.7 g of trioctylphosphine oxide (TOPO, Aldrich). In addition, 0.066 g of 
tellurium powder (Te, Aldrich) and 2.5 mL of trioctylphosphine (TOP, Fluka) were 
added to a separate 50 mL, 14/20, three-neck round bottom flask. A condenser was 
placed in the middle neck of each flask and secured with Teflon tape or vacuum grease, 
while the two remaining necks were sealed with silicone septa (Sigma).  
The CdO-containing flask was then placed in a heating mantle connected to a 
variable transformer and temperature controller. An RTD probe from the temperature 
controller was inserted into the RTD port, and the entire flask was wrapped with glass 
wool and aluminum foil. The CdO solution was degassed on a Schlenk line at 60ºC for 
two hours under 300-500 mtorr of vacuum. Meanwhile, the Te flask was placed on a hot 
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plate. A thermometer was inserted through one of the silicone septa and secured with 
Teflon tape and vacuum grease.  
After the CdO solution had been under vacuum for 2 hours, it was placed under 
nitrogen and heated to 340ºC. Additionally, the Te solution was attached to the Schlenk 
line, placed under N2, and heated to 150ºC. When both solutions had completed heating, 
the temperatures were lowered to 300ºC (CdO) and 120ºC (Te) for injection. A 10 mL 
glass syringe was used to remove the Te solution. Te was quickly injected into the CdO, 
producing a black solution of TOPO-capped particles. The temperature was reduced to 
60ºC and the solution was allowed to stir for 30-45 minutes. After this time, 5 mL of 
chloroform was injected. 
To create water-soluble particles, 16 mL of 0.5 M mercaptopropionic acid (MPA, 
Fluka) in basic methanol (pH = 12) were added to 5.2 mL of the TOPO-capped particles. 
The temperature was reduced to 37ºC, and particles were left to stir under nitrogen 
overnight. Following incubation, particles were extracted and placed in a 50 mL 
centrifuge tube. A ~3 fold excess of 2-propanol was added as an ant i-solvent, and the 
solution was placed in a -20ºC freezer for at least two hours. Then, the mixture was 
centrifuged at 6000 g for 10 minutes at 4ºC. The supernatant was decanted, producing a 
pellet of black nanocrystalline CdTe particles that could be resuspended in aqueous 
solvents (e.g., phosphate buffered saline). Aqueous CdTe particles exhibited an excitation 
peak of 512 nm, an emission peak of 665 nm, and displayed quantum yields of ~15-30%, 
decreasing with particle age. 
Peptide-conjugated nanocrystals were produced through an additional partial 
ligand exchange. MPA-capped nanocrystals were removed from nitrogen and divided 
into 500  µL aliquots without anti-solvent extraction. Each aliquot was placed in a 2 mL 
microcentrifuge tube and left in a vacuum oven overnight to remove excess fluid. Dry 
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particles were stored in a glove box under nitrogen. For peptide conjugation, 6 mg of 
CGGGRGDS peptide were dissolved in 2 mL of PBS (to 4 mM). This solution was then 
added to one 2 mL tube of dry particles. Particles were vortexed and placed in a 10 mL, 
14/20, single-neck round bottom flask. A condenser was placed in the neck, and the flask 
was purged under nitrogen overnight to produce reaction. Peptide conjugation was 
confirmed through increases in fluorescence anisotropy (Chapter 4, Section 4.3.3.4) and 
quantum yield. Quantum yields were amplified because the peptide does not completely 
displace MPA ligands; but instead supplements existing ligand coverage, augmenting 
particle passivation. Following peptide bind ing, anisotropy of the particles increased from 
3.57 x 10-2 to 3.73 x 10-2 (~5%); while quantum yields increased from 11.2% to 15.2%. 
 
5.2.2 Cell Culture and Isolation 
5.2.2.1 SK-N-SH Neuroblastoma Cells 
SK-N-SH neuroblastoma cells were cultured as described previously (Chapter 4, 
Section 4.3.3.6). Briefly, cells were grown in DMEM cell culture medium (Sigma) with 
10% fetal bovine serum (FBS, Gibco) and 1% penicillin-streptomycin (pen-strep, Gibco). 
Cells were plated at densities of 1:8 and passaged every 6 days. Medium was changed 
every 2 days. Cells with passage numbers greater than 20 were discarded. SK-N-SH cells 
exhibit neuronal and fibroblast morphologies. [45] Dense cultures produce the neuronal 
morphology, and plating densities were selected to maximize this morphology. 
 
5.2.2.2 Isolation and Culture of Rat Neonatal Cortical Cells (RNCs) 
Several days prior to harvest, slides were prepared for cell adhesion. Mouse 
laminin (BDBiosciences) was incubated with slides for 20 minutes at 3.03  µg/mL in 
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distilled, deionized water (ddH2O). The solution was then aspirated, and slides were dried 
under UV for at least 1 hour. Next, slides were exposed to poly-D-lysine hydrochloride 
(Sigma, Mol. Wt. > 300,000) for one hour at 0.5 mg/mL in ddH2O. Slides were rinsed 
three times for 10 minutes in ddH2O and dried under UV overnight. MEM (Gibco, 
without L-Glutamine) was placed on cells at least 24 hours prior to harvest.  
Rat neonatal cortical cells were obtained from 1-2 day old Sprague-Dawley rat 
pups. Twenty minutes before harvest, a protease solution of 3 mg Pronase (Calbiochem) 
in 5 mL of MEM was prepared and incubated at 37ºC. To obtain cells, rat pups were 
rapidly decapitated in a tissue culture sterile hood. The skull was opened, and the brain 
was removed and placed in medium at 4ºC. After 1-2 minutes, the cortex of the brain was 
transected from the temporal lobe and hippocampal structures using a razor blade. The 
cortex was homogenized and incubated in Pronase solution for 20 minutes with frequent 
mixing (i.e., tube inversion every 3 minutes).  
After this time, the mixture was centrifuged at 200 g for 3 minutes, and the 
supernatant was aspirated. The cells were rinsed with 3 mL of meglumine buffer (Table 
VI) and centrifuged at 200 g for 3 minutes, followed by supernatant aspiration. This was 
repeated two additional times. Washed cells were resuspended in 1.5 mL of meglumine 
buffer and triturated using a series of 2-3 increasingly smaller-diameter, flame-pulled, 
capillary pipettes. Triturated cells were added to 10 mL of warm supplemented 
neurobasal medium (Table VII). Cells were counted using a hemocytometer and plated at 
concentrations of 2 x 105 cells/cm. Cells were fed 24 hours after initial plating, and every 
2 days thereafter using supplemented neurobasal medium. Cells began to extend 
processes over the course of 2-3 days, and were not used until at least 5 days of age. Cells 




Table VI: Meglumine Buffer 
Component1 Concentration 
0.5 M Magnesium Sulfate 600  µL 
N-Methyl-Glucamine 7.5 g 
Sodium Chloride 0.173 g 
HEPES  0.704 g 
Dextrose 0.533 g 
Distilled, De- ionized Water 300 mL 
 1All components were purchased from Sigma 
 
Table VII: Supplemented Neurobasal Medium 
Component Concentration Manufacturer 
Neurobasal Medium 500 mL Gibco 
B-27 Supplement 10 mL Gibco 
200 mM L-Glutamine 125 µL Fisher 
Penicillin-Streptomycin1 4800 µL Gibco 
1 10000 units/mL of activity 
 
To examine quantum dot toxicity, 20 mM [Cd]initial solutions of nanoparticles 
were precipitated through anti-solvent addition (i.e., 1- propanol for CdS, 2- propanol for 
CdTe) and centrifugation at 6000 g. Pellets were dried in a vacuum oven for at least one 
hour and resuspended in supplemented neurobasal medium. Cells were cultured in 
nanoparticle-containing medium for five days. Medium was changed every two days. 
Cell viability was confirmed using fluorescence microscopy (Section 5.2.5). 
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5.2.3 Attachment of Quantum Dot Complexes to Cells 
For SK-N-SH cells, the control labeling procedure was performed as described 
previously (Chapter 4, Section 4.3.3.8). Prior to exposure, quantum dots were modified to 
pH 7.4 using 1 M and 0.1 M NaOH or HCl as required. Additionally, normal saline 
conditions were obtained through resuspension of dried particle pellets in Dulbecco’s 
PBS (DPBS; Chapter 4, Table IV) or dilution of particle solutions with an equal volume 
of 2X DPBS. Cells were incubated with 5% BSA in DPBS (BSA-DPBS) at 4ºC for one 
hour, followed by one rinse in cold DPBS. Next, quantum dots were introduced and 
exposed to cells for 30 minutes at 4ºC. Then, cells were rinsed three times with cold 
DPBS. Binding was confirmed using fluorescence microscopy (see Section 5.2.5). 
For primary cells, several alterations to the initial procedure were investigated. To 
examine solvent compatibility, artificial cerebrospinal fluid (aCSF, Table VIII) was 
studied as an alternative to DPBS. The effect of shear forces on cells was analyzed by 
modifying the rinsing procedure. The relationship between culture dish size and shear 
was established using 3, 6, and 10 cm dishes, in place of the 1 cm control. Additionally, 
the number of rinses following BSA-DPBS incubation and quantum dot exposure was 
reduced from 1 and 3 to 0 and 1, respective ly. For these studies, cell viability was 
confirmed using phase contrast microscopy (Section 5.2.5) and live-dead staining 
(Section 5.2.3.1). To evaluate endocytosis, experiments were performed at 37ºC in a 5% 
CO2 environment. With this modification, the impact of reduced quantum dot incubation 
times were also studied (i.e., from 30 minutes to 5 minutes). Both of these conditions 
were evaluated with phase contrast and fluorescence microscopy (Section 5.2.5). 
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Table VIII: Artificial Cerebrospinal Fluid (aCSF) 
Component Concentration 
Magnesium Sulfate 0.058 g 
Calcium Chloride 0.040 g 
Sodium Chloride 1.402 g 
Dextrose 0.360 g 
Potassium Chloride 0.049 g 
Sodium Phosphate Monobasic 0.034 g 
HEPES 1.19 g 
Distilled, Deionized Water 200 mL 
 
Non-specific quantum dot-cell interfacing was investigated using CdS and CdTe 
nanocrystals on SK-N-SH neuroblastoma and RNC cells. CdS particles were prepared as 
described above (Section 5.2.1.1) and in Table V. CdTe particles were manufactured 
following the synthesis in Section 5.2.1.2. Quantum dot solutions were created through 
anti-solvent addition (i.e., 1-propanol for CdS and 2-propanol for CdTe) and 
centrifugation at 6000 g. The supernatant was decanted, and particles were dried in a 
vacuum oven for at least one hour. Particles were resuspended in DPBS. To assay 
binding, cells were first incubated in BSA-DPBS solution for one hour; and then quantum 
dot-DPBS solutions for 30 minutes. Cells were rinsed with DPBS following aspiration of 
the quantum dot solution, and evaluated using fluorescence microscopy (Section 5.2.5). 
 
5.2.3.1 Live-Dead Staining 
Cell viability was confirmed using a live-dead cell staining kit containing calcein 
AM and ethidium homodimer-1 dyes (Molecular Probes). Non-fluorescent calcein dye 
permeates cell membranes, where it is converted into a green fluorescent product 
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( λem=515) by living cells. Ethidium enters dead or damaged cells through gaps in the 
plasma membrane and binds to nuclear proteins with a significant enhancement in 
fluorescence (λem=635). Ethidium is excluded from living cells by their intact membrane. 
Calcein-AM and ethidium homodimer-1 dyes were added to cells at concentrations of 
0.25 and 2  µL/mL in DPBS, respectively. Cells were incubated with the dyes for 20 
minutes, and then washed twice with DPBS. Cells were immediately observed using 
fluorescence microscopy (Section 5.2.5). 
 
5.2.4 Formation of Tethered Quantum Dot Films  
5.2.4.1 Siloxane-Based Films 
As an alternative to direct quantum dot-cell attachment, two types of tethered 
films were developed. The first of these utilized published methods [46] to create 
mercaptosilane substrates for quantum dot attachment. Briefly, glass slides were cleaned 
in a 1:3 mixture of concentrated hydrochloric acid:nitric acid for 30 minutes. Then, slides 
were rinsed with ddH2O until the pH = 7.0, and blown dry with argon. The slides were 
further dried in a vacuum oven at 75ºC for at least 3 hours.  
Next, clean, dried slides were placed into solutions ranging from 1–50 mM of (3-
mercaptopropyl) trimethoxysilane (MTS, Fluka) in anhydrous toluene. All solutions were 
prepared in an anhydrous environment under argon. Slides were incubated in MTS 
overnight on a rocker plate. Following incubation, MTS-coated slides were rinsed three 
times with anhydrous toluene, three times with ethanol, and blown dry with argon. Then, 
they were further dried in a vacuum oven at 40ºC for at least 3 hours. Siloxane layer 
formation was confirmed using ellipsometry (Section 5.2.4.3). 
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Then, silanized slides were incubated with quantum dot solutions overnight on a 
rocker plate. Quantum dots were synthesized with CdCl2 concentrations (Section 5.2.1.1) 
ranging from 2-20 mM and reaction pH values of 7 or 11, while maintaining constant 
Cd:S ratio. Quantum dots were exposed to slides 4-24 hours after synthesis. Following 
incubation, slides were rinsed three times with ddH2O, three times with ethanol, and 
blown dry with argon. Quantum dot tethering was confirmed using fluorescence 
microscopy (Section 5.2.5). 
 
5.2.4.2 Ellipsometry 
The presence of siloxane on slide surfaces was confirmed using a J.A. Woollam 
Co., Inc (Lincoln, NE) EC-400 ellipsometer equipped with an M-2000D 
spectrophotometer and XLS-100 stage. Measurements were performed at wavelengths 
from 400-700 nm at an angle of incidence of 70º. Results were analyzed using a Cauchy 
fit, with no backscattering correction, and an assumed index of refraction of 1.5. [46]  
 
5.2.4.3 Poly-D-Lysine-Based Films 
As an alternative to siloxane, poly-D-lysine was used as an adhesion substrate. 
Poly-D-lysine is positively charged at neutral pH because of its –NH3+ functional groups, 
while quantum dots capped with mercaptoacetic acid (MAA) are negatively charged. 
Using electrostatic interactions, films of tethered quantum dots were formed. Poly-D-
lysine hydrochloride (Sigma, Mol. Wt. > 300,000) was incubated with slides at 0.5 
mg/mL in ddH2O for one hour. Then, slides were rinsed three times for 10 minutes in 
ddH2O and dried under UV overnight. Next, sterile-filtered quantum dots were incubated 
with slides for one hour. Quantum dots were prepared with CdCl2 concentrations ranging 
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from 2-20 mM and reaction pH values of 7 or 11, while Cd:S ratio was held constant 
(Section 5.2.1.1). Following incubation, slides were rinsed three times with sterile ddH2O 
and dried in a sterile tissue culture hood. Quantum dot tethering was confirmed using 
fluorescence microscopy (Section 5.2.5). 
 
5.2.4.4 Tethered Quantum Dot Film Stability 
To ascertain the stability of tethered films, the fluorescence of quantum dot-
coated slides was analyzed after exposure to cell culture medium over six days. First, 
slides were prepared for sterile culture. Silanized slides were soaked in absolute ethanol 
for 20 minutes and air dried in a sterile tissue culture hood. As described previously 
(Section 5.2.4.2), poly-D-Lysine slides were exposed to UV overnight prior to quantum 
dot adhesion and prepared with sterile solvents thereafter. Following sterilization, slides 
were incubated with supplemented neurobasal medium and observed at 1-2 day intervals 
using fluorescence microcopy (Section 5.2.5). Medium was changed every 2 days. 
 
5.2.4.5 Cell Culture on Tethered Films 
To establish the ability of quantum dot films to support cell growth, rat neonatal 
cortical cells (RNCs) were cultured on their sur faces. RNCs were isolated as described 
previously (Section 5.2.2.2); however, slide surfaces were not prepared with laminin and 
poly-D-lysine. Instead, RNCs were cultured directly on sterile siloxane-quantum dot or 
poly-D-lysine-quantum dot films (Sections 5.2.4.3 and 5.2.4.4). Cells were grown 
following standard protocols (Section 5.2.2.2) in supplemented neurobasal medium, 
which was changed one day after initial harvest and every two days thereafter. Film-
coated slides were observed every 1-2 days following harvest for cell growth, extension 
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of neuronal connections, and layer stability using phase contrast and fluorescence 
microscopy (Section 5.2.5). 
 
5.2.5 Microscopy 
Fluorescence and phase contrast images were obtained using an Olympus IX70 
inverted microscope with a mercury arc lamp and UV (λexc=330-385), wideband blue 
(WB, λexc=450-480), and narrowband green (NG, λexc=530-550) filter sets. Cell viability 
following rinsing and quantum dot toxicity (Section 5.2.3) were evaluated using a 20X 
objective and phase contrast. Additionally, live-dead cell staining (Section 5.2.3.1) was 
performed using a 20X objective in phase contrast and in fluorescence with the WB 
(calcein AM) and NG (ethidium homodimer-1) filter sets. Images for the endocytosis, 
incubation length, and non-specific binding studies (Section 5.2.3) were collected using 
phase contrast and fluorescence microscopy with a 60X or 100X objective and oil 
immersion. For all of the above experiments, the UV filter set was employed for CdS 
analyses, and the NG filter set was utilized for CdTe. All images were collected with an 
exposure time of 496 ms. The evaluation of quantum dot tethered films (Section 5.2.4) 
was conducted using fluorescence microscopy with a 100X objective, oil immersion, and 
the UV filter set. Exposure time for all images was 733 ms. Some images were modified 
to enhance brightness and contrast using Adobe Photoshop version 5.5. In this case, all 
images from the same experimental set were treated equally. 
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5.3 RESULTS AND CONCLUSIONS 
5.3.1 Optimization of Biorecognition Molecule–Directed Interfacing for Primary 
Cells 
Our model system for neuroelectronic interface formation utilized the SK-N-SH 
neuroblastoma cell line, a cancer-derived line that is unsuitable to final implementation in 
the device. Therefore we chose to adapt our methods to primary rat neonatal cortical cells 
(RNCs), a commonly employed cell type in neuroscience. Primary cells were harvested 
directly from tissue, in this case the cortex of 1-2 day old rat pups. They are known to be 
more sensitive to environmental conditions than immortalized cells, [2] and this was 
evidenced in our attempts to integrate them into a quantum dot interface. Thus, 
optimization of our procedure was required to maximize cell viability. 
 
5.3.1.1 Isolation and Culture of RNCs 
Our initial attempts to culture RNCs met with little success. Although cells were 
harvested, they exhibited an unfavorable glial morphology (Figure 38A). [47] This 
morphology indicates either selective glial survival or is a response of neurons to 
unfavorable environmental conditions. It is unlikely that the culture consisted of glia, as 
the medium selected (supplemented neurobasal) is designed to inhibit glial growth. [48] 
Upon further investigation, we determined that shear stresses in the medium, introduced 
by two factors, contributed to the glial morphology. First, during harvest, cells were 
triturated with increasingly smaller diameter metal needles (e.g., 16, 18, 21, and 23 
gauge), rather than the fire-polished glass capillary pipettes recommended. Second, the 
exchange of medium was performed rapidly, introducing shear forces. When these two 
factors were corrected, cells of the proper morphology [47] were obtained (Figure 38B). 
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These results demonstrate the extreme sensitivity of primary cells, and their suitability to 
evaluate quantum dot toxicity. Similar results were not obtained with SK-N-SH cells. 
Figure 38: Rat 
Neonatal Cortical 









Phase contrast images of (A) initial cultures exhibiting glial morpho logies and (B) normal 
cells exhibiting a neuronal morphology. Glial morphologies appear to be the result of 
shear forces in the liquid introduced during harvest and medium exchange. 
 
5.3.1.2 Rinsing Protocol for Interface Formation 
Based on our findings for the harvesting protocol, we examined methods to 
reduce shear stress in the quantum dot-receptor interfacing procedure. The most 
significant sources of shear are the DPBS washing steps, which are used to ensure 
complete removal of the BSA-DPBS blocking agent and the quantum dot solution. 
Therefore, we investigated methods to reduce shear at these steps. 
First, we examined the role of culture dish size in the rinsing procedure. The 
hypothesis was that a larger culture dish would protect cells from shear forces by 
increasing the distance between the liquid entry point and cells elsewhere on the dish. 
Culture dishes of 3, 6, and 10 cm diameters were compared to the 1 cm diameter dish 
used in the model system. Cells were observed following three rinses with DPBS. 
Surprisingly, we determined that increased-diameter dishes produced the least viable 
cells (Figure 39). Prior to DPBS washing cells had attained ~100% confluency, however 
 A B 
100  µm 
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significant areas of the larger diameter dishes (Figure 39 B-D) display no cells or cell 
debris. 
To establish the viability of remaining cells, live-dead staining was performed. 
Live cells can be identified by delocalized green fluorescence in the cytoplasm, and dead 
cells can be located through red nuclear fluorescence. The majority of cells on all dishes 
were living, as evidenced by wide-spread green fluorescence (Figure 40). However, cell 
death appeared to increase with dish diameter and was localized primarily to areas with 
reduced cell adhesion. These regions probably experienced the greatest shear, as 
evidenced by cell detachment. These results demonstrate that the volume of fluid in a 
rinse (e.g., 1 ml/cm dish diameter) is a more significant factor to cell adhesion and 
viability than the localized forces introduced at the point of fluid application. Thus, for all 
future interface formation procedures, 1 cm diameter dishes were employed.  
Figure 39: Effect of 
Increased Culture 
Dish Diameter on 
RNC Viability. 
Phase contrast 
images of RNC cells 
on (A) 1 cm, (B) 3 
cm, (C) 6 cm, and 
(D) 10 cm diameter 
culture dishes 
following three 
rinses in DPBS. 
Increased dish size 
reduced the number 
of adherent cells. 











Dead RNC Staining 
for Culture Dishes of 
Increased Diameter. 
Fluorescence-phase contrast images of RNC cells on (A) 1 cm, (B) 3 cm, (C) 6 cm, and 
(D) 10 cm diameter culture dishes following three rinses in DPBS. Green and red staining 
indicate living and dead cells, respectively. Cell death increased with culture dish 
diameter, and was most pronounced in areas where cell adhesion was diminished. 
 
In addition to the dish diameter, the number of DPBS rinses was investigated. In 
the initial protocol, cells were rinsed with DPBS once following BSA-DPBS incubation 
and three times after quantum dot incubation. This process resulted in significant cell 
death for RNCs (Figure 41A). The main purpose of rinsing is to eliminate any non-
specific binding that may result from the presence of excess quantum dots in solution. 
Therefore, we eliminated the rinse following BSA-DPBS incubation and decreased the 
number of post-quantum dot incubation rinses from three to one. This procedure resulted 
in a significant improvement in cell viability (Figure 41B), with no increase in non-
specific binding (not shown).  
These results demonstrate the extreme sensitivity of primary cells to 
environmental factors, including shear stress. Similar shear stress exposure did not 





impact our model system, SK-N-SH neuroblastoma cells. All further attempts to create 
quantum dot–RNC interfaces utilized the modified DPBS washing procedure. 
Figure 41: Effect of Reduced Rinsing Steps on RNC Viability. 
Phase contrast images of cells prepared following the (A) initial and (B) modified DPBS 
washing procedures. Cells with a reduced number of rinses evidenced a significant 
increase in viability. 
 
5.3.1.3 Quantum Dot Solvent 
To further improve RNC viability, we also examined the effect of quantum dot 
solvent. In our previous interfacing procedure, the standard solvent used was DPBS 
(Table IV), which consists of phosphate buffered saline with calcium and magnesium 
salts added. As alternatives, we examined PBS (phosphate buffered saline with no 
calcium or magnesium added, Table III) and artificial cerebrospinal fluid (aCSF, Table 
VIII), a commonly used buffer for RNC culture. In our analysis, we evaluated each buffer 
against three criteria: quantum dot solubility, RNC viability, and non-specific binding. 
CdS quantum dots were obtained as solids and resuspended in PBS, DPBS, or 
aCSF. Solubility was evaluated after initial resuspension and also following sterile-
filtration (0.22  µm cellulose acetate filter), using a UV lamp to observe fluorescence. 
Quantum dot solubility was highest in PBS and lowest in aCSF (i.e., quantum dot 




solubility PBS> DPBS> aCSF). Although this might first appear to be an effect of 
increased charge screening, the total ionic salt concentration decreases from PBS to 
aCSF (PBS = 172 mM, DPBS = 160 mM, aCSF = 132 mM). Thus, it is more likely that 
decreased quantum dot solubility result s from an increase in the size and number of 
dissolved species. In addition to the phosphate and sodium salts of PBS, DPBS contains 
Ca and Mg salts; while aCSF includes Ca, Mg, dextrose, and HEPES buffer. The bulk of 
additional solutes may limit the number of water molecules available to solvate the 
particles. Particle-particle collisions would also be more likely to occur, resulting in 
nanocrystal aggregation. 
These solutes are added to increase cell viability, and their removal may be 
detrimental to cells. Therefore, we eva luated the effect of each solvent on RNC and SK-
N-SH viability. Quantum dot-containing solutions were prepared and exposed to cells 
according to the modified protocol (i.e., protocol with reduced rinses). Cells incubated in 
PBS-quantum dot solutions (i.e., without Ca2+ and Mg2+) exhibited rounded 
morphologies and detached from the dish during DPBS washing (not shown). This was 
not unexpected, as the removal of Ca2+ and Mg2+ is known to promote cell detachment. 
[49] Therefore, despite its superior solvating properties, PBS cannot be used for quantum 
dot-receptor interface formation. Cells incubated in DPBS and aCSF did not display any 
difference in viability from control cells that remained in medium (not shown); therefore, 
there does not appear to be any viability benefit to the additional solutes added to aCSF 
buffer. 
The other major concern in altering the quantum dot solvent is a potential increase 
in non-specific binding. Non-specific binding could interfere with the operation of a 
receptor-specific neuroelectronic interface by activating additional types of ion channels. 
To determine the degree of unwanted binding, we compared SK-N-SH cells labeled with 
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quantum dots in either DPBS or aCSF solvents. SK-N-SH cells were examined because 
they contain less debris than RNC cultures. Quantum dots display a high affinity for 
debris and dead cells that could obscure subtle binding to living components. 
Cells labeled with DPBS-quantum dots exhibited more non-specific binding than 
those labeled with aCSF-quantum dots (Figure 42). In DPBS solutions, quantum dot 
binding appears as diffuse yellow labeling surrounding the exterior of the cell (Figure 
42A); while aCSF solutions produce aggregate binding primarily confined to the 
substrate (Figure 42B). The apparent binding reduction in aCSF most likely results from 
a decline in the total number of particles, rather than a decrease in cell affinity. The 
concentration of quantum dots in aCSF is reduced because many aggregated particles are 
unable to pass through the 0.22  µm sterile filter. Additionally, aggregation of the 
remaining particles decreases the number of surfaces available for binding. 
These results demonstrate the importance of solvent selection for interfacing 
methods. While PBS solvents produced the least quantum dot aggregation, they did not 
support cell adhesion. However aCSF solvents, which are frequently used with RNCs, 
produced considerable particle aggregation. Thus, the benefits of increased cell 
compatibility must be balanced against the requirements of an optimal quantum dot 
environment. Given the significant quantum dot aggregation in aCSF solution and no 
perceivable increase in cell viability, we did not alter the quantum dot solvent used in our 




Figure 42: Solvent Effects on Quantum Dot Non-Specific Binding. 
Phase contrast (A,C) and fluorescence images (B,D) of non-specific binding in DPBS 
(A,B) and aCSF (C,D) quantum dot solutions. Non-specific binding is increased in DPBS 
(B), appearing as diffuse yellow labeling surround blue cellular autofluorescence. In 
aCSF solvents (D), quantum dots appear aggregated and bind to the substrate, not the 
cell. It should be noted that the image contrast was significantly enhanced in Figure 42 to 
demonstrate the slight increase in fluorescence produced in DPBS. The non-specific 
binding in either solvent is still far less than that generated by biorecognition molecule-
directed interfacing (Chapter 4, Figures 36-37).  
 
5.3.1.4 Quantum Dot Composition 
To compare the toxicity of various quantum dot materials, we examined CdS 
produced using aqueous synthesis (Section 5.2.1.1) and CdTe produced using organic 
synthesis (Section 5.2.1.2). Both particles were capped with thiol-acids containing 
carboxyl terminal groups (i.e., mercaptoacetic acid for CdS and mercaptoproprionic acid 





for CdTe). Additionally, both particles were cleaned using anti-solvents and 
centrifugation, dried in a vacuum oven, and resuspended in DPBS. Solutions were sterile-
filtered, added to supplemented neurobasal medium at similar concentrations (0.1 mg/ 
mL medium), and placed on RNC cells. Medium was changed every two days, and cells 
were observed over five days. 
Cells incubated with CdS quantum dots exhibited no differences over controls 
cultured only in neurobasal medium. However, cells incubated with CdTe particles 
exhibited a rounded morphology by Day 1 and complete cell death by Day 2 (not shown). 
CdTe particles are not stable in air, with a near complete loss of fluorescence and water 
solubility within 48 hours. [44] Low stability most likely results from oxidation of Te 
atoms, which reduces ligand adhesion sites and releases Cd2+ in the core. Te has been 
shown to be more susceptible to oxidation than CdS and CdSe materials. [50] Oxidation 
of Cd2+ has been linked directly with reduced cell viability, [10] and could explain the 
cell morbidity observed at Day 2. Thus, as prepared, CdTe particles cannot be employed 
in a long-term neuroelectronic interface, and should be used with caution for short-term 
applications. 
These results underscore the importance of shielding the particle core from 
oxidation. Most commonly protection is provided through the addition of a shell, either 
of an inorganic material (e.g., ZnS) or a biocompatible passivating layer (e.g., poly 
(ethylene) glycol, BSA.). [10] However, most biocompatible passivating layers are 
insulating, reducing the electrical properties of the particle; and inorganic shells do not 
provide complete protection. [10] The development of a long-term neuroelectronic 
interface will require alternative approaches, including enhancement of existing synthesis 




While cell viability is the primary concern in deve lopment of a neuroelectronic 
interface, longevity is also an important consideration. One of the most significant 
limiting factors in interface longevity is recycling of the plasma membrane and its 
receptors through a process known as the exocytosis-endocytosis cycle. [51] The 
endocytosis portion of this cycle (i.e., ingesting of components on the extracellular 
surface) can produce particle internalization, negating the ability of particles to 
manipulate the cell membrane potential. Recycling of the plasma membrane can be 
suppressed at low temperature, [36] and our initial experiments (Chapter 4) were 
conducted under these conditions. However, decreased temperatures also affect neuronal 
signaling. [37] To evaluate the effect of endocytosis on interface longevity, we evaluated 
our initial system using both SK-N-SH and RNC cells at physiological temperatures. 
Aqueous CdS quantum dots passivated with the RGDS recognition sequence were 
prepared as described above (Section 5.2.1.1). Particles did not contain any additional 
chemical linkers (i.e., MAA), were manufactured with a reaction pH of 12, and exhibited 
a yellow-green fluorescence. Nanocrystals were incubated with SK-N-SH cells following 
the standard protocol, with the exception of incubation temperature, which was held at 
37ºC. After the 30 minute incubation period, significant internalization occurred (Figure 
43A). Green-yellow quantum dots appear as vesicular structures within the cytoplasm. 
This pattern is consistent with that of endocytotic vesicles and not dead cells or specific 
labeling because particles are excluded from the nucleus. Particle internalization most 
likely occurred through receptor-mediated endocytosis as the RGD peptide has been 
shown to promote this type of internalization. [41-42] 
Addit ionally, we developed a second type of interface, formed through non-
specific binding of cell surfaces. We discovered that MPA-capped CdTe particles exhibit 
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low levels of non-specific binding to cortical cells (Section 5.3.2.6). Comparing this 
binding to directed binding produced by CdTe particles with peptide/MPA surface 
coatings (Section 5.2.1.2), we examined the effects of membrane ingestion and receptor-
mediated endocytosis. Despite the toxicity of CdTe, incubation times were sufficiently 
short (~30 minutes) to preclude cell death. Red CdTe particles conjugated to RGD 
peptide exhibited similar endocytotic labeling to that for CdS (Figure 43B). The increase 
in fluorescent intensity for CdTe is a result of increased particle quantum yield. 
Unconjugated nanocrystals (i.e., MPA-CdTe particles) bound to cell surfaces non-
specifically displayed a considerable reduction in fluorescence (Figure 43C), but were 
also internalized. 
Thus, internalization occurred for particles linked to both endocytotic receptors 
and the cell membrane. The implications for a long-term neuroelectronic interface are 
considerable. Non-specific binding to cell surfaces cannot be used to form stable  
interfaces, and biorecognition molecule-directed interfacing must be used with caution. 
Only those biorecognition molecules that bind fixed receptors with low recycle rates 
(e.g., lactoferrin [38]) can be used to create long-term quantum dot-receptor interfaces. 
Ion channels are recycled as a means of controlling specific neuronal response, [40] but 
using a different mechanism and over longer time scales than receptor-mediated 
endocytosis. Thus, directed-recognition methods could still be used to form long-term 
neuroelectronic interfaces. 
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Figure 43: Endocytosis of CdS and CdTe Quantum Dots. 
Fluorescence images of (A) SK-N-SH cells labeled with CdS RGD-quantum dots, (B) 
RNCs labeled with CdTe RGD/MPA-quantum dots, and (C) RNCs labeled with CdTe 
MPA-quantum dots at physiological temperature (37 ºC). Green (A, CdS) and red (B and 
C, CdTe) particles are seen as vesicular structures in the cytoplasm, indicating 
endocytotic uptake. Uptake is more pronounced in the presence of peptide (A,B), most 
likely due to receptor-mediated endocytosis. 
 
5.3.2 Non-Specific Binding for Quantum Dot-Receptor Interface Formation 
Given the limitations of direct labeling of cellular receptors, we chose to 
investigate additional methods of nanoparticle presentation. One possibility is the use of 
delocalized, non-specific interfacing to produce generalized interactions. Particles may be 
tethered directly to the substrate to prevent endocytosis, and cells can be cultured on their 
surfaces. The electrical implications of a delocalized interface are unclear. The Debye 
length is less than one quantum dot or receptor diameter; [52] therefore, it is unlikely that 
particles will interact with each other. However, competing signals may be conducted 
through the membrane or the cytoplasm, reducing electrical response. If non-specific 
interactions appeared to stimulate more than one type of ion channel, particles could still 
be used to explore cell responses in the presence of blocking agents, [53] which limit the 
number of active ion channels, or for small portions of membrane (i.e., using patch-clamp 
techniques). On the other hand, there is some evidence that particle films produce an 
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increase in collective dipole moment through the formation of aligned structures. [54] 
This could augment the electrical signal to the cells.  
The first step in producing non-specific interfaces is to determine which variables 
modulate nanocrystal attraction to the cell surface. These generally fall into two 
categories: properties of the nanocrystal and contributions from the incubation method. 
We selected one quantum dot material, CdS, and thoroughly studied the role of synthesis 
conditions on non-specific binding to SK-N-SH cells. SK-N-SH cells were selected 
because they exhibit significantly lower levels of debris that could produce false positive 
signals. Then, we investigated the role of cell type, quantum dot material, and incubation 
length on nanoparticle attraction to SK-N-SH and RNC cells. These results were used to 
develop tethered quantum dot films, but also demonstrate limitations to direct quantum 
dot labeling of cell surfaces. 
  
5.3.2.1 Effect of Nanocrystal Reaction pH 
We investigated the role of synthesis pH on quantum dot-cell affinity. Reaction 
pH prior to Na2S addition was varied from 6 to 11 (Section 5.2.1.1). This range was 
chosen because reaction pH values less than 6 produce blue-emitting nanocrystals whose 
fluorescence cannot be distinguished from cellular autofluorescence. Particles with varied 
synthesis pH values were characterized previously (see Chapter 3), and found to increase 
in size with increasing reaction pH. Maximum quantum yield occurred for nanoparticles 
with a reaction pH of 7. Non-specific binding was evaluated through quantum dot 
incubation with SK-N-SH neuroblastoma cells following the modified interface 
formation procedure (Section 5.2.3).  
Fluorescence images (Figure 44) demonstrate that nanocrystal binding is directly 
related to reaction pH, with increased cell affinity at higher values (Figure 44C-F). 
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Binding is widespread, with attachment to both the cells and the substrate. At the highest 
reaction pH values, quantum dots appear to form a film that covers all surfaces (Figures 
44E-F). It is likely that this binding is the result of reduced surface passivation. As pH 
increases, larger particles are produced, yet the concentration of ligand remains the same. 
Thus, an increased surface area must be passivated with a fixed amount of ligand. Our 
previous results (Chapter 3) demonstrating a decrease in quantum yield at high reaction 
pH values support this conclusion. 
Figure 44: Effect of Nanocrystal Synthesis pH on Cellular Non-Specific Binding. 
Fluorescence microscopy images of CdS quantum dot non-specific binding to SK-N-SH 
neuroblastoma cells with nanocrystal synthesis pH values of (A) 6, (B) 7, (C) 8, (D) 9, 
(E) 10, and (F) 11, prior to Na2S addition. Binding increases with reaction pH, and is not 
limited to cellular structures. 
 
5.3.2.2 Effect of Nanocrystal Cd:S Ratio 
To further investigate the relationship between nanocrystal size and non-specific 
binding, we examined nanocrystals produced with Cd:S ratios ranging from 6:1 to 1:1 
(Section 5.2.1.1). Our earlier work (Chapter 3) established that particle size is inversely 
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related to Cd:S ratio, with 6:1 producing the smallest particles. Quantum yield maxima 
occurred for intermediate sized particles (i.e., Cd:S ratio = 4:1 and 2:1). Results were 
similar to those for reaction pH; larger particles displayed a higher affinity for cells than 
smaller particles (Figure 45). As in syntheses with varied reaction pH, Cd:S variations are 
not accompanied by an increase in ligand concentration. Thus, larger particles are 
expected to exhibit reduced passivation. These results support our previous conclusion 
that cell affinity is related to a reduction in ligand surface coverage. 
Figure 45: Effect of Nanocrystal Synthesis Cd:S Ratio on Cellular Non-Specific Binding. 
Fluorescence microscopy images of CdS quantum dot affinity to SK-N-SH 
neuroblastoma cells with nanocrystal Cd:S ratios of (A) 6:1, (B) 4:1, (C) 2:1, (D) 1.5:1, 
and (E) 1:1. Particles with the lowest Cd:S ratios produce the most non-specific binding. 
 
 
5.3.2.3 Effect of Nanocrystal Cd:Ligand Ratio 
Next, we analyzed the effect of Cd:ligand ratio on nanoparticle non-specific 
binding. In our synthesis experiments (Chapter 3), we determined that particle sizes 
increase with increasing ligand concentration (i.e. [MAA]) and constant [CdCl2] and 





[Na2S]. If non-specific binding is a function of nanoparticle size, we should see increased 
cell affinity for particles with the highest concentrations. However, if binding is a product 
of reduced ligand passivation, we would expect reduced or no non-specific binding at 
larger particle sizes. 
Quantum dots with [MAA] ranging from 10-500 mM were synthesized (Section 
5.2.1.1) and investigated for non-specific binding to SK-N-SH neuroblastoma cells. 
Control particles produced using the standard synthesis (i.e., [MAA] = 55 mM) did not 
display non-specific binding (not shown), consistent with previous observations (Figure 
44B and Figure 45C). In fact, the only sample that did exhibit consistent non-specific 
binding was that with the lowest [MAA] (i.e., 10 mM, Figure 46). However, this binding 
was slight when compared to the dramatic increases seen for reaction pH and Cd:S ratio. 
Although further study is needed to measure actual ligand surface coverage va lues, these 
results support our hypothesis that reduced passivation exposes the particle core, 
promoting non-specific binding.  
Figure 46: Effect of Nanocrystal Synthesis Ligand 
Concentration on Cellular Non-Specific Binding. 
Fluorescence microscopy image of CdS quantum dot non-
specific binding to SK-N-SH neuroblastoma cells with 
nanocrystal ligand concentration = 10 mM. Slight non-
specific binding is evidenced. 
 
 
5.3.2.4 Effect of Nanocrystal Reactant Concentrations 
In addition to ligand passivation, non-specific binding may also be related to 
quantum dot concentration. This is definitely true for fluorescent dyes, which frequently 





structures. To explore this possibility, we studied CdS quantum dots at a range of 
concentrations using SK-N-SH cells. CdS quantum dots were prepared using the standard 
procedure (Section 5.2.1.1), except that the [Cd]initial was varied from 2-20 mM with 
constant Cd:S and constant Cd:ligand (Table V). Particles did not exhibit non-specific 
binding at any concentration (not shown), including the control value ([Cd]initial = 5 mM). 
Thus, we can conclude that particles manufactured with the standard synthesis do not 
exhibit non-specific binding, regardless of the concentration at which they are applied. 
Further investigation of the relationship between non-specific binding and concentration 
was performed using CdTe particles, which do have an affinity for RNC cells (Section 
5.3.2.6). 
 
5.3.2.5 Cell Type 
We have shown that nanoparticle properties play an active role in their affinity for 
cells. However, to investigate the role of cell type in binding, we compared SK-N-SH 
neuroblastoma and RNC cells exposed to CdS quantum dots manufactured with a 
reaction pH of 11. These particles were selected for their known binding affinity to SK-
N-SH cells.  
Both cell types displayed nanocrystal affinity, but SK-N-SH cell binding was 
more diffuse than that of RNCs (Figure 47A-B). This may be a result of different 
substrate preparations for the two cell types. RNC cells are plated onto laminin and poly-
D-lysine-coated glass slides that have been exposed to medium for at least 24 hours; 
whereas SK-N-SH cells are plated on polystyrene tissue culture dishes. However, the 
cellular labeling has a different character as well. Binding of RNCs is confined primarily 
to debris surrounding the cell (Figure 47C-D). Debris is a common element of primary 
cell cultures because it is difficult to separate cells from the homogenized tissue they are 
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derived from. The bright, localized labeling of RNCs is exhibited only for dead cells in 
SK-N-SH cultures (not shown).  
Thus, despite initial appearances, non-specific binding of living cells appears to 
be lessened in RNC cultures. This decrease may result from a different complement of 
sugars or proteins on the cell surfaces. [55] Additional experiments are required to 
distinguish cell and substrate labeling in SK-N-SH cultures. Nonetheless, debris in RNC 
cultures creates a potential problem for neuroelectronic interface formation, as 
nanocrystal binding is localized and uncontrolled. This is primarily a problem for systems 
requiring direct binding to the cell surface; however, it may also reflect an affinity of 
tethered quantum dot films for debris. 
Figure 47: Effect of Cell Type 
on CdS Non-Specific Binding. 
(A) Fluorescence image of CdS 
quantum dots exposed to SK-N-
SH cells. (B) Fluorescence, (C) 
fluorescence/phase contrast 
composite and (D) phase 
contrast images of CdS quantum 
dots exposed to RNC cells. 
RNCs exhibited less non-




5.3.2.6. Quantum Dot Composition 
To compare the cellular affinity of different quantum dot materials, we exposed 
RNCs to CdS and CdTe particles. CdS particles were manufactured following the 
standard procedure (Section 5.2.1.1.) with reaction pH values of 11. CdTe particles were 
prepared in organic solution with ligand exchange (Section 5.2.1.2). This synthesis 






produces dense nanoparticle solutions, which were diluted over the range of 2-20 mM 
[Cd]initial. Cells were labeled with particles following the modified interface formation 
procedure (5.2.3) and viewed using fluorescent microscopy (Section 5.2.5). 
CdS particles labeled debris surrounding the cell as in previous experiments 
(Figures 47C, 48A); however, CdTe quantum dots displayed a high affinity for cells and 
their extensions (Figure 48D,G,J). Additionally, unlike CdS with a reaction pH = 7, 
fluorescent intensity was proportional to the concentration of quantum dots applied 
(Figures 48 C,F,I and D,G,J). Examination of fluorescent images for the highest CdTe 
concentrations (i.e., 20 mM and 4 mM [Cd]initial) (Figure 48C,F) reveal cellular shaped 
voids displaying no binding. These regions are surrounded by brightly labeled structures. 
Inspection of phase contrast images (Figure 48B,E) for the same regions shows that voids 
are primarily composed of cellular debris. Most cells in these samples are not intact, and 
remaining cells exhibit rounded morphologies. These facts indicate a toxic effect of CdTe 
particles at these concentrations. CdTe particles at lower concentration values (i.e., 2 mM 
[Cd]initial) did not demonstrate this behavior (Figure 48H-J).  
The cell death observed is most likely caused by the osmotic pressure of highly 
concentrated CdTe solutions. Although the [Cd]initial is similar in magnitude to values 
used for CdS, CdTe solutions appeared to a have higher reaction yield. Synthesis of CdS 
resulted in only 17% yield, and produced clear, yellow solutions; while synthesis of CdTe 
produced opaque brown-black solutions. Additionally, post-cleaning pellet sizes were 
significantly larger than those of CdS for the same volume and [Cd]initial. These results 
indicate an upper limit to the number of quantum dots that may be applied without 
inducing cell death. All further CdTe experiments were conducted using 2 mM [Cd]initial. 
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Figure 48: Effect of Quantum Dot Composition on RNC Non-Specific Binding. 
Fluorescence images of non-specific binding to RNC cells using (A) CdS quantum dots 
(reaction pH = 11, 5 mM [Cd]initial) (B-D) CdTe quantum dots (20 mM [Cd]initial), (E-G) 
CdTe quantum dots (4 mM [Cd]initial), and (H-J) CdTe quantum dots (2 mM [Cd]initial). 
Fluorescence/phase contrast composite images (A,D,G,J) show that CdS labeling (A) is 
confined primarily to debris surrounding the cell, while CdTe particles (D,G,J) bind cells 
and their extensions. Comparing CdTe phase contrast (B,E) and fluorescence images 
(C,F), cellular shaped regions devoid of binding appear to be locations where cells have 
exploded, most likely as a result of osmotic pressures. Bright regions surrounding these 
voids contain cellular debris. 
 










5.3.2.7 Incubation Length 
Non-specific binding of debris by CdS quantum dots could prove problematic for 
the development of a neuroelectronic interface. To establish how quickly non-specific 
binding of debris occurs in RNC cultures, we examined the effect of reduced incubation 
length for CdS particles with a reaction pH of 11 and CdTe quantum dots with 2mM 
[Cd]initial. After only 5 minutes of exposure, CdS particles displayed binding of cellular 
debris (Figure 49A-B). CdTe particles, which label living cells and their extensions, 
exhibited significantly less binding in the same time frame (Figure 49C-D). However, 
endocytosis of CdTe particles was already evident (Figure 49C, arrow). These data 
indicate that uptake of particles by dead cellular material is extremely rapid. Additionally, 
while cellular labeling takes place over a longer time frame, endocytosis begins almost 
immediately. The binding of undesirable components and endocytosis are unavoidable, 
presenting significant limitations to use of non-specific methods for labeling cell 
surfaces. However, tethered-films can overcome these challenges. 
Figure 49: Effect of 
Reduced Quantum Dot 
Incubation Time on RNC 
Non-Specific Binding. 
Fluorescence/Phase 
contrast (A,C) and phase 
contrast (B,D) images of 
RNCs incubated with 
(A,B) CdS and (C,D) 
CdTe particles for five 
minutes. CdS particles 
non-specifically bind 
debris; CdTe binding is 
much less pronounced. 
However, endocytosis is 
evident in the CdTe 
sample (C, arrow). 






5.3.3 Tethered Quantum Dot Films  
Films of glass-tethered quantum dots were developed, based on the results of our 
non-specific binding studies, with two separate adhesion technologies. In the first 
method, the silane terminus of a mercaptosilane compound was used to bind a glass 
substrate (SiO 2), whereas the mercaptan terminus (-SH) provided a surface for quantum 
dot adhesion. Cd-based quantum dots bind strongly to thiols through exposed core Cd2+ 
ions and disulfide interactions. The second method utilized electrostatic attractions 
between poly-D-lysine (-NH3+ side chains) adsorbed on glass and quantum dot surface 
ligands (COO-) to produce binding.  
These films offer several advantages for neuroelectronic interface formation. 
Tethered quantum dots considerably limit the probability of endocytosis, increasing 
interface longevity. Additionally, films can introduce a greater number of quantum dots 
to a cell than directed recognition or non-specific binding. However, the films also 
present limitations, the most significant of which is the inability to control quantum dot-
receptor interface formation. It is unclear how quantum dot–membrane interfaces 
affecting multiple ion channel types would influence cell signaling. Nonetheless, tethered 
films offer a viable strategy to demonstrate the ability of quantum dots to modulate 
cellular receptors. 
 
5.3.3.1 Previous Nanoparticle Tethered Films 
Tethered nanoparticle films have been developed before, chiefly as methods of 
particle self-assembly. These techniques primarily rely upon the strong interactions 
between gold particles and alkanethiols to produce films, [46, 56-58] although silver [59] 
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and Cd-based nanoparticles have also been explored. [60-63] Two basic strategies for 
film formation have been utilized. In the first method, silica substrates (glass [46] or 
SiO2-coated silicon substrates [56, 58]) are coated with siloxanes (i.e., (3-
mercaptopropyl)-trimethoxysilane [46, 56] and (3-aminopropyl) trimethoxysilane [58]) to 
produce nanocrystal binding surfaces. The second method utilizes thiol-containing 
organics, which self-assemble on gold-coated substrates, to provide functional groups 
that bind nanoparticles. [57, 59-63] 
Both methods have been used to create well-characterized particle films. 
However, the siloxane-based method is more compatible with development of a 
neuroelectronic interface because the gold films required for thiol self-assembly may 
interfere with electrical signals produced by the quantum dots. Additionally, siloxane-
based films have already demonstrated compatibility with cell culture techniques. [46] 
Therefore, we chose to utilize siloxane-based chemistry to produce nanoparticle films for 
neuroelectronic interface development.  
In addition to siloxane-based films, we developed an alternative using poly-D-
lysine. These films offer some potential advantages to siloxane-based films, as they are 
substantially easier to fabricate. Also, because attachment occurs through charge 
attraction, the films can incorporate a higher number of nanocrystals than siloxane  
monolayer surfaces.  
Poly-D-lysine has been used in a limited number of applications to create gold 
and silver nanoparticle films. [54, 64-67] Although it has not been examined as a 
substrate for Cd-based quantum dot assembly, results from metal films suggest poly-D-
lysine strategies are promising for neuroelectronic interface development. Polylysine 
substrates promoted nanoparticle alignment into 1-D structures and nanowires, [54, 64-
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65, 67] producing an increase in cumulative dipole moment. [54] This could create a 
greater cellular response than un-tethered nanoparticle interfaces. 
 
5.3.3.2 Siloxane Films 
Siloxane-based films were prepared as described previously [46] (Section 
5.2.4.1). Mercaptosilane was incubated overnight with cleaned glass slides. Then, slides 
were rinsed and exposed to quantum dots overnight. Siloxane concentrations ranging 
from 1 to 50 mM were investigated. The presence of siloxane was confirmed using 
ellipsometry (Section 5.2.4.2). Films formed from 1 mM mercaptosilane were not 
uniform, and the thickness could not be established. 10 mM mercaptosilane produced 
films with thicknesses from 1-3 monolayers (1 nm – 3 nm).  
Quantum dot attachment was confirmed using fluorescence microscopy (Figure 
50). Because silanization techniques produce particle films only a few monolayers in 
thickness, fluorescence intensity is low and difficult to distinguish from the background. 
However, when compared to an unsilanized control (Figure 50A), quantum dot binding is 
evident (Figure 50B-E). Maximal binding occurred for 10 mM mercaptosilane (Figure 
50C). This indicates that coverage of the substrate is essentially complete at a 10 mM 
concentration; therefore, no benefit is derived from additional silanization chemical. 
Future experiments utilized 10 mM mercaptosilane. 
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Figure 50: Effect of Increased Siloxane Concentration on Siloxane-Tethered Quantum 
Dot Films.  
Fluorescence images of glass with (A) 0 mM, (B) 1 mM, (C) 10 mM, (D) 20 mM, and 
(E) 50 mM mercaptosilane after CdS quantum dot incubation (standard synthesis, 
reaction pH = 11). Quantum dot adhesion is apparent on silanized sides (B-E). Binding 
was maximal at intermediate concentrations (C), indicating complete surface coverage. 
 
Next, we analyzed the role of increasing quantum dot concentration on surface 
coverage. CdS particles with reaction pH = 7 were manufactured with [Cd]initial ranging 
from 2-20 mM. Quantum dots at the highest concentration investigated (i.e., 20 mM) 
demonstrated the greatest binding affinity (Figure 51F), indicating that surface sulfhydryl 
groups may not be saturated with particles. Additional experiments are needed to study 
higher concentrations; however, these solutions may be difficult to produce as 
nanoparticle solubility declines with concentration (Chapter 3).  
Figure 51: Effect of Increased CdS Concentration on Siloxane-Tethered Quantum Dot 
Films. 
Fluorescence images of 10 mM mercaptosilane films with (A) 0 mM, (B) 2 mM, (C) 5 
mM, (D) 10 mM, (E) 15 mM, and (F) 20 mM CdS quantum dots applied. The greatest 
degree of binding occurs at the highest quantum dot concentration (F, 20 mM). 
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Additionally, we investigated the role of quantum dot reaction pH on substrate 
binding. Previously (Section 5.3.2.1), we established that particles with higher reaction 
pH values have a greater affinity for glass substrates. We therefore created solutions at 
the highest pH value (i.e., pH 11) with concentrations of 10, 15, and 20 mM [Cd]init ial. 
Similar to results for pH 7 particles (Figure 51), increased quantum dot concentrations 
produced higher degrees of binding (Figure 52), with 20 mM particles exhibiting 
maximal affinity (Figure 52D). Additionally, pH 11 particles displayed a greater degree 
of binding than pH 7 particles of the same concentration (Figure 51 vs. 52). This may 
result from reduced surface passivation of the pH 11 particles. To maximize nanoparticle 
binding, remaining experiments were conducted using 20 mM [Cd]initial CdS quantum 
dots with a reaction pH of 11. 
 
Figure 52: Effect of CdS Concentration and pH on Siloxane-Tethered Quantum Dot 
Films. 
Fluorescence images of (A) 0 mM, (B) 10 mM, (C) 15 mM, and (D) 20 mM CdS 
quantum dots with a reaction pH of 11 bound to mercaptosilane films. Quantum dot 
binding increases with concentration and is more pronounced at higher pH (compare to 
Figure 51).  
 
5.3.3.3 Poly-D-Lysine Films 
Poly-D-lysine films were prepared through adsorption onto glass surfaces 
(Section 5.2.4.3), followed by quantum dot incubation. The concentration and molecular 
weight of poly-D-lysine were the same as those used to promote RNC cell adhesion 
(Section 5.2.2.2). Other concentrations were not investigated. The presence of polylysine 




was confirmed by qualitatively observing the contact angle. Polylysine-coated surfaces 
are significantly less wetting than uncoated glass.  
To optimize quantum dot adhesion, solutions of 2-20 mM [Cd]initial CdS quantum 
dots were prepared and incubated with polylysine surfaces for one hour. Quantum dot 
adhesion was visible for concentrations of 10 mM and greater (Figures 53D-F), and films 
persisted after three washes in ddH2O indicating tethered binding. As expected, binding 
was greater than that of siloxane-based films (Figure 52 vs. 53), but particle aggregation 
also increased. Aggregation was not random, favoring the formation of circular structures 
on top of a more uniform background adhesion layer (Figure 53F). These structures may 
indicate the presence of circular nanowires, which were produced under similar 
circumstances using gold nanoparticles. [67] However, gold nanowires were ~0.5  µm in 
diameter, while our structures approach 2 µm in size. Additional AFM or TEM analysis 
is required to determine the nature of these aggregates. If these regions prove to contain 
nanowires, they could provide favorable electronic properties to the film. [54] 
Nonetheless, to avoid the presence of aggregates remaining experiments were conducted 
with 10 mM quantum dot concentrations. 
Figure 53: Effect of CdS Concentration on Polylysine-Tethered Quantum Dot Films. 
Fluorescence images of glass slides following exposure to (A) a 5 mM quantum dot 
solution and (B-F) polylysine followed by (B) 2 mM, (C) 5 mM, (D) 10 mM, (E) 15 mM, 
and (F) 20 mM CdS quantum dot solutions. Binding increases with quantum dot 
concentration becoming noticeable at values of 10 mM and higher (D-F). Circular 
quantum dot aggregates form at the highest concentrations (E,F). 
 





5.3.3.4 Film Stability 
To ascertain the stability of both films in a biological environment, films were 
incubated in RNC cell culture medium for six days. Layers were sterilized using either 
UV light combined with sterile filtration (polylysine) or exposure to ethanol (siloxane). 
No bacterial or fungal growth was evidenced on either film. Samples from the same 
initial preparation were sacrificed on each day and rinsed with ddH2O three times before 
viewing. Both films appeared to be stable over the test period (Figures 54-55).  
Siloxane films demonstrated an increase in particle aggregation over time (Figure 
54E-F); however, additional experiments are required to rule out sample to sample 
variation as a cause. Polylysine films displayed great variability in both fluorescent 
intensity and in the type of structures exhibited on film surfaces (Figure 55). This 
variation is typical from sample to sample, and is likely caused by the uncontrolled nature 
of polylysine and quantum dot adhesion. Fluorescence intensity for both films is slightly 
increased over that of films not cultured in medium (Figures 54,55 vs. 52D,53F; 
respectively), probably as a result of surface adsorption of fluorescent compounds in the 
medium. The stability of both films is sufficient for initial neuroelectronic interface 
development. Further improvements could be made through additional optimization. 
Figure 54: Stability of Siloxane-Tethered Quantum Dot Films. 
Fluorescence images of siloxane-quantum dot films exposed to RNC cell culture medium 
for (A) 0, (B) 1, (C) 2, (D) 4, (E) 5, and (F) 6 days. Films remained stable over the course 
of observation, although aggregation increased with time (D-E). 
 





Figure 55: Stability of Polylysine-Tethered Quantum Dot Films. 
Fluorescence images of polylysine-quantum dot films exposed to RNC cell culture 
medium for (A) 0, (B) 2, (C) 4, (D) 5, and (E) 6 days. Films remained stable for the test 
period. Sample to sample variation typical of polylysine films is evident. 
 
5.3.3.5 Cell Culture on Tethered Films 
To establish neuroelectronic interfaces, cells must adhere to film surfaces. Both 
poly-D-lysine and siloxane are commonly applied to slides to promote cell adhesion; 
however, the presence of the quantum dot layer may interfere with cell attachment. 
Additionally, cells excrete a variety of biological compounds (e.g., proteases [68], etc.) 
that could damage the quantum dot films. To examine the ability of the films to support 
cell culture, we plated RNCs on sterile, tethered quantum dot surfaces. Cells were 
harvested using standard procedures (Section 5.2.2.2), and medium was changed every 2 
days. 
Both siloxane- and polylysine-tethered films in culture exhibited significant 
differences from those exposed only to medium (Figures 56-57 vs. 54-55). Most notably, 
fluorescence was red-shifted and diminished. Decreased intensity could result from 
particle desorption; however, red-shifted fluorescence suggests that particles may be 
undergoing in situ Ostwald ripening (i.e., growth of larger particles at expense of smaller 
ones). Given that both films were stable for over six days in RNC culture medium, it is 
unlikely that medium catalyzed this process. However, cells are known to release several 
substances, one of which could have promoted oxidation. Smaller particles would 
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degrade, allowing the growth of larger ones. Alternative ly, particles may have migrated 
within the tethered layers, allowing them to aggregate through collision events. 
Lack of film stability in cell culture is a significant problem to implementation in 
a long-term neuroelectronic interface. However, longevity may be sufficient for proof-of-
principle experiments establishing the ability of nanoparticles to interact with cellular 
receptors. Siloxane layers were stable for at least one day; polylysine layers for three 
days. The primary limitation for initial interface testing is the amount of time required for 
RNC cell adhesion. Insufficiently attached cells can be aspirated during whole-cell 
clamping experiments. Polylysine layers were stable for the longest time period; 
therefore, these films are most suitable fo r proof-of-principle experiments. 
Figure 56: Cell Culture on Siloxane-Tethered Quantum Dot Films. 
Fluorescence (A,C,E,G,I) and phase contrast (B,D,G,H) images of cell culture on 
siloxane-tethered quantum dot films at (A) 0, (B,C) 1, (D,E) 3, (F,G) 4, and (H,I) 5 days. 
The film remains intact at least one day, but fluorescence red-shifts and declines in 
intensity. Additionally, the film becomes less uniform with time and aggregates appear. 
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Figure 57: Cell Culture on Polylysine-Tethered Quantum Dot Films. 
Fluorescence (A,C,E,G,I) and phase contrast (B,D,G,H) images of cell culture on 
polylysine-tethered films at (A) 0, (B,C) 1, (D,E) 3, (F,G) 4, and (H,I) 5 days. The film is 
stable for at least three days, but fluorescence is red-shifted and diminished after only one 
day. Aggregates remain fluorescent longer than the more homogenous background.  
 
Several strategies could be pursued to improve the longevity of both layers. 
Increasing the original number of particles increases the persistence of fluorescence, 
although it does not prevent aggregation or red-shifted emission. This can be seen in the 
comparison between siloxane- and polylysine-tethered films (Figure 56 vs. 57). 
Polylysine films, which exhibit greater initial particle adhesion, are fluorescent for a 
longer period than siloxane films. Additionally, methods to improve particle surface 
coatings would improve stability to oxidation; however, these strategies must not 
diminish electrical signals produced by the particle. 
 
5.4 SUMMARY OF OPTIMIZED INTERFACE FORMATION M ETHODS 
We have presented three separate approaches for creating quantum dot–receptor 
interfaces between CdS and CdTe nanoparticles and primary neurons. Recognition-
molecule directed binding, non-specific interactions, and tethered-nanoparticle films all 
produced quantum dot binding to cell surfaces. We examined the suitability of each of 
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these methods for neuroelectronic interface formation, and determined that recognition-
directed binding and tethered films could be used to establish proof-of-principle. No 
method displayed the stability necessary for long-term neuroelectronic devices. 
Biorecognition molecule interfacing was limited by particle uptake through 
endocytosis, constraining the application of this method to those receptors that are fixed 
or recycled at low rates. However, ion channels meet these conditions and quantum dot 
binding could be produced using this method. [40] Non-specific binding methods were 
also hindered by endocytosis, but more importantly by concerns over nanoparticle 
toxicity. Binding was most pronounced for particles presumably having a lower degree of 
ligand coverage on their surface, which has been linked to particle toxicity. [10] Tethered 
films exhibited low stability in cell culture, displaying decreased and red-shifted 
fluorescence after 1-3 days. This may result from cellular release of oxidizing agents. 
[68] If so, improved passivating agents could minimize these effects. [10, 20] However, 
film stability is sufficient for proof-of-principle experiments to demonstrate quantum-dot 
cell electrical interfacing. Our results demonstrate the complexity of developing 
interfaces that are both electrically active and biocompatible, and provide two potential 
means to establishing those interfaces. 
In addition to interfacing techniques, we also examined the toxicity of quantum 
dots to primary cells. Previous reports of quantum dot–live cell interactions  [11-16] did 
not report deleterious effects; however, most of these applications utilized immortalized 
cell lines. The one report investigating primary cell lines [10] found increased cell 
morbidity in the presence of oxidized quantum dot surfaces. Our findings corroborate the 
latter results. CdTe particles caused complete cell death in 48 hours, most likely because 
of oxidation of the particle core. [10, 50] These results emphasize the need for further 
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study of quantum dot toxicity using primary cells, which are more representative of the 
response of living organisms. 
 
5.5 CONCLUSIONS  
 The development of interfacing technologies for electrically active quantum dot-
receptor devices is more complicated than the creation of quantum dot fluorescent labels. 
Although quantum dots have been used in a variety of cultured cell lines [11-12, 14-15] 
and in vivo studies, [13, 16] these applications do not approximate the conditions required 
for a neuroelectronic interface. Neuroelectronic interfaces are designed to serve as 
laboratory models for neuroscience, computational devices, and prosthetics. [1] Thus, 
they require the use of plastic, primary cells capable of altering and forming new 
interconnections. A single study [10] has investigated the impact of quantum dots on a 
primary cell line (i.e., hepatocytes), and found toxicity to be significantly higher than that 
reported for cultured cell lines. Our results support this conclusion. CdTe particles 
produced complete cell death in 48 hours, most likely through oxidation of the particle 
core. [10, 50] This finding underscores the need for further testing of particle toxicity 
using primary cell lines, which are more indicative of in vivo conditions. 
We adapted our previous model system (Chapter 4), using biorecognition-directed 
binding, for a primary neuronal cell line (i.e., rat neonatal cortical cells, RNCs). By 
altering the incubation methods and through careful selection of quantum dot material 
and synthesis conditions, we were able to create biocompatible interfaces with RNCs. 
The primary limitation of recognition-directed binding was the occurrence of 
endocytosis, cellular uptake of nanoparticles bound to the membrane surface. [33] 
Although endocytosis was shown to begin almost immediately after quantum dot 
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attachment, this procedure can be used to label receptors that are not recycled or recycled 
at a low rate. Therefore, ion channel labeling of primary cells is possible. [40]  
Alternatively, we investigated non-specific binding as a method to form quantum 
dot-cell interfaces. We discovered that cell affinity is related to quantum dot synthesis 
conditions, particularly those circumstances leading to low ligand coverage on the 
particle surface. This could prove problematic for neuroelectronic interfacing as poor 
passivation has also been linked to quantum dot toxicity.  [10] Additionally, endocytosis 
occurred, albeit at lower rates than for tagged receptors. Given these limitations, we 
chose to explore a third system using tethered nanoparticles to prevent cellular uptake. 
Two methods of producing nanoparticle-tethered films on glass were explored. 
The first method, using thiol groups from mercaptosilanes to bind quantum dots, [46] 
produced uniform films with low levels of fluorescent intensity. Maximum intensity 
occurred at an intermediate siloxane concentration, indicating saturation of the glass 
surface, whereas fluorescence intensity inc reased with nanoparticle concentration for all 
values investigated. Films were stable for over six days in cell culture medium, but only 
1-2 days with cells grown on their surface. The second method of film formation used 
poly-D-lysine, which binds negatively charged quantum dots through its positively 
charged surface. These films were not as uniform as the siloxane  films, but demonstrated 
a greater degree of quantum dot binding. Affinity increased with increasing nanoparticle 
concentration. These layers were stable for over six days in medium, and 3 days with 
cells cultured on their surface.  
For both siloxane and polylysine films, the loss of stability in cell culture 
appeared to occur through particle growth rather than desorption. This was indicated by a 
red-shift in particle fluorescence, and was most likely a result of Ostwald ripening. 
Oxidizing agents released by the cells may have accelerated this process. [68] In future 
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films, oxidation could be limited by improving the protective ligand layer of the particle. 
[10, 20] Nonetheless, film stability is sufficient to establish proof-of-principle for the 
neuroelectronic interface. 
Thus, we explored a variety of interfacing technologies, utilizing both directed 
and non-specific binding. These systems were optimized for primary cells, which are 
more sensitive to environmental conditions than immortal, cultured cell lines. [2] Each 
system displayed limitations, most notably longevity of the interface and toxicity. The 
addition of a protective shell on the nanoparticle surface could address both of these 
concerns; [10] however, the requirement of electrical interfacing requires thin or 
conducting shells to preserve electrical properties. Our results demonstrate the difficulty 
of optimizing any interfacing method to maximize cell compatibility, interface longevity, 
and nanoparticle electrical properties. The systems presented here can be used to create 
viable neuroelectronic interfaces, and additional improvements will enable the 
development of long-term devices. 
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Chapter 6: Integration of Receptor-Scale Interfaces into Micron-Scale 
Technology5 
Technologies that monitor the nerve membrane potential will be required for 
establishing the ability of quantum dot-receptor connections to modulate neuron 
response. Here, we discuss two possible measurement systems to demonstrate interface 
functionality. Both of these strategies create whole-cell, micron-scale connections 
between cells and electrical components. Integration of our interface with these systems 
would demonstrate compatibility of our device with existing technologies.  
The first of these techniques, whole-cell clamping, measures membrane potential 
changes as small as a few mV. [1-2] However, the method has many limitations that 
make integration with quantum dot-receptor interfaces difficult. We discuss the theory of 
this system, general operation, and our attempts to integrate this method with our 
interface.  
The second strategy, the microelectrode array (MEA), has been used extensively 
to make connections with individual neurons and tissue. Devices are manufactured using 
photolithography techniques, [2] which limit feature size based on the wavelength of 
light used. While devices are suitable for demonstrating interface functionality, additional 
technologies are required to create smaller scale interfaces. We developed a method of 
patterning MEAs using electron beam lithography, which can produce features as small 
as 10 nm. [3] Here, we describe our efforts to develop MEAs and their potential 
integration with quantum dot-receptor interfaces.  
                                                 
5 Portions of this material have been previously published in the following reference: J.O. Winter, C.E. 
Flynn, T.S. Liu, A.M. Belcher, B.A. Korgel, C.E. Schmidt. “Semiconductor–Neural Interfaces.” 
Proceedings of the Second Joint EMBS/BMES Conference and the 24th Annual Conference and the 




6.1 LIMITATIONS TO INTEGRATION WITH EXISTING M EASUREMENT 
TECHNOLOGIES 
We have developed several interfacing techniques that create connections 
between quantum dots and the nerve cell membrane (Chapters 4, 5). To demonstrate 
electrical connectivity of these junctions, measurement technologies are required. The 
two most commonly used strategies to monitor nerve membrane potential are whole-cell 
clamping and microelectrode arrays (Chapter 1, Section 1.2). These methods require 
micron-scale interactions with the entire cell body, and may prove difficult to integrate 
with our interface. [2] Additionally, the development of long-term devices incorporating 
micron-scale and receptor-scale connections is limited by the stability of quantum dot–
receptor and cell–device junctions. Thus, integration of our interfaces with existing 
technologies is challenging. 
 
6.1.1 Whole-Cell Clamping 
The whole-cell clamping technique, a variation of patch-clamp, was first 
demonstrated by Sakmann and Neher in 1976. [1] The technique uses electrolyte-
containing micropipettes to form close interfaces with cell membrane surfaces. The 
membrane is then broken through the application of gentle suction, allowing contact with 
the intracellular fluid. This electrical continuity allows voltage or current changes in the 
cell to be monitored. A microscope and micropositioners are required to place electrodes 
on cell surfaces, whereas a pre-amplifier, oscilloscope, and computer are necessary to 
monitor cell signals. The method is extremely sensitive, displaying signal strengths up to 
two orders of magnitude higher than MEAs, [1-2] and is designed to measure electrical 
properties of single cells. 
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Whole-cell clamping offers many benefits for the monitoring of receptor-scale 
interfaces. The method is extremely sensitive, permitting measurement of the small 
voltage changes that might be produced at quantum dot-receptor junctions. [1-2] 
Additionally, it is compatible with both recognition-molecule directed and tethered-film 
interfaces. Whole-cell clamping measures the properties of single cells; and through the 
use of the patch-clamp variation of this technique, could even monitor individual 
receptors. [1] However, this technique could not be used to create electrical devices. 
Whole-cell clamping is an invasive technique. Cells are impaled with microelectrodes 
and survive at most a few hours. Thus, long-term devices could not be constructed. 
Additionally, the technique is difficult to master and requires equipment than can cost in 
excess of $100,000 for a single recording chamber.  
 
6.1.2 Microelectrode Arrays 
Microelectrode arrays (MEAs) have been employed since the 1970’s as prosthetic 
devices, measurement systems, and computational components. [2] They typically consist 
of a series of planar electrodes manufactured on glass or silicon substrates. The first 
arrays were manufactured on glass using micropatterned gold electrodes to monitor 
neuronal signals. [4-5] However, modern devices are fabricated on silicon using 
photolithography, insulated with polyimide [6] or silicon nitride [7-9], and consist of 
titanium/gold [6], titanium/iridium [7], or titanium/platinum electrodes [8]. 
These arrays interact with cells through induction, and signal strength is 
dependant upon distance. [10] Cell placement on electrode surfaces occurs through 
random cell culture or direct placement using micropositioners. This produces substantial 
separation distances, up to a 100 nm, [11] limiting the sensitivity of MEA devices. These 
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large separation distances result from the presence of the glycocalix, a sugar coating on 
the membrane surface. [12] Because of this limitation, MEAs are most commonly used to 
monitor action potentials, and not subthreshold potentials (i.e., potentials below the 15 
mV change required for an action potential to fire). To increase sensitivity and encourage 
proper cell placement, surfaces are sometimes modified with biomolecules, including 
laminin [13], polylysine [14], and axonin-1 [15]. Even with biomolecule modification, 
the smallest separation distances displayed are ~ 40 nm.  [15] Additionally, the presence 
of biomolecules produced changes in cell morphology and neurite outgrowth patterns that 
may not be desirable. [13-15] Thus, these coatings cannot ensure intimate electrical 
contact between the device and the cell. 
Microelectrode arrays have some advantages to their incorporation with quantum 
dot–receptor devices. MEAs produce non-invasive, long-term interfaces with neurons, 
and have produced functional devices with lifetimes as long as 75 days. [9] They are easy 
to fabricate, requiring access to micron-scale fabrication facilities, and can even be 
obtained commercially.  
However, several challenges persist to integration with quantum dot–receptor 
interfaces. Because arrays are fixed structures, tethered quantum dot films may prove 
difficult to construct on their surfaces. Films deposition before electrode patterning is 
complicated because the UV wavelengths (i.e. < 350 nm) used to create MEAs can 
destroy film adhesion molecules [16] and promote photooxidation of quantum dots. [17] 
Film application after electrode patterning is also challenging because uniform films will 
cover the electrodes and may interfere with their function, whereas patterned films will 
require alignment with underlying electrode structures. Also, the use of biomolecules to 
promote MEA adhesion may interfere with film formation. Thus, of the interfacing 
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strategies that we explored (Chapter 5), MEAs are most compatible with recognition-
molecule directed binding. 
The main limitation in the use of MEAs is their lack of sensitivity. Devices cannot 
detect subthreshold signals, [2] and the signals produced by quantum dot- interfaces may 
fall in this range. Sensitivity could be improved by increasing the charge density of 
electrode materials; however, no suitable material has yet been identified. [18] The 
second route to increase sensitivity is to increase the contact surface area of the electrode. 
This demands large electrodes (i.e., order of 100  µm) that may interact with multiple cell 
bodies, a requirement that negates the benefits of receptor-scale interfaces.  
 
6.1.3 Comparison of Measurement Technologies 
Given the limitations of both whole-cell clamping and MEA technologies, the 
best option is to optimize quantum dot–receptor interfaces using more sensitive 
technologies (i.e., whole-cell clamping), and then to incorporate these improved 
interfaces into MEAs for long-term applications. Using this strategy, whole-cell clamping 
will be employed to establish the ability of quantum dots to modulate neuronal receptors. 
The technique can be applied to either biorecognition-mediated or tethered-film 
interfaces, allowing maximal application of our previously developed systems. Interfaces 
can then be optimized to obtain junctions capable of producing action potentials. We 
present our initial efforts to integrate quantum dot-receptor interfaces with whole-cell 
clamping measurement technologies.  
Once optimized, quantum dot-receptor interfaces can be combined with MEAs to 
produce long-term devices. One of the major limitations in developing devices is the 
large feature size used in photolithography. [2] These sizes are suitable for demonstrating 
the ability of quantum dots to modulate the nerve membrane potential, but will ultimately 
 216 
need to be decreased to take advantage of a receptor-scale interface. We demonstrate an 
alternative MEA patterning technique, electron beam lithography (EBL), which can 
produce feature sizes as small as 10 nm. [3] This technique could ultimately be used to 
produce subcellular contact with receptor-scale interfaces. This approach, combining 
whole-cell clamping for optimization of quantum dot-receptor interfaces and MEAs for 
long-term integration, offers an excellent strategy for development of a composite device. 
 
6.2 MATERIALS AND M ETHODS 
6.2.1 Whole-Cell Clamping 
6.2.1.1 Cell Culture 
Rat neonatal cortical cells (RNCs) were harvested and cultured as described 
previously (Chapter 5, Section 5.2.2.2). Cells were isola ted from 1-2 day old rat pups, 
dissociated, and plated on laminin and poly-D-lysine-prepared substrates. The size of the 
whole-cell clamping recording chamber required substrates of 12 mm-diameter or less. 
Cells were cultured on 12 mm, No. 1, coverslips in supplemented neurobasal medium 
(Chapter 5, Table VII). Medium was changed 24 hours after harvest, and every 2 days 
thereafter. 
 
6.2.1.2 Preparing for Whole-Cell Clamping 
Capillary pipettes (TW150F-4, World Precision Instruments) were prepared as 
electrodes. Pipettes were fire-polished in a Bunsen burner and pulled to target resistances 
of 1-5 MΩ (see below) using a Sutter Flaming-Brown P-97 pipette puller. Meanwhile, 
aCSF (Chapter 5, Table VIII) was introduced into the recording chamber. The solution 
was continuously cycled using a perfusion pump for introduction and a vacuum aspirator 
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for removal. The aCSF solution was oxidized by bubbling with 5% CO2 / 95% O2 for 10-
15 minutes before exposure to cells, and continuously thereafter.  
Next, pipettes with electrode resistances in the target range (i.e., 1-5 mΩ) were 
identified. First, pipettes were filled with intracellular solution (Table IX) and mounted 
on the electrode holder, taking care not to damage the AgCl wire. Then, the electrode tip 
was slowly lowered into the aCSF solution, at which point the amplifier voltage declined. 
After re-zeroing, a 5 mV square wave was applied using the amplifier seal-test function, 
and the resulting change in current was determined using an oscilloscope. The electrode 
resistance was calculated using Ohm’s law (i.e., V=IR, where V= 5 x 10-3 for the voltage 
step, I = the measured current, and R is the electrode resistance). Only electrodes with 
resistance values between 1-5 MΩs were used. 
 
Table IX: Intracellular Solution   
Component1 Concentration2 
Potassium Methane Sulfonate 135 mM 
NaCl 12 mM 
EGTA 0.5 mM 
HEPES 10 mM 
Mg-ATP 2 mM 
TRIS-GTP 0.3 mM 
1Obtained from Sigma 
2In distilled, deionized water 
 
6.2.1.3 Monitoring Membrane Potential  
An Olympus BX-50WI focusing head microscope with infrared differential 
interference optics (IR-DIC) and epifluorescence was employed to visualize cells, while 
electrical signals were monitored using Axon Instruments 200B patch clamp amplifier 
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and Digidata data acquisition system. First, 12-mm coverslips containing cells were 
placed in the microscope recording chamber and visualized with a 4X objective. Cells 
were centered in the viewing area with an S and D Instruments MC1000 course 
manipulator connected to the translational stage. An electrode was attached to the 
electrode holder and lowered into solution. Using the 4X objective and a programmable 
micromanipulator (Sutter Instruments, MP-285), the electrode was positioned next to a 
target cell. Then, switching to a 40X water immersion objective, the electrode was 
lowered onto the cell until a slight indentation in its surface was apparent.  
Next, a 5 mV square wave was applied using the amplifier seal test function. 
Gentle suction to the cell surface was given by mouth, using tubing attached to the 
electrode holder. This produced a decline in the current, indicating the presence of a seal. 
When a seal was obtained, a holding voltage of -60 mV was applied, until current 
dropped to < 0.020 nA, indicating the formation of a strong (i.e., GΩ) seal. Capacitance 
was reduced using the amplifier capacitance adjustment knob, and 60-cycle line noise 
was diminished with a Humbug (Quest Scientific). 
Then, additional suction was applied to break open the cell membrane, producing 
an increase in current. Control of the cell membrane potential was then transferred to the  
computer, and was modulated and monitored using ClampX software (Axon 
Instruments). Cells were exposed to negative voltage steps, to determine the access 
resistance (i.e., the resistance between the interior of the pipette and the cell cytoplasm). 
Access resistances were calculated in a similar manner to electrode resistance.  A known 
voltage step was applied, the resulting current measured, and the resistance calculated 
using Ohm’s law. Resistances less than 40 MΩ (e.g., average 10-20 MΩ) were used to 
ensure a good seal. Then, the cell was switched from voltage clamp (i.e., voltage 
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controlled by computer, monitoring cell current) to current clamp (i.e., current controlled 
by computer monitoring cell voltage) mode for monitoring the static membrane potential. 
 
6.2.1.4 Optical Excitation 
Optical excitation of the nanoparticles was supplied at the excitation wavelength 
of the nanoparticles (e.g., 362 nm for CdS pH 7 control particles (see Chapter 3)) using a 
computer controlled monochromator and delivered via liquid light guide (Cairn 
Instruments, London, UK). Cells placed in a BX-50WI microscope (Olympus, Tokyo, 
Japan) fitted with a Fura-2 fluorescence cube set (Omega Optical, Brattleboro, VT), 
which lacked an excitation filter. This allowed excitation wavelengths to be tuned, while 
providing visualization of fluorescence. 
 
6.2.2 Microelectrode Array 
6.2.2.1 Array Design 
 Arrays were manufactured on 1 cm square silicon chips cut from 4-6 inch wafers 
with thermally-grown 100 nm SiO 2 layers obtained from Wafer World. Arrays were 
composed of four 20 x 20 micron square electrodes attached to a triangular linker arm 
(Figure 58). This electrode size was chosen because the average cell body size for RNCs 
is ~20 µm, allowing single cell contact. The bond pads consisted of 2 x 2 mm squares 
attached to 2 x 1 mm linker arms that terminated in the linker-electrode structure. Both 
the triangular and rectangular linker structures were insulated with poly (methyl 
methacrylate) (PMMA), which also served as the EBL resist. Ultimately, the MEA 












A four-electrode microelectrode array was created on a silicon substrate. Electrodes were 










Ultimately, MEAs will be integrated with quantum dot–receptor interfaces through direct 
cell culture. Cloning rings glued on MEA surfaces isolate cells from bond pads, which 
are connected to a two-point probe for monitoring. Quantum dots are applied to cell 
surfaces using biorecognition molecule-directed binding, and are excited externally with 
either a laser or UV lamp. 
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Arrays were manufactured in a three-step process. First, bond pads were patterned 
using metal evaporation (Section 6.2.2.2). Gold was deposited onto silicon chips through 
a stainless steel mask fabricated using a drill bit. Then, electrodes were attached to the 
bond-pads using PMMA deposition (Section 6.2.2.3), EBL (Section 6.2.2.4), metal 
evaporation (Section 6.2.2.2), and PMMA-metal removal (Section 6.2.2.5). Finally, the 
electrodes were de-insulated using PMMA deposition (Section 6.2.2.3) and EBL (Section 
6.2.2.4). Arrays were visualized using SEM (Section 6.2.2.7). 
 
6.2.2.2 Metal Deposition 
Evaporation was used to produce both bond pads and electrodes. Chips were 
placed in a Denton DV502 Vacuum Chamber Evaporator for gold deposition. Contact 
with a conductive surface was required to prevent overheating. The evaporator was 
placed under vacuum until pressures of at least 4 x 10-6 torr were achieved, typically 1.5 
hours. Then, 10 nm of chromium was deposited (deposition current ~60 A) from a Cr-
plated tungsten-rod source (RD Mathis Company), followed by 200 nm of gold deposited 
(deposition current ~100 A) from gold wire (Hauser and Miller). Thicknesses were 
determined using an XTM/2 deposition monitor with a quartz crystal transducer (Kurt J. 
Lesker, Co.).  
 
6.2.2.3 PMMA Deposition 
Silicon chips were prepared for PMMA deposition by sonicating for 10 minutes in 
successive solutions of acetone, ethanol, and distilled, deionized water (ddH2O). Chips 
were blown dry with nitrogen or argon. Then, 100  µL of 4% or 6% 950,000 MW PMMA 
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in chlorobenzene (Microchem) was applied using a P-6204-A spin-coater (Specialty 
Coating Systems) at 3000 rpm, for 60 s. For electrodes, 4% PMMA was used, producing 
thicknesses of ~400 nm, as measured with an Alphastep 200 profilometer (KLA-Tencor). 
The thickness was optimized to be sufficiently large to permit lift-off, but small enough 
to minimize charging effects in the e-beam. For insulation, 6% PMMA was used, 
producing film a thickness of ~1 µm. Thick films were required to provide insulation 
between the gold wires and the conductive cell culture medium. Following spin coating, 
both PMMA layers were annealed at 170ºC for one hour. 
 
6.2.2.4 Electron Beam Lithography (EBL) 
Annealed samples were placed in the sample chamber of a Raith 50 EBL unit 
with LaB6 source. The chip was aligned using its edges (electrodes) or pre-existing 
alignment marks (insulation; Figure 58). The instrument was focused and stigmation 
adjusted until a round spot size of ~100 nm was obtained. Then, the pattern was written 
using a current of 100 pA, 20 kV accelerating voltage, 6 pixel step size, 220 µA/cm2 dose 
(for PMMA resist), and a 45 s exposure time. Patterns were generated in 400 µm write-
fields. Following e-beam exposure, current was reduced to 10 pA and a single image of 
one write field was obtained to confirm e-beam development of the PMMA resist. 
Then, the chip was retrieved from the sample chamber and placed in a 1:3 methyl 
isobutyl ketone (MIBK):isopropanol (IPA) solution for 45 seconds to remove developed 
PMMA. Next, the chip was exposed to an absolute solution of IPA for at least 1 minute 
to quench the reaction. Chips were blown dry with compressed air, nitrogen, or argon. At 
this point, the chip was viewed using a scanning electron microscope (SEM, Section 
6.2.2.7) or stereomicroscope to confirm the presence of the pattern. 
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6.2.2.5 PMMA-Metal Removal 
Metallization (Section 6.2.2.2) produces a solid layer of chromium/gold on top of 
the mask. To remove the unnecessary gold and mask, the chips were sonicated in acetone 
for 5 minutes. Longer sonication times interfered with gold adhesion to the silicon. 
Removal of PMMA/gold was confirmed using SEM (Section 6.2.2.7). Incomplete 
removal typically resulted from an inadequate resist thickness, which allowed the 
formation of bridges between gold on the mask and gold within the patterned regions. 
 
6.2.2.6 Cell Culture 
To demonstrate device compatibility with cells, SK-N-SH cells were cultured on a 
PMMA test pattern (PMMA = 2%, 60 nm thickness) following the previously described 
protocol (Chapter 4, Section 4.3.3.6). To prepare chips for cell culture, they were first UV 
irradiated overnight. Then, freshly passaged SK-N-SH cells were plated on their surfaces 
at standard densities (~1 X 104 cells/cm2). Cells were fed every two days with DMEM 
medium, supplemented with 10% FBS, and 1% penicillin-streptomycin. After four days, 
cells were observed using SEM (Section 6.2.2.7)  
 
6.2.2.7 SEM 
Images of MEAs were obtained with a LEO 1530 scanning electron microscope 
(SEM). Accelerating voltages of 2 kV and 10 kV were used to view cells and electrodes, 
respectively. Electrode samples did not require preparation and were viewed after 
electrode patterning and resist de-insulation to confirm MEA creation. However, cell-
coated chips required additional processing for SEM visualization. Cells were fixed and 
dehydrated to provide compatibility with the SEM vacuum chamber. Cells cultured on 
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chip surfaces were rinsed twice with PBS and fixed through exposure to 3.7% 
formaldehyde solution (Table X) for 15 minutes. Then, cells were dehydrated using a 
series of increasing ethanolic solutions in water (Table XI). Remaining absolute ethanol 
was removed through overnight evaporation in a standard chemical hood. To increase 
electron density and allow for SEM viewing, cells were plated with chromium using a 
deposition chamber. Cells cultured on chips were then viewed using SEM to confirm 
adhesion and spreading on PMMA surfaces. 
 
Table X: 3.7% Formaldehyde Solution   
Component1 Amount 
Paraformaldehyde 0.8 g 
Sucrose 0.8 g 
1 M NaOH 133  µL 
PBS 10 mL 
1Heat solution to 60 ºC to dissolve 
paraformaldehyde 
 
Table XI: Cell Dehydration Protocol   
Solution Time 
Water 30 minutes 
Water 30 minutes 
30% Ethanol 10 minutes 
30% Ethanol 10 minutes 
60% Ethanol 10 minutes 
90% Ethanol 10 minutes 
95% Ethanol 10 minutes 
100% Ethanol 10 minutes 
100% Ethanol 10 minutes 
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6.3 RESULTS AND DISCUSSION 
6.3.1 Whole-Cell Clamping 
Initially, we attempted to perform whole-cell clamping measurements us ing 
unlabeled SK-N-SH neuroblastoma cells. While we were able to generate action 
potentials through computerized voltage steps (Figure 60), cells died shortly after 
electrical stimulation. It is believed that this occurred because immortalized cell lines do 
not necessarily display the normal complement of ion channels. [19-21] Thus, the voltage 
steps required to produce action potential are excessive and damaging. Given these 
results, SK-N-SH cells are not a good model system for evaluating quantum dot-receptor 




Figure 60: Whole-Cell Clamping 
Measurement of SK-N-SH 
Neuroblastoma Cell. 
A positive voltage step was 
applied to an SK-N-SH 
neuroblastoma cell, producing 
an action potential. Initial spikes 
indicate capacitive charging of 
the membrane surface, followed 
by the opening of K+ channels. 
The cell remains at this elevated 
voltage until the computer 
stimulation is removed. Then, 









To address these limitations, we selected a different cell type, rat neonatal cortical 
cells (RNCs). Our efforts to adapt quantum dot interfacing to this cell type were 
described in detail elsewhere (Chapter 5). The major limitations of integrating those 
interfaces with whole-cell clamping have been the sensitivity of the cells and the lack of 
interface longevity. RNC cells, as a primary cell line, are not as hardy or adhesive as 
immortal cells. [22] It can take several days for cells to extend neurites and as much as a 
week to form good contacts with the culture dish (or coverslip).  
For recognition molecule directed binding this is not problematic. Cells may be 







whole-cell clamping experiments. However, since endocytosis occurs within 30 minutes 
of labeling (Chapter 5, Section 5.3.1.5) and the formation of whole-cell clamping 
connections to a viable cell requires 20 minutes, the window for data collection is 
extremely short.  
An obvious solution would be to attach quantum dots to ion channels directly, as 
these are recycled at a low rate. [23] There are many commercially available antibodies 
to ion channels; however, we have been unable to locate ones that bind the extracellular 
surface without activating or inactivating the channel. This is most likely because the 
extracellular surface of ion channels is highly glycosylated, [24] reducing the number of 
potential antibody binding sites. Additionally, we have been unable to identify a peptide 
that binds channels without producing activation or inactivation. This is not surprising as 
the majority of ion channel research is directed to pharmacology; most researchers are 
attempting to chemically modulate ion channel behavior and seek peptides for this 
purpose. [e.g., 25-28] One possibility would be to generate genetically engineered ion 
channels that display an adjacent binding site that could be targeted with an antibody (e.g. 
green fluorescent protein [29]). Alternatively, techniques like phage display [30] could be 
used to identify suitable binding peptides. 
Tethered-films offer only a slight improvement to recognition molecule directed 
binding. The primary difficulty of tethered quantum dot films is their lack of stability in 
cell culture (Chapter 5, Section 5.3.3.5). Our films demonstrated good stability in 
medium, but were intact for only 1-3 days in culture. Because RNCs require 5-7 days to 
form good focal adhesions to the culture substrate, it is difficult to conduct whole-cell 
clamping experiments in this time window.  
Improving film stability is critical for obtaining satisfactory measurements. Film 
stability could be increased through a variety of approaches. Particles that are more stable 
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to oxidative conditions encountered in culture could be employed (e.g., CdSe [31]). 
Ligand affinity to the quantum dot surface could be increased, or protective shells could 
be applied to quantum dot surfaces. [17] However, the use of shells is limited as they 
must not increase the separation distance between the particle core and the receptor, and 
they must not interfere with electrical signal conduction. Thus far, we have been unable 
to produce an interface with stability sufficient for whole-cell clamping measurements; 
however, optimization of either recognition molecule directed binding or tethered films 
should produce the desired longevity. 
 
6.3.2 Microelectrode Array 
6.3.2.1 Electrodes 
As discussed previously (Section 6.1.3), MEAs are unlikely to measure low 
voltage potential changes that might be encountered during quantum dot–receptor 
interface optimization. However, they provide an excellent platform for long-term device 
development. To demonstrate the potential to integrate quantum dot–receptor interfaces 
with MEA technologies, we designed and fabricated four-electrode MEAs using electron 
beam lithography (EBL). EBL offers substantial advantages over photolithography. Most 
notably, substantially smaller feature sizes can be obtained (i.e., 10 nm for e-beam vs. 90 
 nm for best practice photolithography [3]). Thus, future devices could be manufactured 
with components that are capable of subcellular interfacing, unlike the micron-scale 
feature sizes currently used. Additionally, EBL offers ease of fabrication because the 
resist can be used as an insulator without the need of additional processing steps. [PMMA 
resists display a similar dielectric constant to polyimide, a typically used insulating 
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material [32].] Our electrode design consisted of a three-step process (6.2.2.1) that 
produced de-insulated gold electrode surfaces (Figure 61). 
Figure 61: SEM Image of EBL 
Patterned MEA Electrode. 
Gold electrodes were patterned using 
EBL and metal deposition. The 
electrode surface (square) appears 
brighter than surrounding structures 
because it is de- insulated.  Remaining 
structures (i.e. triangular linker arm 
and bond pad (right)) are insulated 
with PMMA. Crosses surrounding the 
electrode are alignment marks, and are 






6.3.2.2 Cell Culture on MEAs 
To demonstrate the ability of PMMA-insulated electrodes to support cell culture, 
we plated SK-N-SH cells on a test pattern consisting of boxes and lines. Cells were 
grown in culture for four days, fixed, dehydrated and observed (Section 6.2.2.6). Cells 
were able to adhere and spread on PMMA insulated surfaces (Figure 62). Additionally, 
cells demonstrated an affinity for the test pattern, extending neurites along the lines of 
exposed silicon. Cracking of the PMMA insulation resulted from both the thin layer used 
to test cell compatibility (i.e., 60 nm thicknesses) and the drying process used to prepare 
cells for SEM. Cracking was not demonstrated in patterns with the 1  µm thicknesses 
used for insulation. Thus, PMMA-insulated surfaces were found to support cell culture 





Figure 62: Cell Culture on MEAs. 
(A,B) SEM images of SK-N-SH neuroblastoma cells grown on a test pattern of lines and 
squares. Dark regions are PMMA, light regions are underlying silicon. Cells adhere and 
spread on PMMA surfaces. 
 
6.4 SUMMARY OF INTEGRATION CHALLENGES  
These results demonstrate the difficulty of incorporating quantum dot–receptor 
interfaces with micron-scale neuroelectronic devices. The most sensitive technique, 
whole-cell clamping, requires stable quantum dot-cell junctions that are challenging to 
obtain. Directly- labeled cells quickly internalize particles, while tethered-films do not 
remain intact long enough to support optimal cell adhesion. Optimization of interfacing 
technologies can address these limitations; however, whole-cell clamping is invasive [1] 
and cannot be used to create long-term neuroelectronic devices. On the other hand, 
MEAs, which can be used over months, [9] do not have the sensitivity to detect 
subthreshold signals. [2] Thus, they cannot be used for device optimization. Additionally, 
the creation of tethered films on MEA surfaces is difficult, as MEA patterning can 
interfere with film formation. [16-17] Further, MEAs do not current ly display feature 
 A B 
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sizes that take advantage of receptor-scale interfacing. [2] We have demonstrated an 
alternative patterning technique, electron beam lithography that could be used to produce 
cell-culture compatible MEAs with small feature sizes. However, development of tighter 
cell-electrode contacts or novel materials is required to increase the sensitivity of the 
system. Ultimately, these findings demonstrate that the creation of receptor-scale 
interfaces integrated with current micron-scale technologies is a challenging process. 
 
6.5 CONCLUSIONS  
Measurement systems are required to demonstrate the functionality of quantum 
dot–receptor interfaces. The two most commonly used technologies, whole-cell clamping 
and MEAs [1-2], depend upon micron-scale contacts with cell surfaces for measurement. 
Integration of both systems with our interface is difficult. Whole-cell clamping displays 
excellent sensitivity, but is invasive and requires a stable interface. [1] MEAs cannot 
detect subthreshold signals  [2] and are not compatible with tethered film quantum dot 
interfaces. [16-17] 
To measure electrical connectivity of quantum dot-receptor interfaces, we 
attempted to integrate recognition-molecule directed and tethered-film junctions with 
whole-cell clamping systems. Our initial efforts were unsuccessful, primarily because of 
poor quantum dot–cell interface stability. However, recognition molecule directed 
binding could be improved by conjugation to fixed receptors, while the stability of 
tethered-films can be increased through greater passivation of the quantum dot surface.  
[17] Thus, whole-cell clamping can ultimately be used to measure interface functionality. 
Additionally, we developed a system to support the future integration of quantum 
dot–receptor interfaces into long-term devices. We fabricated four-electrode MEAs using 
electron beam lithography, which can produce feature sizes as small as 10 nm. [3] These 
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small sizes will allow for the development devices that can take full advantage of the 
receptor-scale interface. Thus, we have addressed some of the initial limitations to 
creating integrated receptor-scale neuroelectronic systems. 
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Chapter 7: Conclusions and Future Directions 
7.1 SUMMARY OF DISSERTATION 
Current neuroelectronic interfaces (e.g., microelectrode arrays and whole-cell 
clamping) have been used as methods to study neuron function and signaling, prosthetic 
devices, and computational systems. However, these micron-scale devices fail to take 
advantage of cell-signaling capabilities, which occur primarily through nanometer-sized 
proteins on the membrane surface. Present technologies cannot be manufactured in this 
size range, and alternative strategies are needed for receptor-scale interfacing. 
We have presented one possible system, utilizing semiconductor quantum dots, to 
create these interfaces. Quantum dots are small crystalline solids with diameters less than 
the Bohr exciton length. They exhibit quantum confinement of the exciton, which 
produces interesting optical and electrical phenomena. Among these features, quantum 
dots can convert light into electrical signals through the formation of a dipole moment, 
electron transfer, and heat production. Additionally, quantum dots exhibit fluorescent 
emission with high quantum yields, narrow bandwidths, continuous excitation past the 
onset of absorption, and photostability. Because of these advantages, quantum dots have 
been used as components of both optoelectronic and biological systems. Our interface 
endeavors to combine these two applications to create a biological system with electrical 
capabilities. Although several modes of interaction between quantum dots and cells are 
possible, we believe that the electric field produced by the transition dipole moment is of 
suitable magnitude to modulate ion channels. Thus, utilizing optically excited quantum 
dots, it may be possible to modulate neuronal signaling. 
To test our hypothesis, we created CdS quantum dots through arrested 
precipitation in aqueous media. We systematically varied our synthesis conditions to 
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identify particles with electrical properties optimal for the neuroelectronic interface 
(Chapter 3). Specifically, we examined the effect of increased reactant concentrations, 
altered reactant and ligand ratios, ligand length and charge, and pH on the resultant 
quantum dot absorbance and photoluminescence spectra. These optical spectra have been 
linked to the desired electrical properties for our interface. We found that reactant 
concentrations have little effect on the size and fluorescent emission wavelengths of the 
quantum dots produced, but particle stability in aqueous solution was reduced at higher 
concentrations. This is most likely a result of charge screening caused by increased salt 
concentrations, but could also occur because of increased solute concentrations in the 
fluid. On the other hand, reactant and ligand ratios, ligand length, and pH all produced 
changes in particle size and fluorescence. Larger particles were created at the smallest 
reactant ratios and ligand length, and at the highest ligand ratio and pH. Quantum yield 
was maximal at intermediate sizes, possibly indicating the formation of 
thermodynamically stable complexes that mediate controlled particle growth. Our results 
for ligand charge supported this theory. Quantum dot size trends for acid, base, and 
neutral ligands resembled published equilibrium data for aqueous CdS complexes. These 
equilibrium complexes may serve as intermediates to quantum dot formation. Based on 
our synthesis results, we determined that intermediate-sized particles with maximal 
quantum yields were most suitable for development of a neuroelectronic interface. 
Next, we created close-range interactions between quantum dots and SK-N-SH 
neuroblastoma cells using biorecognition molecules (Chapter 4). Antibodies were 
coupled to quantum dot surfaces through the formation of amide bonds, and their 
presence was confirmed with UV-visible absorbance spectra. Antibody-quantum dot 
conjugates were exposed to cells, producing a fluorescent signal at their receptor targets. 
The conjugation chemistry for antibody linkage resulted in the formation of aggregates 
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and produced ~15 nm (per antibody used) separation distances between cells and the 
particles. To create more intimate contacts with cell surfaces, we utilized thiolated-
peptides as quantum dot capping ligands. These peptides contained a recognition 
sequence capable of binding cell surface receptors. The presence of peptides was 
confirmed using UV-visible absorbance spectra, fluorescence anisotropy, and FTIR 
spectroscopy. Quantum dot-peptide conjugates exposed to cells produced much more 
discrete and intimate binding than the antibody system. Thus, we demonstrated two 
routes to forming nanoparticle interfaces with cell surfaces at close-proximity. 
However, the interfaces were developed using an immortal cell line, which does 
not possess normal neuronal signaling patterns and also proliferates continuously. These 
features are not favorable for neuroelectronic device formation; therefore, we optimized 
our interface for use with a primary cell line: rat neonatal cortical cells (RNCs) (Chapter 
5). These optimizations revealed the extreme sensitivity of primary cells to environmental 
conditions and potential toxicity of quantum dots that was not apparent in studies 
employing immortalized cell lines, which are more robust than primary cell lines. 
Additionally, we found that quantum dots bound to cell surface receptors are likely to 
undergo receptor-mediated endocytosis, which can begin in as little as 5 minutes. Thus, 
the use of recognition-molecule directed binding for quantum dot attachment is limited to 
those receptors that are not recycled or are recycled at extremely low rates. Although ion 
channels are in this category, we have had great difficulty in identifying a suitable 
molecule to produce external binding that does not also modulate channel behavior.  
Therefore, we identified two alternative systems, using non-specific interactions, 
to form quantum dot–receptor interfaces (Chapter 5). The first of these employed non-
specific affinities between quantum dots and cells to create delocalized binding of the 
membrane surface. This binding is believed to be the result of reduced ligand passivation 
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at the particle core. While binding was achieved, endocytosis occurred for these particles 
as well, limiting the application of this method in long-term neuroelectronic interface 
formation. Thus, we developed a third system using tethered quantum dot films to 
produce connections with cell surfaces. These films demonstrated good stability in cell 
culture medium, but exhibited diminished, red-shifted fluorescence when exposed to 
cells. This appears to be the result of Ostwald ripening, which may be accelerated by 
oxidizing agents released from cells. Additional nanoparticle passivation should produce 
more stable surfaces. Thus, two additional modes of nanocrystal-cell binding were 
created, one of which was suitable for neuroelectronic interface formation. 
Finally, we attempted to confirm electrical continuity of our interfaces with two 
existing micron-scale measurement technologies (Chapter 6), whole-cell clamping and 
microelectrode arrays (MEAs). Measurement of our interfaces with the whole-cell 
clamping measurement technique proved difficult because it is an invasive, time-
consuming process that requires stable interactions between quantum dots, cells, and the 
substrate. Our attempts to create stable interactions were limited at the quantum dot–cell 
interface and we suggested possible improvements. Additionally, we evidenced the 
potential to integrate our interface into a long-term device using the MEA platform. We 
created MEAs with electron beam lithography, which can produce substantially smaller 
feature sizes than the photolithography techniques currently used. These devices can 
ultimately display feature sizes that are compatible with receptor-scale interfacing. 
Whole-cell clamping and MEAs, combined with improvements in quantum dot–cell 
junction stability, will allow us to confirm interface electrical connectivity and to create 
new device classes. 
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7.2 CONCLUSIONS  
Our results demonstrated three methods for forming quantum dot–cell interfaces 
with close-range proximity. Our primary interest was the establishment of electrical 
connectivity between quantum dots and individual cell receptors, but our techniques have 
far-reaching applications. Quantum dot-antibody binding is now used extensively for cell 
labeling [1], and quantum dot-peptide binding [2] has been employed to target specific 
structures in vivo. Additionally, the close interfaces formed by our methods are ideal for 
specialized fluorescence techniques, including FRET [3], which can be used in basic 
biological investigations [4] and in the development of biosensors [5]. Thus, our methods 
have already produced an impact in the field, and continue to display the potential for 
future application. 
 One of the most significant findings in our research was the extreme difficulty of 
optimizing quantum dots for both electrical and biological applications. In general, the 
highest quality Cd-based quantum dots produced are CdSe/ZnS core-shell particles, [6] 
and biological applications have employed these almost exclusively. [7] However, the 
presence of a ZnS shell may interfere with the formation of a dipole moment in the core, 
and almost certainly increases the separation distance between the dipole and the cell 
surface. Thus, these particles are not ideal for neuroelectronic interfaces. The alternatives, 
core-only particles, have been shown to be more susceptible to photooxidation, reducing 
nanoparticle stability and releasing toxic Cd2+ ions from their surfaces. [8] Particles can 
be protected by adding a biocompatible shell, but the most commonly used materials 
(e.g., SiO 2 [9], BSA [10], etc.) are insulating, and would reduce electrical signaling. 
Therefore, alternative passivation methods are needed.  
Through careful optimization of quantum dots and their cellular interfaces, these 
challenges can be surmounted, allowing receptor-scale neuroelectronic devices to be 
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developed. These devices will provide new insights into cell signaling and propagation. 
Additionally, they can be incorporated with micron-scale technologies to create new 
kinds of prosthetic devices. For example, the current retinal implant devices utilize 16 
pixels that interact with multiple cell bodies. [11] Quantum dot–receptor interfaces would 
allow subcellular contacts, providing unprecedented fine control. Further, new 
computational devices could be created that more closely approximate true neural 
networking. Ultimately, these devices display enormous potential to impact many fields 
and present a rich and challenging field of study. 
 
7.3 FUTURE DIRECTIONS 
7.3.1 Alternative Nanomaterials 
Quantum dots exhibit strong dipole moments because of charge separation in the 
exciton, which results from trapping of the electron. However, round particles do not 
display an oriented moment, [12] meaning that the alignment of adjacent particles may 
produce destructive, as well as constructive electrical interference. Systems that promote 
particle alignment may create a greater collective dipole moment than individually-bound 
quantum dots.  [13] This could be accomplished through controlled organization of 
quantum dots on self-assembled monolayers, using some of the tethering techniques that 
we developed. Additionally, the orientation of quantum dot dipole moments has been 
linked to the direction of particle growth. [14] Therefore, asymmetrical quantum dots 
[15] and nanowires [16] may offer a strategy to control dipole presentation to the cell. 
These additional organization techniques and nanomaterials should be explored as 
alternatives to individually-bound quantum dots. 
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7.3.2 Increasing Quantum Dot Resistance to Oxidation 
The most significant limitation in the development of quantum dot–receptor 
interfaces is the competition between the desires for well-protected particles that are 
resistant to photo-oxidation and for uninsulated, electrically active particles that can 
conduct signals from their surfaces. Innovative passivation of nanocrystal surfaces is the 
key to overcoming this challenge. The passivation layer should be sufficiently dense to 
provide a barrier to oxygen diffusion, but must also allow for transmission of electric 
fields produced in the particle core. 
Typically particles are passivated with monodentate thiols, [17] which contain 
one binding site for the particle core. During photooxidation, these thiols are converted to 
disulfides, with the nanocrystal acting as a catalyst. Depending upon their solubility, the 
disulfides may disassociate from the nanocrystal surface. Further, the particle core is also 
photooxidized, most likely at the group VI atomic sites. [18] These oxidation products 
break away from the nanocrystal surface, producing dangling Cd2+ sites. Eventually, the 
ligands detach, the particle degrades, and the quantum dots precipitate from solution. 
This results in several undesirable outcomes. Free Cd2+, which is extremely toxic to cells, 
is released into solution. [8] The particle decay produces photobleaching and a loss of 
electrical properties. Thus, for stable nanoparticle-receptor interfaces, it is imperative to 
limit oxidation of the particle surface. 
Several strategies could meet these needs. One possibility is to use multidentate 
ligands, which provide additional binding sites to the nanoparticle surface. This would 
further anchor the ligand, and also reduce the number of non-bonded core surface atoms 
available for photooxidation reactions. However, multidentate ligands must be chosen 
with care. There is some evidence that dithiols are not good choices because of their 
propensity to form disulfides, and their inefficient packing densities on the particle 
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surface. [17] A better approach might be to utilize ligands with different binding 
affinities. For example, adenosine triphosphate binds nanoparticle cores at nitrogen and 
phosphate groups. [19] This dual affinity may prove more resistant to oxidation than 
single thiols. 
Alternatively, nanocrystals could be passivated with short-chain ligands that are 
cross- linked increasing the barrier to oxygen diffusion. [8] Cysteine-acrylamide has 
already been used for this purpose, producing nanoparticles that are stable for over a year. 
[20] Mercaptoacetic acid chains could be modified to contain methacrylate end-groups 
that could be cross- linked using UV irradiation, [21] or cysteamine-capped particles 
could be cross- linked using glutaraldehyde. [22] The primary limitation of this approach 
is the need for short monomers to promote intimate quantum dot–cell connections and 
minimize insulation of the electrical signal.  
Finally, thick conducting shells could be used to provide oxidation barriers, 
although it is unclear how a conducting shell would affect particle electrical properties. 
Electrically conducting polymers, such as polypyrrole, offer one strategy to conductive 
nanoparticle passivation. [23] Alternatively, metal shells could be constructed directly on 
quantum dot surfaces. Conductive gold nanoshells have been grown on silica [24] and 
polystyrene [25] nanoparticles, and copper has been deposited on copper oxide [26]. 
Although metal shells have not been demonstrated on semiconductor quantum dots, there 
is no theoretical barrier to their creation. [26] 
These strategies provide novel means to protect particles from oxidation, while 
promoting electrical interfacing. Additionally, these methods would impact other fields, 
as oxidation is a problem that extends beyond neuroelectronic interfacing. Oxidation 
limits the use of nanoparticles in biological systems and in aqueous media. [17, 27] The 
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reduction of particle oxidation could provide significant advances in nanocrystal 
biocompatibility and stability. 
 
7.3.3 Improving Interfacing Techniques 
The interface techniques that we developed have some limitations to integration 
into long-term neuroelectronic interfaces. Recognition molecule directed binding and 
non-specific binding to the cell surface are both subject to endocytotic uptake. To address 
this limitation it is necessary to use recognition molecules that target fixed receptors or 
receptors recycled at a low rate. Ion channels may provide a suitable target, but no 
strategy has been demonstrated for binding ion channels directly without activating or 
inactivating the channel. Commercially available proteins bind almost exclusively to the 
intracellular surface, which is inaccessible in living systems; and peptides that bind 
channels modulate channel behavior. However, viable peptides could be identified using 
phage display [28]. This technique scans libraries of peptides for affinity to a known 
surface, and would offer a strategy for relatively rapid identification of ion channel 
binding peptides. Alternatively, ion channels could be genetically mutated to express an 
additional protein in close proximity. For example, if a channel was engineered to be co-
expressed with green fluorescent protein (GFP) [29], antibodies to GFP could be used to 
produce intimate binding to ion channels. 
The most promising strategy for producing controlled interfaces that are not 
subject to endocytosis is the formation of tethered quantum dot films. We demonstrated 
some initial films, and with improvements in quantum dot resistance to photooxidation, 
these films offer significant advantages to direct labeling of the cell surface. Tethered-
films allow for alignment of nanoparticle dipoles [13],  and if combined with asymmetric 
materials, significant increases in electrical signaling could result. Functionalization with 
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biomolecules and patterning of the films could provide localized binding, similar to that 
of the biorecognition molecule approach. Together with improvements in quantum dot 
resistance to photooxidation, these strategies provide a straightforward means to 
developing long-term neuroelectronic interfaces. 
 
7.3.4 A Look to the Future  
Neuroelectronic interfaces with receptor-scale precision would offer significant 
advancement in the fields of neuroscience, medicine, and computation. These devices 
represent the first opportunity to probe neuronal signaling at the receptor level over the 
long-term. This capability provides a means to answer one of the most important 
questions in neuroscience: What is the nature of learning and memory? Additionally, new 
classes of prosthetic devices could be developed. While present devices target large 
deficits in neuronal function (i.e., loss of sight, hearing, sensation, motion), new devices 
could address more localized problems in neuronal signaling, including treatment of 
Parkinson’s disease and epilepsy. Further, new kinds of computational systems could be 
developed to harness the computation power of a single cell and its receptors. Thus, 
receptor-scale neuroelectronic interfaces are poised to make a dramatic impact in the 
fields of biotechnology and medicine. 
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Glossary 
 Absorbance Onset- The wavelength at which absorbance of light begins. 
 Access Resistance- In whole-cell clamping, this describes the resistance between 
a capillary pipette and the cytoplasm. 
Action Potential- A rapid change in cell membrane potential due to the influx of 
Na+ ions. Action potentials occur when the resting potential of a cell rises 15 mV or 
more. 
Alpha Helix- A secondary protein structure consisting of amino acids rotated into 
a helical formation. 
Amino Acids -The smallest unit of a protein. Amino acids consist of the 
H2NCHRCOOH chemical structure, where R changes. There are 20 naturally occurring R 
groups. 
Antibody- A molecule produced by the immune system to bind foreign elements 
in the body. Antibodies can be created with binding capability for any protein in a cell by 
injecting that protein into a foreign host. The antibodies are then isolated from the host, 
and used to bind the selected target. 
Arrested Precipitation- A process by which normally insoluble compounds are 
suspended in a solvent. This occurs by binding of an external water-soluble component to 
the insoluble compound. 
Artificial Cerebrospinal Fluid (aCSF)- A buffer used to approximate conditions 
in the cerebrospinal cavity. 
Avidin- A protein present in egg white that forms strong connections to biotin, 
another biomolecule. 
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Axon- Extensions from neuron cell bodies that carry signals away from the cell. 
Axons can extend for up to 1 meter from the cell body before making contact with 
muscle targets. 
Axon Hillock- A region near the cell body that integrates synaptic potentials. 
This region contains an abundance of voltage-gated ion channels. If the combined signal 
received is sufficient to open these channels, the cell will fire an action potential. 
Band Gap- A region between the conduction and valence energy bands of a 
material. Because this region contains no potential energy states, electron occupation is 
forbidden. The band gap energy is the amount of energy required to transverse this band. 
Bioconjugation- Chemical processes used to attach substances, such as 
fluorescent dyes, to biological molecules. 
Bioelectronic Interfaces- Interfaces formed between biological entities and 
electrical components. 
Biorecognition Molecule- Generic term for a molecule that demonstrates specific 
interactions with a cell component. Biorecognition molecules include peptides, 
antibodies, proteins, and DNA/RNA fragments. These molecules interact with a cellular 
component through hydrophobic/hydrophilic, electrostatic, hydrogen bonding, and van 
der Waals interactions. Interactions are usually very specific, with a single atom change 
capable of disrupting binding in many cases. 
Biotin- A coenzyme in carbon dioxide transfer that binds strongly to avidin. 
β-Mercaptoethanol- See Mercaptoethanol. 
Bohr Exciton- The normal separation distance of an exciton (electron-hole pair) 
in a bulk material. 
Bond Pad- The point of external electrical contact in a microelectrode array. 
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Bovine Serum Albumin (BSA)- A protein solution derived from a cow that is 
used to reduce non-specific binding to cells and tissue. 
Carbodiimide - See EDC. 
Carcinogen- A compound which has been shown to cause cancer in certain tests. 
Cell Surface Receptor- Receptors for biorecognition molecules that are found on 
the cell surface. Typically, these receptors are engaged in cell motility, adhesion, and 
growth functions. 
Central Nervous System (CNS)- The central nervous system includes the brain, 
spinal cord, and auditory, visual, and olfactory systems. The central nervous system also 
contains all neuron cell bodies. 
Cochlear Implant- The cochlear implant interfaces nerve endings in the cochlea 
(inner ear) with a microelectrode array. A receiver worn externally interprets sound 
waves and converts them to electrical signals. These signals are then transmitted via radio 
waves to the microelectrode array. These signals are then sent to the brain via the nerve 
endings. The device is designed to bypass damaged mechanical components and cochlear 
hair cells in the inner ear. 
Coherent Light- Light that possess the same wavelength and phase. 
Colloids - A mixture of solvent and particulates that is in between a true solution 
and a suspension. Colloidal particles are usually less than 1 micron in diameter. 
Conduction Band- A potential energy band containing the excited state energy 
values available for electron occupation. 
Core-Shell Nanoparticles- Nanoparticles that are passivated by an inorganic 
shell. The shell material is usually a wider-band gap (i.e., more insulating material) than 
that used for the core. 
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Coulombic Attractions - Attraction of positive and negative charges to each 
other. 
Cysteine - An amino acid (peptide component) with an SH functional group as the 
R group. 
De Broglie Wavelength- The wavelength of a particle with momentum. 
Debye Length- The length over which an electrical signal drops by a value of e 
from its initial value.  
Debye Screening- Electrical interactions are screened in the presence of 
additional charges, reducing their strength. This reduction can be described by the Debye 
length. 
Dendrite- Short neuronal extension that carries signals toward a nerve cell. 
Dipole Moment- Charge separation in a molecule. Dipole moments may be 
permanent, created by defects in a material, or transient, occurring upon excitation. 
DNA- A molecule composed of nucleotides which contains the blueprint for 
protein production. 
EDC- 1-Ethyl-3-(3-Dimethylaminopropyl)-Carbodiimide Hydrochloride (see 
Figure 1A for structure). This chemical is commonly used to form amide (or peptide) 
bonds between carboxyl and amine groups. 
Effective Mass- An approximation used to account for the effect of neighboring 
atoms and electrons in a crystal lattice in free electron equations. 
Electrical Induction- A process where charge accumulation of one type attracts 
charges of the opposite type, usually across a membrane. 
Electric Dipole Moment- A charge separation in a molecule that results in a 
magnetic or electric field between the poles of separation. Dipoles may be transient or 
permanent. 
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Electrode Resistance- The resistance of an electrode to current flow. In whole-
cell clamping, this is directly related to the diameter of the capillary pipette employed. 
Electron Beam Lithography (EBL)- A patterning technique that uses focused 
electron beams (provided by an SEM) to expose electron-sensitive resists. 
Electron Decay- The decay of an excited electron from a state in the conduction 
band to a state in the valence band. 
Electron-Hole Recombination- The combination of an excited electron in the 
conduction band and a hole in the valence band. This event usually produces an emitted 
photon with an energy value equivalent to the band gap. 
Electron Transfer- A process by which an excited electron can be transferred 
from the lowest energy state in the conduction band of one material to a lower energy 
state in the conduction band of a second material. 
Electrostatic Attractions - See Coulombic Attractions. 
Endocytosis- A process by which the cell recycles its membrane and receptors. 
This process is used to engulf molecules on or near the particle surface. 
Endocytosis, Receptor-Mediated- Endocytosis that is initiated by the binding to 
a ligand to a class of membrane-bound receptors. 
Energy States- See Potential Energy States. 
Energy Bands - Continuous bands of potential energy values that may be 
occupied by excited electrons. Bands are formed by overlapping potential energy states. 
Exciton- An electron-hole pair coupled by Coulombic attractions. 
Extracellular Matrix (ECM)- The protein matrix that surrounds cells. ECM is 
made of many proteins including fibronectin, laminin, elastin, and collagen. 
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Fab Fragment- The smallest portion of an antibody that maintains recognition 
capabilities. Fab fragments are comprised of the short arms of an antibody and average 5 
nm in length. 
Fibroblast- A cell type common in connective tissue. Fibroblasts are known for 
cell adhesion and a well-spread morphology. 
Fluorescence Anisotropy- A spectral technique that evaluates polarization of 
emitted light. This technique is used to evaluate the bulk of fluorescent molecules. 
Heavier molecules display a greater degree of anisotropy in their fluorescence as a result 
of a low tumbling rate in solution. 
Fluorescence Microscopy- Microscopy observing the output of fluorescent light 
rather than transmitted light. An excitation light source impacts the object in question, 
while the fluorescent output of the object is observed. Excitation wavelengths are filtered 
from the output so that only light related to the object is observed. 
Fluorescence Resonance Energy Transfer (FRET)- The transfer of an excited 
electron from a donor material to an acceptor material. Fluorescence in the donor is 
quenched, and fluorescence in the acceptor may be produced. 
Fluorescent Labels- Fluorescent molecules used to label components of cells. 
Fluorophore - A fluorescent molecule. 
Formaldehyde - A fixative used to cross-link cells and preserve their structure for 
later analysis. 
Fourier Transform Infrared Spectroscopy (FTIR)- An analytical technique 
that examines the molecular absorption or transmittance of light in the infrared region of 
the electromagnetic spectrum (i.e., wavelengths > 800 nm wavelength). 
Glia- Support cells in the nervous system. Examples of glia include 
oligodendrocytes, astrocytes, and Schwann cells. 
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Glycine - An amino acid (peptide component) with an H functional group as the R 
group. 
Glycocalix- A protective sugar coating found on the outside of cells. 
Green Fluorescent Protein (GFP)- A protein, produced by jellyfish, that 
produces a green fluorescent product when expressed. GFP is commonly used as a 
marker in genetically engineered species to confirm transfection. 
Hepatocytes- Liver cells. 
Hole- A positive charge in a crystal lattice resulting from the absence of an 
electron. 
Immortal Cells- Cells that have divide continuously. These cells are either 
obtained from cancerous tumors or transformed using mutagenic agents. Immortal cells 
are often altered by the transformation process and do not behave entirely like their 
normal counterparts. 
Immunoglobulin G- An antibody class that binds to foreign proteins. 
Immunocytochemistry- A technique used to stain cellular components using 
antibodies. Antibodies known to bind the component in question are conjugated to 
reporter molecules (e.g., fluorescent dyes). If the antibody binds the cellular component 
in question the reporter molecule is activated. 
Immunofluorescence- A form of immunocytochemistry employing fluorescent 
molecules. 
in Situ- A process that occurs in place.  
in Vitro- An experiment that takes place using cultured cells, external to an 
animal. 
in Vivo- An experiment that occurs in an animal model. 
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Induction- An electrical response that occurs through indirect interactions 
produced by electrostatic attractions. An electrical signal can be transferred from a 
primary object to a second object without contact. 
Integrin- A class of cell surface receptors that promote cell-ECM adhesion.  
Ion Channel- A protein containing four repeated subunits with six 
transmembrane segments that regulates ion flow through nerve cells. 
Ion Channel, Ligand-Gated- An ion channel that opens in response to ligand 
binding. Typically these channels open in response to neurotransmitters, allowing Ca2+ 
ions to enter the cell, producing synaptic potentials. 
Ion Channel, Voltage-Gated- An ion channel that opens in response to a change 
in the cell membrane potential. Most voltage-gated channels pass Na2+ ions and open in 
response to synaptic potentials. 
Laminin- One type of ECM protein. Laminin has been shown to play a role in 
neurite extension and cell adhesion. It is composed of an alpha and beta chain and 
promotes cell adhesion. 
Laser- A device which produces coherent emitted light of a single wavelength. 
Lasers produces light through stimulated emission, emission created by excited electron 
adsorption of a photon at the same wavelength as would be emitted during electron-hole 
recombination. 
Ligand- A molecule that binds to a particular binding site. In biological systems, 
typically refers to the component that binds a receptor with high affinity. For quantum 
dots, refers to the outer coating of the particle that binds the particle core. 
Ligand Exchange- A process used to exchange nanocrystal passivating ligands. 
Particles are usually dried and resuspended in a gross excess of the target ligand, thus 
driving desorption of the existing surface ligand. 
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Light Emitting Diodes (LEDs)- Materials that emit light upon application of a 
voltage. This occurs when a positively charged and negatively charged material (p-n 
junction) are brought into contact with each other. The application of a voltage promotes 
recombination of the positive and negative charges producing emitted light. 
Membrane Potential- The natural voltage potential that occurs across the cell 
membrane due to intracellular-extracellular charge separation. For mammalian cells, the 
resting potential is –70 mV. Increases of 15 mV or greater will cause the cell to fire an 
action potential. 
Mercaptoacetic Acid (MAA)- Nanocrystal passivating ligand containing thiol 
and carboxyl end groups. [HSCH2COOH] 
Mercaptoethanol (MBE)- Nanocrystal passivating ligand containing thiol and 
alcohol end groups [HS(CH2)2OH] 
Mercaptoethylamine (MEA, Cysteamine)- Nanocrystal passivating ligand 
containing thiol and amine end groups. [HS(CH2)2NH2] 
Mercaptopropionic Acid (MPA)- Nanocrystal passivating ligand containing 
thiol and carboxyl end groups. [HS(CH2)2COOH] 
Microelectrode Arrays (MEAs)- Arrays of electrodes constructed on glass or 
silicon surfaces used to measure neuronal action potentials. The electrodes are usually 
from 10-100 microns in size. The most common type of array consists of platinized-gold 
contacts on glass substrates. 
Monodentate Ligands - Ligands containing a single binding site for a 
nanoparticle surface. 
Multidentate Ligands - Ligands containing multiple binding sites for the 
nanocrystal surface. 
Nanocrystals- Crystalline particles smaller than 100 nm in diameter. 
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Nanoparticles- Particles smaller than 100 nm in diameter. 
Neural Networks- Computational platforms that attempt to emulate neuronal 
signaling. 
Neurite- Generic term for neuronal extension. Neurites can be either axons or 
dendrites. 
Neuroelectronic Devices- Devices that integrate neurons with electrical 
technologies. Examples include prosthetic devices, microelectrode arrays, and biosensors. 
Neurotransmitter- A ligand that is released at the synaptic terminal. 
Neurotransmitters bind ligand-gated ion channels initiating membrane potential changes 
at the post-synaptic neuron. 
Neuron- The primary cell of the nervous system. Neurons are responsible for 
transmitting and interpreting electrical signals. 
Nerve- Nerves consist of axon bundles extending from the central nervous 
system. 
Non-Radiative Energy Loss- The loss of energy from an excited electron 
through mechanisms other than photon emission. For example, energy could be lost 
through crystal vibrations. 
Nucleotide - The smallest components of DNA and RNA. Nucleotides include 
adenine, cytosine, guanine, thymine, and uracil. 
Oligonucleotide - A molecule containing a small number of nucleotides. 
Optoelectronic Devices- Devices which interconvert light and electricity. 
Examples include solar cells, LEDs, and lasers. 
Ostwald Ripening- A process of nanoparticle growth where less 
thermodynamically stable small particles dissolve to promote the growth of large 
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particles. Ostwald ripening is characterized by an increase in the absorbance onset 
wavelength and a red-shift in particle fluorescent emission. 
Papain- A molecule which promotes the break-up of antibodies into light and 
heavy chains. This molecule can be used to produce Fab fragments. 
Passivation- Insulating layers that protect electrical materials from the external 
environment. 
Patch-Clamping Technique - A technique that allows measurement of membrane 
potential changes. An electrolyte-filled micropipette is placed in contact with the cell 
surface. Then a portion of the cell membrane is ripped away from the cell surface. 
Voltage and current measurements may be collected from the removed portion of the 
membrane. 
Peptide - A portion of a protein, composed of several amino acids.  
Peripheral Nervous System (PNS)- Portion of the nervous system that includes 
all extensions from the central nervous system. The peripheral nervous system includes 
only axons, not cell bodies. 
Phage Display- An approach for isolating peptides with specific binding 
affinities. Peptide libraries are screened against a surface. Peptides that do not bind the 
surface are washed away. Binding peptides are selectively removed from the surface 
using pH changes. Tests are repeated until the peptide with the strongest bind ing affinity 
is identified. That peptide is then sequenced and identified. 
Phenotype - The shape and structure displayed by a given cell type. 
Phosphate Buffered Saline  (PBS)- A buffered solution used to approximate 
extracellular fluid. 
Phosphate Buffered Saline, Dulbecco’s (DPBS)- Phosphate buffered saline with 
Ca2+ and Mg2+ ions added to promote cell adhesion. 
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Photobleaching- The loss of fluorescence over time when exposed to excitation 
light. Occurs as a result of molecule-molecule and molecule-solvent interactions that 
result in chemical changes in the molecule. 
Photoluminescence (PL)- Emission of light in response to photon absorption. 
Photoluminescence Emission Bandwidth- The range of wavelengths over which 
fluorescent light is emitted in response to photon absorption. Photoluminescence 
emission wavelengths commonly display a Gaussian distribution. 
Photoluminescence Excitation (PLE)- The range of absorbed wavelengths 
which produce a fluorescent emission response in a molecule. 
Photooxidation- Oxidation of a material that occurs during exposure to light of a 
given wavelength. 
Photovoltaic Devices- See Solar Cells. 
Plasticity- The ability of neurons to alter and form new connections with 
neighboring cells. 
Poly-D-lysine (polylysine)- A chemical consisting of multiple lysine amino acids. 
This chemical adheres to easily to glass and promotes cell adhesion, most likely through 
its abundant positively-charged amine groups. 
Polyimide - A polymer coating used to insulate microelectrode arrays. 
Poly(methyl methacrylate) (PMMA)- A polymeric resist used for electron beam 
lithography. 
Potential Energy States- The energy values which an excited electron may 
assume. These values are dependant upon the composition of the material in question. 
Precursor Decomposition- A quantum dot synthesis approach that utilizes 
reactants that decompose at high temperature. Reactants are heated and then combined to 
produce nanoparticles. 
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Primary Cells- Cells that are isolated directly from tissue. Primary cells usually 
do not divide and have a limited lifetime. 
Probability Distribution Function- See Wavefunction.  
Prosthetic Device- A device designed to replace lost function in the body. 
Quantum Dots- Small clusters of atoms that have a size smaller than their 
exciton. This implies that the particle will behave as a wave, rather than a particle, and 
display quantum mechanical properties. 
Quantum Confinement- Confinement of an electron, hole, or exciton 
wavefunction as a result of particle size. Quantum confinement produces quantum 
mechanical features in nanoparticle electrical and optical behavior. 
Quantum Yield- The number of photons that are released as fluorescent output as 
a percentage of the number of photons absorbed. 
Rat Neonatal Cortical Cells (RNCs)- A primary cell line harvested from the 
cortex of 1-3 day old rat pups. 
Receptor- See Cell Surface Receptor. 
Retinal Implant- The retinal implant interfaces nerve endings in the retina (eye) 
with a microelectrode array. A CCD camera worn by the user interprets light signals and 
recreates the pattern on the array using a laser. The array then transmits signal to nerve 
cells located in the retina. 
RGDS- A peptide known to bind to integrins (i.e., cell surface receptors). The 
peptide is composed of the amino acids arginine-glycine-aspartic acid-serine. 
Scanning Electron Microscopy (SEM)- A microscopy technique that uses 
scattered secondary electrons to form an image of electron dense samples. 
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Schrödinger Equation- An equation that describes the quantum mechanical 
behavior of molecules, particularly the probability of finding an electron in a given 
location at a given time. 
Schlenk Line - A glass manifold that contains access to gas and vacuum lines, 
used to create an oxygen free environment. 
Siloxanes- Molecules containing SiO groups. These molecules bind to glass (i.e., 
SiO2) surfaces. 
SK-N-SH Neuroblastoma Cells- A cancerous, immortal cell line isolated from 
neuroblastoma tumors of a 4-year old human patient. These cells approximate normal 
human brain cells, but do not display all the features of normal tissue. 
Solar Cells- Devices which convert absorbed light into an electrical signal. This 
occurs by extraction of optically excited electrons from the conduction band. 
Spontaneous Emission- See Photoluminescence. 
Stimulated Emission- Photon emission that results from the excited electron 
adsorption of a photon possessing an energy value equivalent to that which would be 
emitted during electron-hole recombination. 
Streptavidin- A biotin binding protein isolated from Streptomyces avidinii. See 
Avidin. 
Synaptic Potential- A change in the neuronal membrane potential produced by 
opening of ligand-gated ion channels. Synaptic potentials do not propagate along dendrite 
lengths, instead traveling through diffusion. Potentials are integrated at the axon hillock. 
Synaptic Terminal- The terminus of an axon that is in synaptic contact with a 
neighboring cell. Neurotransmitters are released from this terminal in response to an 
action potential. 
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Synapse- The region of connection between an axon and dendrite of neighboring 
neurons. 
Trap Energy States- Energy states that are introduced into the forbidden band 
gap region by the presence of crystal defects or impurities. 
Trapped Electron- An electron that occupies a forbidden energy level in the 
band gap. This occurs as a result of crystal defects or contaminants.  
Valence Band- The potential energy band containing ground states for a material. 
Wavefunction- A mathematical function, given by the Shrödinger equation, 
which describes the probability of finding an electron in a given location over time. 
Whole-cell Clamping- A technique for measuring the cell membrane potential. 
An electrolyte-filled micropipette is placed in contact with the cell, and then the 
membrane is ruptured. The pipette is in direct contact with the intracellular fluid. Current  
and voltage changes can then be monitored. 
X-Ray Photoelectron Spectroscopy (XPS)- A spectroscopic technique that can 
determine surface composition based on the energy of photons emitted as a result of the 
photoelectric effect. 
YIGSR- A peptide component of laminin known to bind laminin integrins. It is 
composed of the amino acids tyrosine- isoleucine-glycine-serine-arginine. 
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